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ABSTRACT
This study characterized the oxidative biotransformation capacity o f the hepatic
cytochrome P-450 system o f selected avian species representing the Galliformes
(chicken, turkey and Japanese quail) and Anseriformes (goose, Pekin duck, Khaki
Campbell duck, and Muscovy duck) orders.

Two objectives were addressed; first,

important biotransformation pathways were evaluated in economically m ajor and
m inor food-producing avian species to provide a framework on which to base drug
approval decisions in these species.

Second, the potential use of the selected species

as sentinel organisms utilizing cytochrome P-450 induction as a biomarker of
environmental chemical exposure was evaluated.

The male rat was utilized for the

mammalian model and as a point of reference.

Two groups of animals for each

species were evaluated, a control group, which received no treatment, and a treatment
group which was administered /3-naphthoflavone (/3NF). Investigations included the
quantitation of microsomal protein, cytochrome P-450, NADH- and NADPHcytochrome

c

reductase

activity,

ethoxyresorufin

O-deethylase

activity

and

benzo[<z]pyrene hydroxylase activity with the development o f profiles for four major
metabolites.

\
This study found that constitutive microsomal protein levels, cytochrome P-450
content, NADPH-cytochrome c reductase activities and ethoxyresorufin 0-deethylase
activities were similar among the species studied while NADH-cytochrome c reductase
activities differed. In response to /3NF, microsomal protein levels, cytochrome P-450

content, and ethoxyresorufin 0-deethylase activities were increased but no change was
observed in NADPH- or NADH-cytochrome c reductase activities.

Interspecies

differences were observed in the response of the hepatic microsomal system to /3NF
treatment.

Interspecies differences were also observed in the capacity of the avian hepatic
microsomal system to hydroxylate benzo[a]pyrene and in the effect o f (3NF treatment
upon metabolite production. 3-Hydroxybenzo[a]pyrene was the primary metabolite
produced by all the species studied; interspecies and interorder differences in product
distributions were observed for the 9-hydroxybenzo[a]pyrene, benzo[a]pyrene 7,8dihydrodiol and benzo[a]pyrene 9,10-dihydrodiol metabolites.

1.0.

IN TR O D U C TIO N

The hepatic cytochrome P-450 enzyme system functions in the metabolism of
exogenous as well as endogenous compounds and, therefore, plays a critical role in
controlling the biological activities of drugs, toxins and other xenobiotics. Extensive
research in the biotransformation of xenobiotics has led to recognition o f the biological
importance of this system.

The majority of cytochrome P-450 studies have been

directed at the characterization of the mammalian hepatic microsomal system.
Consequently, relatively little is known about the hepatic cytochrome P-450 system
o f avian species. Hence, further studies on the processes o f xenobiotic metabolismin
avian species were deemed necessary to evaluate potential risks in the use of drugs,
pesticides and other chemicals in the poultry industry and for interpreting responses
o f domestic and wildlife avian species to environmental toxicological challenges.

The present study was conducted to characterize the oxidative capacity o f the hepatic
microsomal systems of Anseriformes and Galliformes birds' utilizing a model
substrate, benzo[a]pyrene (B[a]P). The oxidative metabolic pathways o f B[a]P have
been well described in laboratory rodents and to a lesser extent in birds. Cytochrome
P-450 activities in control and /3-naphthoflavone (/JNF) treated groups of avian species
were measured and comparison of these activities were made between avian species,
between avian orders and between avian species and a mammalian model, the rat.

'The avian species considered were the W hite Leghorn chicken (G allus g a llu s), Japanese quail ( C oturnix
cotu rn ix), turkey (M eleg ris g a llo p a v o ), Khaki Campbell duck (A nscr p la tyrh yn ch o s), Pekin duck (A nser
p la tyrh yn c h o s), M uscovy duck ( C airina m osch ata) and go o se (A n ser an ser).

1
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The resulting database provided the tools to evaluate two distinct areas o f scientific
interest and public concern which may be profoundly affected by the activities o f the
cytochrome P-450 system.

These areas include drug approval processes in minor

food-producing avian species; and the use of domestic avian species as environmental
sentinels for ecotoxicological studies. Two objectives were addressed by this study.
First, an important biotransformation pathway was evaluated in economically major
and m inor food-producing avian species to provide a framework on which to base
drug approval decisions in these species.

Second, the potential use o f the selected

species as sentinel organisms utilizing cytochrome P-450 induction as a biom arker of
environmental chemical exposure was evaluated. The research described herein has
served to initiate a database for addressing these areas for selected avian species.

1.1

Approval o f Minor Use New Animal Drugs

The Food and Drug Administration (FDA) has the responsibility o f ensuring that
animal drugs are effective and safe for their intended use and that food products
derived from medicated animals are safe for human consumption. This responsibility
stems from the 1968 amendment to the Federal Food, Drug and Cosmetic Act which
set forth regulations governing the use of animal drugs (21 C FR 500-599).

These

amendments specifically address the safe and effective use o f animal drugs and the
prevention of unsafe drug residues in products intended for human consumption (Food
and Drug Administration, 1992).

M inor use new animal drugs are defined by the

FD A as drugs "(1) used in minor species of animals or (2) used in animal species for

the control o f a disease that occurs infrequently and in limited geographic areas."
(Food and Drug Administration, 1979; Food and Drug Administration, 1983; 21 CFR
514.1). For purposes of drug approval, the FDA defines minor species as "animals
other than cattle, horses, swine, chickens, turkeys, dogs, and cats" (Food and Drug
Administration, 1979; Food and Drug Administration, 1983; 21 CFR 514.1). Due
to the economic limitations o f the minor species industry, no drugs have received
approval for use in control o f disease in minor avian species.

Lack of treatment in

diseased flocks may result in injury or death of affected individuals and may
potentially result in a significant loss in production, and may eventually present health
hazards to other species or to humans whether by direct or indirect contact, or by
serving as a source of unwholesome food products for human consumers (Food and
Drug Administration, 1983). O f equal concern to regulatory agencies is that use of
non-approved drugs in minor species may result in unexpected or unusual drug
metabolism with bioaccumulation of drug or metabolites and possible development of
organisms resistant to the compound and its marketed analogs (Food and Drug
Administration, 1983).

In recognition of these issues and in an attempt to encourage the submission of
applications for needed minor use drugs, the FDA proposed, in July 1979, to amend
the animal drug regulations (21 CRF 514.1) to provide for the use of supporting safety
and effectiveness data in the approval of new animal drug applications. Concurrent
to the issuance of this proposal, guidelines specifying the types o f data needed to meet
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the requirements of animal safety and effectiveness, as set forth in the Animal Drug
Act, were issued by the FDA.

These guidelines included specific requirements for

studies o f drug applications in domestic ducks and game birds (Food and Drug
Administration, 1979; Food and Drug Administration, 1986; Food and Drug
Administration, 1986a).

In January 1983, the final ruling on new animal drug

applications was issued allowing sponsors, where appropriate, "to use data supporting
an approved major use of a drug to support a new animal drug application for a minor
use o f the same drug" (Food and Drug Administration, 1983).

In general, these

regulations require prior approval of the drug in a major species in conjunction with
supporting metabolic and residue data in the minor species (Juskevich, 1987).

To

further promote drug approval in minor species, the Food and Drug Administration
Center for Veterinary Medicine (FDA/CVM ) is exploring the use of alternative studies
to satisfy the data requirements set forth by the animal drug regulations (Juskevich,
1987).

In support o f this objective, the FDA/CVM sponsored an extramural drug research
program for minor species (Dalvi, 1988; Juskevich, 1987; Teske, 1987; Short et al.,
1988).

The objectives of this program were to "investigate the comparative

physiology, metabolism, pharmacology, and toxicology of major and minor animal
species and to study the applications and limitations o f pharmacokinetic parameters
as a basis for the extrapolation of data from approved major use drugs to minor use
drugs for fish, game birds, goats, rabbits, and similar food animals" (Teske, 1987).

A portion of the FDA/CVM program was implemented as a consortium between
Louisiana State University. Auburn University, University of Illinois, and Mississippi
State University (Teske, 1987).

As part o f the program, a study was conducted on the comparative metabolism and
disposition o f fenbendazole in minor species (Short, et al., 1988). One phase o f this
project included a comparative study o f the metabolism of fenbendazole by the hepatic
microsomal enzyme system of the chicken, turkey, and duck. In summary, dramatic
differences in the rate of p-hydroxylation of fenbendazole were observed among these
avian species. Furtherm ore, the results showed that for the avian subset studied, the
differences in oxidative metabolism were often greater between major species within
an order (chicken and turkey) than between a minor species (duck) and a member of
the major species group of another order.

Studies utilizing model substrates were

conducted to compare a variety o f other microsomal activities in these avian species
and it was found that for the various microsomal activities evaluated, the metabolic
capacity o f the duck was frequently different from that o f the chicken and turkey.
Taken together, these observations necessitated further studies in which certain
metabolic activities o f the avian Galliformes and Anseriformes orders were compared
(Short et al., 1988 and Short, et al., 1988a).

In order to address the need for further information on comparative oxidative
metabolism in minor and major avian species, the research project described in this

dissertation was undertaken. A major objective of this study was to characterize the
aryl hydrocarbon hydroxylase (AHH) activity in Galliformes and Anseriformes birds
utilizing the classical substrate model, benzo[a]pyrene. Characterization of a specific
mixed function monooxygenase (MFO) activity, e.g. aryl hydrocarbon hydroxylation,
has provided data for the estimation of the activity of this system and for the relative
rate o f oxidation o f structurally similar, untested compounds in the represented avian
species (Walker, 1978). Therefore, a major objective o f this research was to provide
information on the cytochrome P-450-dependent metabolic capacity o f seven avian
species for a given class of xenobiotics and to characterize the differences in
metabolism o f model compounds between the species.

This objective was intended

to develop tools to support interpretation o f data submitted for the purpose of
obtaining approval of minor use avian drugs.

1.2

Avian Species as Sentinels in Ecotoxicological Studies

1.2.1

Biological Markers

Chemical contamination of the environment has become a major public concern
throughout the last half century (Basscietto, et al., 1990; Carson, 1962; De Witt,
1955; Harris, et al., 1990; Keith, 1966; Mendelssohn, 1962; Ratcliff, 1967; Peakall,
1967;

Stickel,

1946).

In

recognition

of

this

concern,

the

identification,

characterization, and remediation of hazardous waste sites has become a top priority
of the U.S. Environmental Protection Agency (EPA), which has a major objective of
protecting human health and the environment.

The regulations governing these

activities, the Comprehensive Environmental Response Compensation and Liability
Act (CERCLA), as amended by the Superfund Amendment and Reauthorization Act
(SARA), stipulate that the remedial actions implemented at a hazardous waste site
achieve protection of terrestrial and aquatic organisms (Environmental Protection
Agency, 1989). In an effort to comply with these regulations, considerable attention
has been focused on the assessment of ecological risks (Bascietto, et al., 1990). This
focus has lead to the realization in scientific and regulatory communities that cause
and effect relationships associated with environmental chemical exposures are poorly
understood and that research into environmental toxicology is of paramount
importance for evaluating impacts to ecological systems and for achieving compliance
with environmental regulations.

Utilization o f biological markers in plants and animals (sentinel species) has been
explored as an innovative approach for assessing environmental quality and chemical
exposure (Ahokas, et al., 1976; Beardsley, et al., 1978; Bend, et al., 1977;
Elangbam, et al., 1989; Fossi, et al., 1992; Khattab, et al., 1993; Knight and W alker,
1982a; Kurelec, et al., 1977; Lubet, et al., 1992; M cCarthy and Shugart 1990;
Payne, 1976; Payne, 1977; Peakall, 1967; Peakall et al., 1987; Rattner et al., 1989;
Sandhu and Lower, 1989; Talmage and Walton, 1991; W alker, 1992). A sentinel
species could be any domestic or wild animal, plant or microorganism that can serve
as an indicator of chemical exposure for the purpose of assessing the potential impacts
o f pollution on environmental and human health (EPA, 1991). A sentinel species may

be a organism indigenous to the area o f concern or it may be a "control" organism
confined at the site for the assessment of in-situ exposures (DiGiulio, 1989; Sandhu
and Lower, 1989; Shugart, et al. 1992) . The use of sentinel species for this purpose
is referred to as biological monitoring or biomonitoring (EPA 1991).

The term

biological marker, or biomarker, refers to the measurement of a physiological or
biochemical parameter in individual organisms that serves as a sensitive indicator of
environmental chemical exposure and sublethal stress (Baker, 1989).

The use of

biom arkers in the evaluation of environmental contamination presents a unique
opportunity for environmental managers to obtain information concerning potential
ecological impacts that is not available from the chemical analyses of affected
environmental media and/or tissues of exposed organisms routinely conducted at
hazardous waste sites.

Biomarker data can provide a measure o f environmental

chemical exposure as well as a measure of the magnitude o f the organism ’s response
to the exposure (McCarthy and Shugart 1990; Shugart, et al., 1992). Biornarkers can
validate the biological significance o f chemical exposure on a site-specific basis by
providing evidence that the chemical(s) was absorbed by the organism, distributed
within the tissues, and that a physiological or biochemical response was elicited at a
critical target (McCarthy and Shugart 1990). This type o f data, in conjunction with
laboratory studies, can aid in the elucidation of dose-response relationships for
environmental chemical exposure in wildlife species (Baker, 1989).

Furtherm ore,

biom arkers can provide a biologically relevant indication o f the cumulative effect o f
toxicological and pharmacological interactions associated with exposure to chemical
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mixtures. Biomarkers used in conjunction with site-characterization data can provide
an indication of bioavailability.

These can also provide evidence of exposure to

constituents that are readily metabolized and excreted, and therefore do not
bioaccumulate, such as organophosphates and polycyclic aromatic hydrocarbons
(PAHs) (Baker, 1989; Khattab, et al., 1993; McCarthy and Shugart 1990; Sandhu and
Lower, 1989; Shugart, et al. 1992; Walker, 1992). Biomarker data can also serve as
an indicator that basic physiological or biochemical responses have been disrupted at
defined concentrations of environmental chemicals which in turn can provide valuable
input to the assessment of potential human health hazards associated with a hazardous
waste site (Baker, 1989; McCarthy and Shugart 1990; Sandhu and Lower, 1989).
Based on these considerations, it is apparent that biological monitoring is an
informative and logical complement to routine sampling of contaminated media for the
assessment of ecological impacts resulting from chemical releases to the environment.

1.2.2

Mixed-Function Monooxygenases as Biological Markers

Many common and toxicologically significant contaminants,
polychlorinated

biphenyls,

polybrominated

biphenyls,

such as PAHs,

dioxins,

petroleum

hydrocarbons, organochlorine pesticides, and organophosphorus insecticides, are
known inducers of the MFO system (refer to Section 2.1.3 for a discussion on
induction of the M FO system). Based on this, induction of the M FO system has been
examined for its potential use as a biomarker of environmental exposure to these types
o f constituents (Bend, et al., 1977; DiGiulio, 1989; Kleinow, et al., 1987; Knight and

W alker, 1982a; Jimenez, et al., 1990; Kurelec, et al., 1977; Payne, 1976; Payne,
1977; Payne, J .F ., 1987; Rattner, et al., 1989; Shugart, et al., 1992; W alker and
Ronis, 1989). In addition, there has been considerable interest in the critical role of
the M FO system in xenobiotic detoxification and the toxicological implications
associated with induction of this system (DiGiulio, 1989; Kleinow, et al., 1987;
Hutson, et al., 1991; Rattner, et al., 1989; Payne, J.F ., 1987; Peakall, 1967; Sell,
et al., 1971; W alker, 1991; W alker, et al., 1991; Varanasi, et al., 1987). One area
of interest that has been identified is the potential for increased xenobiotic activation
and the augmentation of toxicity in organisms subjected to chronic environmental
chemical exposures. Other concerns include the induction of tumors and reproductive
impairment due to imbalances in the synthesis and metabolism o f endogenous steroids.
There has also been considerable interest in the potential for exposed organisms to
develop an increased capacity for xenobiotic detoxification with the subsequent
development o f tolerance.

The use o f M FO induction as an indicator of environmental chemical exposure offers
a number o f advantages in biological monitoring programs (Baker, 1989). Induction
of the M FO system is usually detectable in exposed organisms prior to the onset of
more serious pathologies. Therefore this response can be used as an early warning
signal that basic biological processes have been altered as a result o f environmental
chemical exposure.

And, unlike other physiological or biochemical responses to

chemical stress, M FO induction is indicative of a detoxification response (Payne, et
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al., 1987). M ixed-function oxidase studies can be conducted under both laboratory
and field conditions, thus providing an important linkage between traditional toxicity
testing and effects observed under field conditions (Baker, 1989). For example, doseresponse relationships established for MFO induction under laboratory conditions
provide important data for making decisions concerning the "acceptability" or "non
acceptability" o f chemical concentrations detected in the environment. M ixed-function
oxidase measurements made in the field provide an important index o f bioavailability
and biological response for actual exposure conditions (DiGiulio, 1989). And, since
M FO induction is a biochemical response that crosses taxonomic lines, M FO data
obtained in sentinel species can provide inferences for potential human health effects
(Baker, 1989; DiGiulio, 1989).

Characterization of the mixed-function oxygenase system provides inform ation on the
constitutive and inducible properties of the xenobiotic-metabolizing enzymes of
organisms that may be exposed to chemicals released to the environment. Studies o f
this nature can serve to identify species which may be more, or perhaps less,
susceptible to environmental pollution due to the presence, or absence, o f certain
constitutive MFO enzymes or due to the inducibility, or lack of inducibility, of
specific M FO enzymes (Walker, 1978). For example, the increased susceptibility o f
certain avian species to environmental contamination has been linked to speciesspecific characteristics of the hepatic MFO system (Knight and W alker, 1982a;
Peakall, 1967; Knight, e ta l., 1981; Walker, et al. 1987; W alker, et al., 1991). The
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detoxification of environmental contaminants, particularly pesticides, by foodproducing avian species such as the chicken, turkey, goose and duck is also an
important concern for the protection of human health (W alker and Ronis, 1989).

Because M FO induction responds rapidly to changes in environmental quality, it can
serve as an early and sensitive warning system for the detection o f potentially
significant ecological effects due to environmental contamination.

Biological

monitoring of the M FO system o f ecological species can serve as a practical and
economical tool for environmental managers faced with real or perceived concerns
regarding chemicals present at, or migrating from, a hazardous waste site (Payne, et
al., 1987).

Mixed-function oxidase biomarkers can also be used as short-term

indicators o f changes in exposure conditions associated with changes in environmental
quality and thus can serve to delineate boundary limits for point sources of
contamination

and

provide

a practical

method

to

assess

improvements

in

environmental quality associated with remedial efforts (Payne, et a l. , 1987 and Flarris,
et a l., 1990).

1.2.3

Historical Perspective on the Use of M ixed-Function Monooxygenases as
Biological Markers

Induction of the MFO system has been validated as a biomarker of environmental
chemical exposure in a number of wildlife species (Payne, et al., 1987; Lubet, et al.,
1990). The majority of work in the field of M FO biomarkers has focused on aquatic
invertebrates and fish. Research efforts have successfully demonstrated that a variety
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o f organic chemicals, when released into an aquatic system, result in M FO induction
and that the response is of such sensitivity that it can be used to assess w ater quality
overbro ad geographic regions (Kleinow, et al., 1987; Payne, J .F ., 1987; Rattner, et
al., 1989). However, data on the applicability of MFO induction to m onitor exposure
in other wildlife species, such as mammals, birds, reptiles, and amphibians is very
limited (Rattner, et al., 1989).

Interest in the MFO activity o f these groups has

increased in recent times due to the continuing concern over the environmental and
biological fate of lipophilic contaminants released to the environm ent (W alker and
Ronis, 1989). This interest has lead to the characterization of baseline M FO activity
in a variety of avian species (Fossi, et a l., 1986; Peakall, et a l., 1987; Knight and
W alker, 1982; Knight and W alker 1982a; Walker, et al., 1991).

In addition, a

number of environmentally important chemicals have been demonstrated to induce the
hepatic mixed-function oxidase system o f avian species (Pan and Fouts, 1978). This
finding has lead researchers to recognize the applicability of induction o f the avian
monooxygenase system as a biochemical indicator o f environmental chemical exposure
(Ronis and Walker,

1989).

Available data on the effects of environmental

contamination on avian species suggest that the measurement of M FO activity in
embryos and hatchlings may be useful as a biomonitoring tool (Rattner, et a l., 1989;
Hoffman, et a l., 1990). Data generated to date with adult birds indicate that there is
high variability in MFO activity among individuals and therefore, the relationship
between exposure and induction is much less predictable (Buckpitt and Boyd, 1982;
Fossi, et a l., 1990; Peakall, et al., 1987; Rattner, et al., 1989).

Consequently,
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researchers have concluded that a more detailed characterization of the avian MFO
system, and the factors that influence it, is needed before M FO responses can be
applied as a routine biomarker of environmental contamination (Fossi, et a l., 1990;
Jimenez, et al., 1990; Knight, et a l., 1981; Peakall, et a l., 1987; Rattner, et a l.,
1989; Ronis and W alker, 1985).

Substrates that have been used to characterize induction o f the cytochrome P-450
system associated with chemical exposure include cytochrome c (as a measure of
NADPH cytochrome P-450 reductase activity), benzo[a]pyrene, ethoxyresorufin,
pentoxyresorufin,

benzyloxyresorufin,

ethoxycoumarin,

benzphetamine,

aldrin,

aniline, aminopyrine, ethylmorphine, and p-nitroanisole (Lubet, et a l., 1990; Payne,
et a l., 1987; Peakall, et a l., 1986; Rattner, et al., 1989; Simmons and McKee, 1992;
W alker, et al., 1991).

The efficacy of using AHH and 7-ethoxyresorufin-O-

deethylase (EROD) activities as indicators of exposure to 3-methylchloanthrene
(3M C)-type environmental chemical inducers has been established by a number of
investigators for a variety o f wildlife species including birds (Lubet, et a l., 1990;
Simmons and McKee, 1992; Payne, 1976; Rattner, et a l., 1989;

Mineau, et al.,

1984; Gilbertson and Fox, 1977; Ellenton, et a l., 1985; Jewell, et al., 1989; Kleinow,
et a l., 1987; Knight and W alker, 1982; Lubet, 1992; Hoffman, et a l., 1987; Martin,
et al., 1987; W alker, 1991). Due to the degree o f variation in substrate specificity
o f phenobarbital (PB)-inducible forms of cytochrome P-450, pentoxyresorufin and
benzoxyresorufin dealkylase activities have been recommended as sensitive biomarkers
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o f P-450 induction for the detection of exposure to phenobarbital-type environmental
inducers in mammals (Lubet, et al., 1990; Simmons and McKee, 1992). However,
preliminary

studies indicate that the chicken has very low basal levels of

pentoxyresorufin depentylase and that this activity is not inducible by phenobarbital
in this species (Lorr and Bloom, 1987).

Therefore, the use of this activity for

biomonitoring purposes in avian and other nonmammalian species requires further
study.

Hepatic M FO activities are most commonly utilized for biomonitoring

purposes but some work has been done to characterize induction o f M FO systems
present in other tissues such as the skin, kidney, and duodenum (Lubet, et al., 1990;
Knight and W alker, 1982).

The development and inteipretation of biomarker responses and the validation and
application of biomarker-based monitoring is a relatively new field (Shugart, et a l.,
1992) and the association between MFO induction and environmental contamination
has not yet been unequivocally demonstrated (Payne, J.F ., 1987; Rattner, et al.,
1989.) Nevertheless, based on the demonstrated success of using M FO induction as
a biomarker in aquatic species and the encouraging data generated in other wildlife
species, further study on the use of MFO activity as a biomonitoring tool is warranted
(Rattner, et a l., 1989). Numerous directions for future research in wildlife M FO have
been proposed by investigators. Recommendations relevant to this study include:
characterization of constitutive and inducible cytochrome P-450 isozymes in avian
species (Rattner, e ta l., 1989); evaluation o f the inducibility of the hepatic cytochrome

16
P-450 system in avian species (Rattner, et a l., 1989); and investigations o f the
metabolism of environmentally relevant substrates, such as benzo[a]pyrene including
the quantitation o f individual metabolites by HPLC analysis (Payne, et a l., 1987).

The second specific objective o f this study was, therefore, to characterize AHH and
EROD activities in control and |3NF-treated Anseriformes and Galliformes birds to
evaluate the use o f cytochrome P-450 induction as a biomarker of environmental
chemical exposure in avian species.

2.0

LITERATURE REVIEW

2.1

Cytochrome P-450-Dependent Mixed Function Monooxygenase System

The cytochrome P-450 dependent mixed function monooxygenases were first identified
in 1958 as a reduced pigment characterized by a maximum absorption o f light (Soret
band) at 450 nm when bound to carbon monoxide (Klingenberg, 1958; Garfinkle,
1958). In 1961, Omura and Sato provided evidence that this pigment was a new P450 cytochrome of liver microsomes and that the unique spectral properties o f this
hem oprotein were lost when dissociated from the microsomal membrane (Omura and
Sato, 1962; Omura and Sato, 1964, Omura and Sato, 1964a). In 1965, researchers
identified the P-450 hemoprotein as having a role in the microsomal mixed function
monooxygenase system (Cooper, et al., 1965; Omura et al., 1965). Since that time,
the cytochrome P-450 system has been studied intensely leading to the recognized
importance o f the physiological and detoxification roles this system plays within the
biological system (Ioannides, et a l., 1984).

In the physiological role, the M FO

system functions in the biosynthesis and metabolism o f endogenous substances such
as steroid hormones, bile acids, cholesterol, fatty acids, and vitamin D (Coon et al.,
1992; Gonzalez, 1989; Kupfer, 1980; Parke, 1980; Waterman, et al., 1986). In the
detoxification role, the cytochrome P-450 monooxygenases function in the metabolism
o f foreign chemicals, thus providing a protective mechanism against the accumulation
and harmful effects of these chemicals (Ioannides, et al., 1984).
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In general, chemicals that are fat-soluble are readily absorbed through the
gastrointestinal tract, lungs and skin, but are poorly excreted. These chemicals are
metabolized to more water-soluble, polar metabolites. This process serves to enhance
excretion o f the xenobiotics. Biotransformation refers to the metabolic conversion to
which a xenobiotic

is subjected

following

uptake by an

organism.

The

biotransformation o f xenobiotics is catalyzed by a group of enzymes located primarily
in the liver. The biotransformation reactions catalyzed by these enzymes have been
defined by Williams (1959) to include oxidations, reductions, hydrolyses, and
syntheses.

These reactions occur sequentially and the extent to which a substrate

undergoes metabolism is primarily dependent on chemical structure.

Many

xenobiotics are metabolized by a series of reactions which include oxidation,
reduction, and/or hydrolysis followed by a synthetic reaction.

However, there are

some compounds that are metabolized via oxidation, reduction, or hydrolysis and do
not undergo a subsequent synthetic reaction.

Ethanol is an example o f such a

compound. Other compounds, such as phenol, do not undergo oxidation, reduction
or hydrolysis but rather are metabolized solely via synthesis reactions.

Some

chemicals may be sufficiently polar to be excreted unchanged and thereby bypass
metabolism altogether (Williams, 1967).

Oxidation, reduction and hydrolysis

reactions serve 2 functions: (1) to introduce a functional group into the molecule to
enhance the water solubility, and thus, promote excretion, and (2) to transform the
molecule to a suitable substrate for synthetic or conjugation reactions. The synthesis
reactions function to conjugate xenobiotics directly or those metabolites produced by
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the oxidation, reduction or hydrolysis reactions with endogenous moieties to further
enhance water solubility and excretion. Representative compounds or groups involved
in conjugation processes include glucuronic acid, glutathione, glycine, methionine as
well as miscellaneous agents such as acetyl, sulfate and thio group functionalities
(Williams, 1959; Williams 1967). The cytochrome P-450-dependent mixed function
monooxygenases are the major enzyme system involved in oxidation and reduction
biotransformations. Other enzymes which may function in the initial metabolism of
xenobiotics include the flavin-containing monooxygenases; these were historically
referred to as the mixed function amine oxidases (Kimura, et a l., 1983; Sabourin, et
a l., 1984; Zeigler, 1988; Zeigler and Mitchell, 1972).

The mixed function amine

oxidases often compete with cytochrome P-450 monooxygenases in the oxidation of
amine, hydrazine, and organic sulfur compounds.

2.1.1

Properties and Characteristics of the Cytochrome P-450 Monooxygenase
System

The cytochrome P-450 monooxygenase system is a group o f enzymes containing an
iron-protopoiphyrin IX prosthetic group with molecular weights ranging from
approximately 48,000 to 59,000 Daltons (Estabrook, 1984; Schlenk, et a l., 1993).
The cytochrome P-450 system involved in the metabolism o f xenobiotics consists of
cytochrome P-450 and NADPH-cytochrome P-450 reductase at a molecular ratio of
approximately 20 to 1, respectively (Guengerich, 1988). This system is in intimate
association with the phospholipid matrix of the smooth endoplasmic reticulum (Fouts,
1961; Holtzman, et al., 1968).

The association of this system with the membrane
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structure o f the endoplasmic reticulum serves to facilitate the interaction between the
cytochrome P-450 molecule and the associated cytochrome reductase.

It is

hypothesized that the cytochrome P-450 enzymes are integral proteins o f the
membrane structure while the reductase is a peripheral protein anchored to the
membrane surface via a hydrophobic peptide tail (Ito and Sato, 1969).

Two

hypotheses of membrane protein organization have been proposed to account for the
transfer o f electrons from one molecule o f reductase to several molecules of
cytochrome P-450.

Yang and coworkers proposed that the fluid nature o f the

membrane allows the reductase molecule to transverse the membrane surface, allowing
access to multiple P-450 molecules (Chapman, 1975; Lichtenberg, et a l., 1983;
Strobel, et a l., 1970; Yang et a l., 1975). The second hypothesis proposed describes
an organized protein complex within the membrane in which flavoprotein islands are
surrounded peripherally by P-450 molecules (Estabrook, e ta l., 1971; Peterson, et al.,
1978).

Other components of this system include cytochrome b5 and the associated

reductase, NADH-cytochrome b5 reductase (Hildebrant and Estabrook, 1971). The
cytochrome P-450 dependent monooxygenase system is concentrated predominantly
in the liver.

However, cytochrome P-450 enzymes are also present in all other

tissues, with exception of erythrocytes and striated muscle (Guengerich, 1988).

In contrast, the cytochrome P-450 system involved in endogenous metabolism consists
of cytochrome P-450 and may utilize ferredoxin (an iron-sulfur protein), adrenodoxin
o r cytochrome P-450 reductase as the electron donor system (Niramjan et al., 1984).
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These enzymes are located primarily in the mitochondria of steroidogenic tissues such
as the adrenal cortex, testis, ovary, and placenta and in tissues involved in the
metabolism of vitamin D such as the liver, kidney, and intestine (W aterman et al.,
1986).

Some endogenous P-450 isozymes, like the detoxifying P-450s, are located

in the endoplasmic reticulum o f these tissues. The activities o f endogenous P-450s
are under the regulation of tissue-specific peptide hormones (W aterman, et a l. , 1986).
Those located in the mitochondria, in general, have a high degree of catalytic
specificity (Guengerich, 1988).

Cytochrome P-450 exists as a group of multiple isoforms rather than as a single
enzyme form.

These isoforms differ in their physicochemical properties, substrate

specificity, enzyme kinetics, amino acid sequencing and immunological characteristics
(Lu and West,

1980).

A nomenclature system has been developed for the

identification of P-450 isoforms, genes and transcripts based on evolution of the P-450
superfamily (Nebert, et al., 1991).

According to this system, the P-450 gene is

indicated by the italicized root symbol CYP which denotes cytochrome P-450. This
root symbol is followed by an Arabic number which designates the P-450 family. (By
definition, P-450 isoforms within a family exhibit protein sequences which are > 4 0 %
identical.) Following the family designation, the P-450 subfamily is indicated by a
letter. [P-450 isoforms (mammalian) within the same subfamily demonstrate > 5 5 %
hom ology]. Lastly, an Arabic number is used to denote the individual gene within the
subfamily. The same nomenclature, but nonitalicized, is used for the mRNA and gene
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product (isozyme) (Nebert, et a l., 1991). Gene families designated 1 through 4 code
for the cytochrome P-450 enzymes involved in primary xenobiotic metabolism. The
cytochromes P-450 involved in steroid biosynthesis are coded for by gene families 11,
17, 19, 21 and 22 (Gonzalez, 1989).

Individual cytochrome P-450 isoforms exhibit overlapping specificity with regard to
substrate and the type o f oxygenation reaction catalyzed.

However, for certain

substrates and reactions, varying degrees o f selectivity may be demonstrated.

This

characteristic was first identified following the treatment of animals with the PAH
3MC (Conney, 1967; Conney, et a l., 1956; Conney et a l., 1957) and later with PB
(Orrenius, 1965; Orrenius and Erickson, 1966; Orrenius, et a l., 1965). The isoforms
induced following these treatments were noted to have different substrate specificities
as well as different catalytic rates for similar substrates (Alvares et a l., 1967; Sladek
and M annering, 1966; Sladek and Mannering, 1969; Sladek and Mannering, 1969a;
M annering, 1971; and Gnosspelius et a l., 1969). Following the isolation o f these two
hemoproteins and the correlation o f specific catalytic activities with each, it was
recognized that two distinct cytochrome P-450 enzymes, designated as cytochrome P450 (induced by PB) and cytochrome P-448 (induced by 3M C), were present (Sladek
and M annering, 1966).

The two most notable differences in these two families of

cytochromes include differences in substrate binding sites and preference o f substrate.
The cytochrome P-450 isoforms, designated as CYP2B1 and CYP2B2, are inducible
by PB and have a broad substrate specificity with an affinity for non-planar, bulky
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molecules. Specific substrates which interact with isozymes of the CYP2B subfamily,
and are frequently used in the study of P-450 activity, include benzphetamine,
ethylmorphine, aldrin, aminopyrine, and hexobarbital (Hodgson, et a l., 1980).

In

contrast, the isoforms inducible by 3MC and other PAHs, designated as CYP1A1 and
CYP1A2, exhibit a narrow substrate specificity and react readily with rigid, planar
molecules (Lewis, et al., 1986; Safe, et al., 1985). Substrates metabolized by this
subfamily include benzo[a]pyrene, ethoxyresorufin, acetanilide, and p-nitrophenol
(Hodgson, et a l., 1980).

However, differences in substrate specificity have been

noted between the CYP1A1 and CYP1A2 isozymes.

For example, both isozymes

catalyze the metabolism of benzo[a]pyrene, but CYP1A1 has been demonstrated to be
approximately 50 times more active than CYP1A2 (Ryan, et a l., 1980). Conversely,
the CYP1A2 isozyme has been shown to be more active than CYP1A1 in the
metabolism o f aromatic amines (Hammons, et al., 1985).

Another substrate,

ethoxyresorufin, is metabolized almost exclusively by the CYP1A1 isozyme (Burke
and M ayer, 1975; Guengerich, et a l., 1982; Goldstein, et a l., 1982). Substrates such
as aniline, chlorpromazine and zoxazolamine are metabolized by both subfamilies of
cytochromes (Lu and West, 1980).

Since the identification of these two important subfamilies o f isozymes, researchers
have identified over 150 cytochrome P-450 isoforms present in diverse phylogenetic
groups which appear to be highly conserved through evolution (Coon, et a l., 1992).
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The cytochromes P-450 that have been characterized in the rat are presented in Table
1-1 (Nebert, et a l., 1991; Wrighton, 1990).

2 .1 .2

F unctions of th e C ytochrom e P-450 M onooxygenase System

As previously

noted,

a major

role

of the

microsomal

cytochrome

P-450

monooxygenase system is to biotransform fat-soluble xenobiotics to hydrophilic
metabolites that are more

readily excreted.

In this role,

the microsomal

monooxygenases function specifically to catalyze the oxidation o f xenobiotics through
the incorporation of one atom of molecular oxygen into the molecule with the
reduction of the remaining oxygen atom to water (Brodie, et al., 1958; Estabrook and
W erringloer, 1977; Gillette, 1971; Gillette, 1966; Hodgson and Dauterman, 1980).
This oxidation process requires the following sequence of cytochrome P-450 reactions:
(1) Cytochrome P-450, in its oxidized form (Fe+3), reacts with the substrate to form
an enzyme/substrate complex; (2) NADPH, via NADPH-cytochrome P-450 reductase,
transfers an electron to the complex resulting in the reduction o f the heme moiety o f
cytochrome P-450 (F e+2); (3) The reduced cytochrome P-450/substrate complex then
combines with molecular oxygen; (4) NADPH, via NADPH-cytochrome P-450
reductase, transfers a second electron to the complex and both accepted electrons,
through an unknown mechanism, are transferred to the oxygen molecule creating an
unstable, highly-reactive oxygen species.

It is postulated that with some forms o f

cytochrome P-450, and with certain substrates, cytochrome b5 serves as a transferase
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T able 1-1
R at C ytochrom e P-450 Genes an d T h eir P ro d u cts
P-450 G ene1

C om m on N am e(s)1,2

C om m ents1,2,3,4’5

CYP1A1

c, 0NF-B

PAH-inducible form;
benzo[a]pyrene hydroxylase,
ethoxy resorufin-O-deethylase

CYP1A2

P-448, d, HCB

Isosafrole- and PAH-inducible form

CYP2A1

a l, a, 3, UT-F

PAH-inducible form;
testosterone 7a-hydroxylase

CYP2A2

a2, RLM2

CYP2A3

a3

CYP2B1

b, PB-4,PB-B

PB-inducible form

CYP2B2

e, PB-5, PB-D

PB-inducible form

CYP2B3

IIB3

CYP2B8

gene IV

CYP2C6

PB1, k, PB-C, pTF2,
P45k

CYP2C6P

(pseudogene)

CYP2C7

f, p T F l

Constitutive

CYP2C11

h, M -l, 16a, 2c,
UT-A, P450h

Constitutive

CYP2C12

i, 15(8, 2d, UT-1, P450i

Constitutive

CYP2C13

+ g , P450g

Constitutive

CYP2C22

Md

CYP2C22

cll7

CYP2D1

d b l, UT-H

CYP2D2

db2

CYP2D3

db3

CYP2D4

db4

Constitutive and PB-inducible form

Debrisoquine hydroxylase

.......................................

(table continued)
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T able 1-1
R a t C ytochrom e P-450 G enes an d T h eir P roducts
CYP2D5

db5, C M F lb

CYP2E1

j, P450j

CYP2G1

o lfl

CYP3A1

p cn l, PCN-E, P-450p

PB-, macrolide antibiotic-, steroidinducible form;
erythromycin N-demethylase

CYP3A2

pcn2

PB-inducible form;
sex-specific expression (male)

CYP3A9

olf2

CYP4A1

LA,

CYP4A2

IVA2

CYP4A3

IVA3

CYP4A8

PP1

CYP4B1

form 5

CYP7

la

CYP11A1

see

CYP11B1

11/3

CYP11B3

11/3 aldo 2

CYP19

arom

CYP27

25-hydroxylase

'N ebert, et a l., 1991
2W righton, 1990
3Ryan, et a l., 1980
4Guengerich, et a l., 1982
5Goldstein, et a l., 1982

Ethanol-, acetone-, isoniazid,
pyrazole- inducible form;
nitrosodimethylamine N-demethylase
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for the second electron equivalent. In this role, cytochrome b s is thought to accept
an electron from NADH via NADH-cytochrome b5 reductase and to transfer the
electron to the oxygenated substrate/P-450 complex.

The function of the NADH-

cytochrome b5 microsomal electron transport chain system in P-450 catalyzed
reactions has not yet been fully established (Correia and M annering,

1973;

Guengerich, 1988; Hildebrant and Estabrook, 1971; M annering, et a l., 1974; Oshina
and Sato, 1972); (5) One atom of oxygen is then incorporated into the substrate
molecule and the other is reduced to water; (6) The cytochrome P-450/oxygenated
substrate complex dissociates releasing the oxidized substrate metabolite and
regenerating the cytochrome P-450 molecule thus completing the cytochrome P-450
catalytic cycle (Figure 2-1). The term mixed-function monooxygenase or oxidase is
frequently used to refer to the cytochrome P-450 enzymes, due to the requirement of
this system for both molecular oxygen and a reducing agent (Mason, 1957; Mason,
1965).

The rate limiting step in the cytochrome P-450 catalytic cycle varies with the P-450
isoform and the substrate.

Electron transfer (Davies, et a l., 1969), hydrogen

extraction and product release have all been identified as rate-limiting steps in various
cytochrome P-450 reactions (Guengerich, 1991).

The specific types of oxidative

reactions catalyzed by the cytochrome P-450 enzymes include aliphatic and aromatic
hydroxylation, epoxidation, N-, 0 -, 5-dealkylation, deamination, sulfoxidation,
desulfuration, A-hydroxylation, and oxidative dehalogenation (Williams, 1959;
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NADPH
e-

XOH

cyt.P45o reductase

H (3
2H

NADH cyt. b5 reductase

Figure 2-1 Cytochrome P-450 catalytic cycle.
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W illiams, 1967).

To a lesser extent, the cytochrome P-450 monooxygenases also

catalyze reduction reactions. These reactions include azo reduction, aromatic
nitro reduction, and reductive dehalogenation (Williams, 1959).

Depending on the

physicochemical characteristics of the substrate, it has been postulated that all of these
reactions could be catalyzed by a single P-450 isozyme (Guengerich, 1988).

The

biotransformation process, in general, yields products with decreased activity and,
therefore, functions in the role of detoxification. However, with some compounds,
biotransformation reactions result in the formation o f intermediate or final products
that exhibit greater reactivity than the parent compound, thereby serving as a
bioactivation mechanism (Hodgson and Dauterman, 1980).

For example, the

oxygenation of PAHs in conformationally hindered positions, such as the bay region,
results in the formation of reactive epoxide intermediates (Brookes and Lawley, 1964;
Gelboin, 1969; Grover and Sims, 1968; Miller, 1951; Boyland, 1950; Comiey, et al.,
1957; Sims, 1975; Sims, et a l., 1974; Parke and Ioannides, 1984; Ioannides and
Parke, 1987). These electrophilic metabolites react with critical nucleophiles, such
as DNA, which may lead to various pathological processes. Another example is the
conversion of parathion, a relatively nontoxic organophosphate pesticide, to paraoxon
which is a potent inhibitor of cholinesterase activity (Davison, 1954; Davison, 1955).
The bioactivation and/or detoxification o f a xenobiotic is dependent on the catalytic
selectivity of the individual cytochrome P-450 isoforms present.

Therefore, the

balance between the overall activation and detoxification o f a xenobiotic is influenced
by the P-450 isoforms present and the partitioning o f the xenobiotic between the

30
metabolic pathways catalyzed by the different isoforms (Guengerich and Liebler,
1985). Other factors which influence this balance include genetics, age, nutrition, and
the selective induction of cytochrome P-450 isozymes following chemical exposure
(Parke and Ioannides, 1984). For example, an increase in the activity o f the CYP2A
isozyme family (as with induction following PB administration) will result in an
increase in the activation of some compounds such as 2-naphthylamine and
cyclophosphamide while an increase in detoxification will occur with other xenobiotics
such as aflatoxin and A-2-fluorenylacetamide (Hodgson, et a l., 1980).

2 .1.3

Factors Affecting the Cytochrome P-450 Monooxygenase System and
Biotransformation

One o f the most profound factors influencing the biotransformation o f xenobiotics is
the enhancement o f cytochrome P-450 activity following exposure to certain
chemicals. This process is referred to as induction and results from an increase in the
rate o f synthesis o f cytochrome P-450 enzymes (Conney, 1967).

Hundreds of

chemicals have been demonstrated to induce the cytochrome P-450 system, but the
m ost widely studied inducing agents are PAH and PB.

The two major families of

inducible cytochromes associated with these agents include CYP1A (PAH-inducible
isoforms) and CYP2B (PB-inducible isoforms) (Nebert, et al, 1991). In addition to
PAHs,

the

CTP1A1

family

is

induced

by

such

compounds

as

2,3 ,7 ,8 -

tetrachlorodibenzo-p-dioxin (TCDD) (Poland and Glover, 1973), /3NF (Lau and
Strobel,

1982),

planar polyhalogenated biphenyls

(Parkinson,

et al..

1983),

aminoazobenzenes (Degawa, et al., 1985), aromatic amines (Ioannides, et a l., 1984)

and amides (Astrom and DePierre, 1985).

The CYP2B family is also induced by

nonplanar polyhalogenated biphenyls and the pesticides l,l,l-trich lo ro -2 ,2 -b is(p chlorophenyl)-ethane (DDT) and gamma chlordane (Parkinson, et a l.,

1983).

Constitutive levels of these isoforms comprise less that 5 percent of the total hepatic
cytochrome P-450 population (Pickett, et a l., 1981; W axman and W alsh, 1982).
Following induction, their levels may increase 70-fold (Thomas, et a l., 1979;
Thomas, et a l., 1981) and thereby comprise nearly 80 percent o f the total cytochrome
P-450 content (Ioannides and Parke, 1987). In the absence of induction, the P-450
gene subfamily CYP1A is not expressed in extrahepatic tissues while the CYP2B
subfamily is, most notably in the lung and sebaceous glands (Freidberg, et a l., 1990).
Other agents, such as Aroclors (polychlorinated biphenyl mixtures) (Parkinson, et al.,
1983), safrole and isosafrole, and certain drugs (phenothiazine and chlorpromazine)
(Thomas, et a l., 1983), have been demonstrated to act as mixed-type inducers by
producing a response characteristic of both PB and PAH induction (Ioannides and
Parke, 1987). The onset, magnitude and duration of induction may vary with species,
strain and sex o f the organism, type and dose o f chemical received or administered,
the duration of the exposure and the tissue and substrate used to measure
monooxygenase activity (Hodgson et al., 1980). Not all agents capable of inducing
the cytochrome P-450 monooxygenases are readily metabolized by the system
(Guengerich, 1988). In addition, the induction of one family of cytochromes P-450
may result in the suppression of another family of P-450s (Vlasuk, et a l., 1982;
Vlasuk, et al., 1982a, Serabjit-Singh, et al., 1983).
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The mechanism of cytochrome P-450 {CYP1A) induction has been described for PAHtype inducing agents. Initiation of the induction process involves the binding o f the
inducing agent or its metabolite with a cytosolic receptor [referred to as the aromatic
hydrocarbon (Ah) receptor], translocation of the receptor-1 igand complex to the
nucleus,

reaction

of the

complex

with

specific

genomic

recognition

sites,

transcriptional activation of the CYP1A1 and CYP 1A2 genes and a subsequent increase
in cytoplasmic CYP1A1 and CYP1A2 mRNA and associated proteins (Poland and
Glover, 1976; Poland and Knutson, 1982). This regulation process plays an important
role in determining individual risk of environmentally-caused toxicities and cancer
since the CYP1A1 gene product is thought to activate procarcinogens, such as
benzo[a]pyrene (Heidelberger, 1975; Miller, 1970; Kapitulnik, et a l., 1978; Nebert
and Jones, 1989; Sims and Grover, 1974). Induction o f the CYPA gene family by
clofibrate, a hypolipidemic drug, has also been demonstrated to occur via a receptor
(Lalwani, et al., 1987).

For the other types o f inducers, neither receptors nor

molecular mechanisms governing the induction response have been identified.
However, it has been demonstrated that the CYP2 and CYP3 gene families, induced
by PB (Atchison and Adesnik, 1983; Hardwick et a l., 1983; Pike, et a l., 1985) and
dexamethasone (Gonzalez, et a l., 1986; Hardwick, et a l., 1983), respectively, are
regulated via transcriptional activation which leads to an increase in mRNA and
cytochrome P-450 in the endoplasmic reticulum.
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In contrast to the induction process, certain chemicals are able to inhibit cytochrome
P-450 monooxygenase activity and, thus, decrease the ability of the system to
metabolize xenobiotics (Conney, 1967). The inhibition of cytochrome P-450 activity
is dependent on the substrate, type of reaction and type of isozymes present (Lu and
W est, 1980).

For example, ellipticine inhibits B[a]P hydroxylation in constitutive,

PAH-induced and PB-induced microsomes while 7,8-benzoflavone only inhibits this
activity in PAH-induced microsomes (Weibel, et al., 1971). Inhibitory mechanisms
and representative agents that have been described include, but are not limited to,
decreased synthesis of P-450 enzymes (3-am ino-l,2,3-triazole), generalized destruction
o f P-450 (associated with lipid peroxidation), competitive inhibition due to two or
more xenobiotics competing for P-450 active sites (benzene and toluene metabolism),
suicide inhibition due to destruction of the heme moiety by a reactive metabolite (vinyl
chloride, allylisopropylacetamide), coordination to the heme moiety (cyanide);
destruction o f the protein structure by a reactive metabolite (carbon disulfide,
parathion, chloramphenicol), and reduction of P-450 content due to loss of tissue mass
(DeM atteis, 1978; Halpert and Neal, 1980; Guengerich and Strickland, 1977; Oritz
de M ontellano and Correia, 1983; Oritz de Montellano and Mico, 1981; Sato and
Nakajima, 1979).

Other important factors affecting biotransformation include species, strain, sex, age,
and diet.

Quantitative and qualitative differences in the cytochrome P-450

monooxygenase system and associated activities have been described for different
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species and strains.

These differences in the cytochrome P-450 system have been

attributed, in part, to variations in isozymes, content, and response to inducers and
the presence o f enzyme defects or unique enzyme activities in certain species (Walker,
1980; W illiams, 1967).

In addition, variation in genetic constitution among

individuals within a given species or strain has been identified as a source o f variation
in monooxygenase activity. This source of variation is expected to be considerably
greater in wild species than in laboratory species (Walker, 1980). Gender differences
in cytochrome P-450 monooxygenase activity have been noted in several species of
laboratory animals with the most dramatic difference demonstrated in the rat.

The

female rat has been shown to have a 10 to 30 percent lower hepatic microsomal P-450
content than the male rat and also has been observed to have a slower rate of
xenobiotic and drug metabolism. This profound sex-related difference is seen at 4 to
51 weeks of age and is thought to be due to differences in the contribution o f sexspecific P-450 isoforms to the total P-450 content (Chengelis, 1988; Kato and Onoda,
1970; Waxman, et al., 1985). Other sex-related differences that have been observed
in the M FO of the rat include a greater NADPH-cytochrome c reductase activity in
the male at age 12 to 78 weeks, greater NADH-cytochrome c reductase activity in the
female at age 12 to 51 weeks and inconsistent differences in cytochrome bs at various
ages (Chengelis, 1988). Sex-related variations in MFO have been observed in some
species o f birds at certain stages of the reproductive cycle.
findings is presented in Section 2.3.1.

A discussion o f these

Gender differences in cytochrome P-450

content and activity have also been demonstrated in certain fish species.

For these
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species, the females have generally been shown to have lower P-450 content and
activity than their male counterparts (Kleinow, et al., 1987). Differences in age have
also been shown to affect xenobiotic biotransformation.

The cytochrome P-450

monooxygenase system of mammalian species has been shown to develop during the
gestational period with the onset o f maturation beginning at birth (Short, et a l., 1976).
Postnatal patterns o f development have been observed to vary with the species and
substrate studied. For the rat, MFO activity has been shown to peak at 3 weeks of
age in the female and at 3 to 8 weeks of age in the male. Following the peak, activity
levels plateau or decrease in the female and plateau in the male (Short, et a l., 1976).
In contrast to mammals, avian species, in general, have been demonstrated to have
significant M FO activity during the embryonic and neonatal periods. A discussion of
the development of the avian M FO system is presented in Section 2.2.1. Age-related
differences in the cytochrome P-450 content and activity have also been observed in
certain fish species (Kleinow, et a l., 1987). Another age-related difference is seen
in older animals. Older animals have a decreased capacity for biotransformation due
to decreased concentrations of cytochrome P-450 and its associated reductase. Other
related factors may include decreased hepatic and renal blood flow, reduced hepatic
mass and decreased efficiency o f excretory systems (Sipes and Gandolfi, 1991). Diet
can affect biotransformation in a number of ways. Nutritional deficiencies, such as
vitamin, mineral, and protein deficiencies, or periods of starvation, can decrease
cytochrome P-450 monooxygenase activity by reducing basal levels o f cytochrome P450. They can also reduce the availability of high-energy cofactors required in Phase
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II reactions. Furtherm ore, chemicals present in the diet can affect biotransformation
through the induction or inhibition of certain P-450 activities (Walker, 1980; Yang,
et al., 1992). For example, diallyl sulfide, a natural constituent o f garlic (Brady, et
a l., 1991); phenethyl isothiocyanate, a component o f cruceriferous vegetables
(Ishizaki, et a l., 1990); and psoralens, present in edible plants such as parsley, celery,
and parsnip (Tinel, et al., 1987) have been demonstrated to inactivate certain
cytochrome P-450 isozymes. Other dietary components such as ethanol (Koop, et a l.,
1982) and flavinoids (Conney, 1982) have been reported to enhance cytochrome P450-dependent activities.

2.2

Avian Hepatic Cytochrome P-450 M onooxygenase System

The avian hepatic cytochrome P-450 monooxygenase system is similar in structure and
function to the mammalian M FO system.

However, there are some important

differences between these classes in relation to cytochrome P-450 content, activity,
and regulation.

In addition, there are significant qualitative and quantitative

differences in the M FO systems o f species within the Aves class.

2.2.1

Cytochrome P-450 Content and Activity

Mixed function monooxygenase studies have been conducted on a variety o f avian
species which collectively represent 10 orders: Passeriformes, Striges, Accipitres,
Anseriformes,

Pelecaniformes,

Tubinares,

Pygopodes,

Columbiformes

and

Galliformes (Ronis and W alker, 1989; W alker and Ronis, 1989). The majority o f the
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work has focused on characterizing basal M FO activity of birds and lesser amounts
o f data are available on the induced system. The cytochrome P-450 content o f avian
hepatic microsomes has, on average, been shown to be approximately one-fourth that
of mammalian microsomes (W alker and Ronis, 1989). It is currently speculated that
this difference in P-450 content is due to differences in endogenous metabolism
between the avian and mammalian classes.

W ithin the Aves class, Passeriformes

(house sparrow, black bird, African bulbul, starling) and Galliformes (domestic fowl,
grey partridge, red partridge, Japanese quail) demonstrate relatively high levels of
cytochrome P-450 (0.20 to 0.51 and 0.18 to 0.45 nmol P-450/mg protein,
respectively)

while

the

fish-eating

Pelecaniformes

(cormorant,

shag)

and

Charadriformes (puffin, razorbill, guillemot) demonstrate relatively low P-450 levels
(0.15 to 0.29 nmol P-450/mg protein) compared to other orders o f birds (0.3 nmol/
mg protein on average) (Ronis and W alker, 1989; W alker and Ronis, 1989).

In

keeping with the relatively low levels of P-450 in birds, the monooxygenase activities
reported in avian species are, in most cases, lower than those in mammalian species.
W alker and Ronis (1989) reported that, in general, avian monooxygenase activities for
aminopyrine, aldrin, and HCE (l,2 ,3 ,4 ,9 ,9 -h ex ach lo ro -l,4 ,4 a,5 ,6 ,7 ,8 ,8 a-o ctah y d ro exo-7,8-epoxy-1,4-methanonaphthalene) have been shown to be lower than those seen
in mammals and in contrast, activity levels observed for aniline hydroxylation (ANH)
are comparable to those observed in mammals while the activity levels for EROD are
greater (W alker and Ronis, 1989).
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M ost monooxygenase activity in the bird is present in the liver but other tissues have
been demonstrated to have significant MFO activity in certain species. For example,
the duodenum has been shown to have relatively high M FO activity compared to the
liver in the grey partridge, domestic fowl and Japanese quail (Galliformes) for certain
substrates (Bartlet and Kirinya, 1976; Riviere, 1980; Riviere, et a l., 1983).

In

contrast, duodenal activity in the cormorant was relatively low (Knight and W alker,
1982). Avian species have also been shown to have significant MFO activity in the
kidney (Pan and Fouts, 1978). This finding is postulated to be associated with the
renal portal shunt present in birds (but not in mammals) which carries blood from the
gastrointestinal tract directly to the kidneys. Renal activity in the razorbill and herring
gull, in contrast to other birds, was found to be relatively low (Ronis and W alker,
1989).

Buckpitt and Boyd (1982) investigated the P-450 system in the lung and

kidney o f the Japanese quail and the chicken and found relatively low P-450 content
and oxidative activity towards the substrate 4-ipomeanol. Although M FO activity has
been shown to be high in some extrahepatic tissues, the overall contribution o f these
M FO sources to the total M FO activity is minor due to the relatively small mass of
these tissues compared to that o f the liver. Nevertheless, these extrahepatic activities
may play a significant role in the detoxification and/or activation of certain xenobiotics
in target tissues (Ronis and W alker, 1989).

An interesting feature o f the avian MFO system is the reported presence o f significant
activity in embryos and neonatal birds.

Hepatic monooxygenase activities in the
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chicken embryo have been demonstrated to be comparable to or greater than those
of an adult from day 3 of incubation through hatching (Drummond, et a l., 1972;
Hamilton, et a l., 1983; Powis, et al., 1976). Immediately following hatching, hepatic
M FO activities have been observed to reach a peak and then gradually decrease to
adult levels within one week (Ilaug, et al., 1980; Brunstrom, 1986).

In addition,

substantial hepatic M FO activity has been shown in the embryos of the Herring gull
(Ellenton, et al., 1985; Boersma, et al., 1986; Peakall, et al., 1986) and blackcrowned night heron (Hoffman, et a l., 1986). This characteristic of the avian MFO
system is in sharp contrast to the development of the M FO system in mammals.
Mixed function monooxygenase activity in mammals is absent or very low at birth and
gradually develops during the postnatal period (Short, et al., 1976).

Data on temporal variations in activity in birds are very limited and are discussed in
Section 2 .3 .1 . Gender differences in MFO activity are seldom seen in avian species
(Ronis and W alker, 1989). However, a few exceptions have been noted and these
observations are discussed in Section 2.3.1.

2.2.2

Induction of the Avian Cytochrome P-450 System

In general, the response of the avian MFO system to inducers has been demonstrated
to be similar to that of mammals. However, there are some important distinguishing
characteristics between the Aves and Mammalia classes (Ronis and W alker, 1989).
The avian monooxygenase system, represented by the chicken, Japanese quail, homing
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pigeon, robin and Forster’s tern, has been shown to be readily induced by 3MC,
TCDD and other 3MC-type inducers such as /3NF, PAHs, and coplanar PCBs
(Brunstrom, 1990; Brunstrom, 1992; Hoffman, et a l., 1987; M artin, et a l., 1987;
Husain, et a l., 1982; Husain, et al., 1984; Ronis and W alker, 1989). The pattern of
induction observed is similar to that seen in mammals, i.e., increases in P-450 content
and AHH and EROD activities.

Distinct differences in the induction response to

3M C-type inducers that have been seen in avian species, which are not seen in the
mammalian species, include the induction o f aminopyrine A-demethylase (APDM ),
ethylmorphine A-demethylase (EM DM), biphenyl 2-hydroxylase (Ronis and W alker,
1989) and 4-dimethylaminoantipyrine A-demethylase activities (Sawyer, et a l., 1986).
In addition, 3MC-type inducers tend to produce a greater increase in microsomal
protein and total P-450 content in birds than in mammals (Buynitzky, et a l., 1978;
Ronis and W alker, 1989) and there is some evidence that M FO activity in the
Japanese quail is induced to a greater extent by 3MC than in mammals (Ronis and
W alker, 1989).

Also, 1,2,4-trichlorobenzene has been shown to induce EROD

activity in the quail and the chicken but not in the rat (Riviere, et a l., 1985; M iranda,
et al., 1984).

Another interesting difference in the inducibility of the avian M FO

system is the reported ability o f the embryonic system to be induced by 3M C-type
inducers.

Mixed function monooxygenase activity of the chicken embryo has been

demonstrated to be highly sensitive to induction by 3MC, /3NF, TCDD, and 3 ,3 ’,4 ,4 ’tetrachlorobiphenyl (Althaus et al., 1972; Brunstrom, et al., 1976; Darbey, et al.,
1984; Darbey, et al., 1985;

Darbey, et a l., 1986; Dogra and Israels, 1987;

Hamilton, et al., 1983; Poland and Glover, 1977; Topp and van Bladeren, 1986).
Aryl hydrocarbon hydrolase activity has been demonstrated to be inducible in the
chicken at day 5 o f incubation, with inducibility reaching adult levels by day 7 and
peaking at day 1 post hatch (Hamilton, et al., 1983).

Limited study has been

conducted on the role of a high affinity cytosolic Ah receptor in the induction o f the
avian hepatic cytochrome P-450 system by 3MC type inducers.

Sawyer and

coworkers (1986) were unable to detect a receptor in embryo or 2-week-old chickens.
In contrast, Denison et al. (1985) reported low levels o f the receptor in the cytosol
o f chick hepatocytes and Brunstrom and Lund (1988) detected a TCDD receptor in
the liver of 7-day-old chick embryos. However, in the same study, a receptor was
not detected in the embryonic turkey liver (Brunstrom and Lund, 1988). Brunstrom
(1992) demonstrated that coplanar PCBs and PAHs avidly bind to an Ah receptor in
chicken embryos and that the most toxic compounds were the most avid Ah receptor
binders.

The coplanar PCB,

3 ,3 ’4 ,4 ’-tetrachlorobiphenyl, and

its hydroxy

metabolites, were shown by W ehler et al. (1990) to bind to an Ah receptor in chick
embryos.

Variable responses to PB and PB-like inducers such as DDT and dieldrin, have been
reported in avian species. The chicken has been shown to be readily induced by PB
and the pattern of induction is similar to that of the rat (W alker and Ronis, 1989).
Other species that have been demonstrated to be sensitive to PB induction include the
homing pigeon, ring dove, Khaki Campbell duck and mallard duck (Husain, et al.,

1981; Husain, et a l., 1984; Patterson and Roberts, 1971; Peakall, et a l., 1970; Sifri,
et al., 1975). In contrast to these species, the Japanese quail and fish-eating birds,
such as the cormorant, are reported to be refractory to induction by PB (Ronis, et al.,
1987; W alker and Ronis, 1989).

It is also noteworthy that the chicken, although

observed to be responsive to PB, was not shown to be responsive to DDT and dieldrin
which are PB-type inducers (W alker and Ronis, 1989). In addition, Davison, et al.
(1976) showed that mirex, another organochlorine compound, did not induce the M FO
systems o f the chicken and quail. The mallard duck, on the other hand, was readily
induced by PB as well as DDT and dieldrin (Davison and Sell, 1972; W alker and
Ronis, 1989). In fact, in one study, PB was shown to increase ANH activity in the
Khaki Campbell duck twice as much as in the rat (Patterson and Roberts, 1971). It
is interesting to note that, in another study, Buynitzky and coworkers (1978)
demonstrated that induction following exposure to DDT was greater in mallard ducks
infected with the duck hepatitis virus than in control ducks.

Other compounds that

have been demonstrated to produce PB-like patterns o f induction in birds include
allylisopropylacetamide (Rifkind, et al., 1982) and

organophosphorus pesticides

(Lapadula, et al., 1964).

Unlike the mammal, PB induction has been observed in birds at very early stages of
development (Lorr and Bloom, 1987; Ronis and W alker, 1989; Strittmatter and
U mberger, 1969; Topp and Bladeren, 1986). In addition to PB, other compounds that
have produced PB-type induction in the chick embryo include the porphyria-causing
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drugs 2-propyl-2-isopropylacetamide (Althaus, et a l., 1972) and 3,5-diethylcarbonyl1,4-dihydrocollidine (Rifkind, 1979) and the in vitro inhibitors metyrapone, SKF525A,
and nicotinamide (Rifkind, et a l., 1974; Giger and M eyer, 1982).

Compounds such as polychlorinated biphenyls (PCBs), polybrominated biphenyls
(PBBs), and hexachlorobiphenyl (HCB), which are classified as mixed-type inducers,
have also been studied in avian species.

Induction has been observed with these

inducers in the Japanese quail (Bunyan and Page, 1978; Carpenter, et a l., 1985;
Riviere, et a l., 1985), adult chicken (Ehrich and Larsen, 1983), chick (Rinsky and
Perry 1981), chick embryo (Rifkind, et al., 1984; Topp and van Bladeren, 1986),
nestling and adult barn owl (Rinsky and Perry 1981; Rinsky and Perry 1983) and
Eider duck (Brouwer, 1991). In addition, the carcinogen 2-acetylaminofluorene was
shown to produce a mixed-type induction in the chick embryo (Darby, et a l., 1984).

Other compounds that have been investigated for their effect upon the avian M FO
monooxygenases include ergosterol biosynthesis inhibiting fungicides, glucocorticoids,
ethanol, glutethimide, aflatoxin Bl5 fenbendazole, and pyrethroids.

Prochloraz, an

ergosterol biosynthesis inhibiting fungicide, has been shown to be a potent inducer of
hepatic and duodenal M FO activity in a variety of birds including the Japanese quail
(Riviere, et a l., 1983), chicken, grey partridge (Perdixperdix), pheasant (Phasianus
colchicus) (Riviere, et al., 1984) and the red-legged partridge (Alectoris rufa)
(Johnston, et a l., 1989).

Other fungicides of the same class were also shown to
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induce the hepatic and duodenal M FO activities o f the Japanese quail (Riviere, et al.,
1983; Riviere, et al., 1984).

In contrast, prochloraz pretreatm ent in the rat was

shown to produce only small increases in hepatic cytochrome P-450 content and
activity (Riviere, et al., 1983). Increases in avian hepatic M FO activity have been
observed in chick embryos following glucocorticoid treatment (Leakey, et al., 1979).
Ethanol and glutethimide were investigated in the chicken embryo and shown to be
inducers o f hepatic microsomal activity (Sinclair, et a l., 1989). A comparative study
with aflatoxin Bi showed that the hepatic cytochrome P-450 content and activity were
decreased in the rat and quail but that no change in either param eter occurred in the
chicken upon administration of this toxin (Gawai, et a l., 1992).

Studies which

examined the effects of fenbendazole on the hepatic microsomal enzymes found no
increase in activity in the rat and chicken while enhanced M FO activity was seen in
the quail (Dalvi, 1989; Dalvi, et al., 1991). The pyrethroid pesticides examined did
not produce an inductive response in the Japanese quail (Riviere, et al., 1983).

2.3

Cytochrome P-450 Biomarkers in Avian Species

A number of studies have been conducted to evaluate the response o f the avian
cytochrome P-450 system to chemical exposure and to assess the applicability of
utilizing this system as a biomarker in environmental monitoring programs.
general, two approaches have been used for these studies:
laboratory studies.

In

field investigations and

Field investigations, for the most part, have been based on 3

approaches: (1) determining if correlations exist between contaminant burdens and
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M FO activity; (2) monitoring alterations in M FO activity subsequent to a chemical
release or the introduction of a migratory species to a contaminated area; and (3)
comparing the MFO activities o f birds residing in areas o f chemical contamination
with those of birds obtained from "clean" areas, i.e., controls (Rattner, et a l., 1989).
Laboratory studies have been directed at characterizing hepatic cytochrome P-450 in
avian species with respect to metabolic capacity for environmentally-relevant
chemicals, biotransformation mechanisms related to chemical toxicity, changes in the
system resulting from exposure to environmental chemicals, and the identification of
specific activities for application in biomonitoring programs.

M uch o f the research that has been conducted on the use o f biomarkers in avian
species has focused on assessing the response o f the M FO system to environmentally
persistent constituents such as organochlorines.

Early field and laboratory studies

provided evidence that these types of pollutants were bioaccumulating in raptor species
and that this effect was related to the population decline o f such species as the
peregrine, sparrowhawk, osprey, and bald eagle (Walker, e ta /., 1991; W alker, e ta /.,
1987). This work lead researchers to question the ability o f these and other birds to
metabolize environmental contaminants and subsequently, a number of studies were
undertaken to characterize the M FO system of avian species.

A variety of species,

environmental chemicals and M FO activities were investigated by a number of
researchers (Table 2-1).

Results of these efforts indicate: (1) there is significant

variability in M FO activity within and between avian species; (2) the avian hepatic
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M FO system is readily induced by a range of environmental pollutants and a number
o f avian hepatic MFO activities have potential use as biomarkers of environmental
exposure; (3) laboratory data indicated that M FO activity is correlated with tissue
residues and other toxic effects in avian species; and (4) the monitoring of MFO
activity in developmental stages, such as embryos and nestling, offers a number of
advantages when using avian species in biomonitoring programs.

2.3.1 Variability o f MFO Activity
High variability in M FO activity between avian species, as well as among individuals
within a given species, has been documented by a number of researchers (Boersma
et a l., 1986; Fossi, et al., 1990; Husain, et al., 1981; Knight and W alker, 1981;
Peakall, et a l., 1987; Rattner et al., 1989; W alker, et al., 1981).

Variations in

genetic constitution, physiological factors, substrate specificity, and environmental
influences make it difficult to compare cytochrome P-450 levels and activities between
avian species (Riviere, et a l., 1985). Profound interspecies differences in avian M FO
activity have been observed between the predators and other species o f birds. This
dramatic difference in M FO activity has been suggested to be related to the difference
in feeding ecology o f the two groups (Walker et a l., 1987). Predator species have
narrow dietary ranges which are postulated to result in limited xenobiotic exposure
and, thus, a reduced need for detoxification by the MFO system.

For example,

piscivorous birds, such as the razorbill (Alca torda), puffin (Fratercula arctica), shag
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T able 2-1
Avian Species and C ytochrom e P-450 P aram eters
E xam ined in Ecotoxicological Studies

Species

P otential E xposure,
P re tre a tm e n t, or
Tissue R esidue

P aram e ter
C h aracterized 1

R eference

Puffin

DDE

ANH, BDM

Bend et a l., 1987

Herring Gull,
Cormorant,
Eider Duck

PCBs

EROD, P-450

Brouwer, 1991

Forster’s
Tern

PCBs, TCDD,
PCDD

AHH

Hoffman, et a l., 1987

Puffin

Crude Oil

EROD, AHH,
AE

Peakall, et a l., 1987

Puffin,
Razorbill,
Guillemot,
Shag,
Cormorant,
Manx
Shearwater

PCBs

HCE, AE

Black-Headed
Gull, Herring
Gull, Rook

None

Herring Gull

Knight et a l., 1981
W alker et al., 1982a

HCE, AE

Knight et al., 1981
Walker et a l., 1982a

Organochlorines

AHH

Ellenton, et a l., 1985

Herring Gull

Organochlorine
Pesticides and PCBs

AHH, APDM ,
EROD, P-450

Peakall, et a l., 1986

Herring Gull

Organochlorine
Pesticides and PCBs

APDM, ANH,
EROD

Boersma, et a l., 1986

Blackcrowned
Night Heron

Organochlorine
Pesticides and PCBs

AHH

Hoffman, et a l., 1986
(table continued)
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T able 2-1
A vian Species and C ytochrom e P-450 P aram eters
E xam ined in Ecotoxicological Studies

P otential E xposure,
P re tre a tm e n t, o r
Tissue R esidue

P aram e ter
C h arac teriz ed 1

R eference

Pigeon

Organochlorine
Pesticides

AHH

Husain, et a l., 1981

Robin

Dioxins

AHH

M artin, et a l., 1987

Black-necked
Grebe

Organochlorine
Pesticides and PCBs

AE, EROD

Fossi, et a l., 1986

Black-headed
Gull

PCBs

AE, EROD

Fossi, et a l., 1986

None

AHH, APDM

Husain, et a l., 1981

Mallard Duck

Crude Oil

AHH, P-450

Gorsline, et a l., 1981

Barn Owl,
Chicken

PCBs

APDM , AE,
P-450

Rinkzy and Perry
1983

Chicken

PCBs

A H H ,E R O D

Rifkind, et a l., 1984

Chicken

Crude Oil

A H H ,E R O D

Lee, et a l., 1986

Chicken

PCBs, DDT

ANH, APDM

Cecil, et a l., 1978

Chicken

Organophosphate
Pesticide

ANH, CADM

Varshneya, et al.,
1986

Japanese
Quail

Pyrethroids,
Dicarbomide
Fungicide

AE, ANH,
ECOD, EROD,
P-450

Riviere, et a l., 1983

Species

Pigeon,
Crow , Kite,
Vulture,
Cattle Egret

(table continued)
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T able 2-1
A vian Species an d C ytochrom e P-450 P aram eters
Exam ined in Ecotoxicological Studies

P otential E xposure,
P retrea tm e n t, o r
Tissue R esidue

P aram e ter
C h arac teriz ed 1

Prochloraz

AE, ANH,
EROD, P-450

Riviere, et a l., 1985

Pigeon

None

AE, HCE

Ronis and W alker,
1985

Pigeon

Organochlorines

AHH

Kaphalia, et a l., 1981

Kestral,
Sparrowhawk

None

AE, HCE

W alker, et a l., 1987

H erring Gull

Crude Oil

AHH, ANH,
APDM , EROD

Lee, et a l., 1985

DDT

ANH, APDM

Sifri, et al., 1975

Species

Japanese
Quail,
Chicken,
Pheasant,
Partridge

Japanese
Quail,
Chicken,
M allard Duck

R eference

'A E, aldrin epoxidase; AHH, aryl hydrocarbon hydrolase; ANH, aniline hydroxylase;
APDM , aminopyrine demethylase; BDM, benzphetamine demethylase; CADM ,
p-chlorom ethyl aniline demethylase; ECOD, ethoxycoumarin dealkylase; EROD,
ethoxyresorufin-D-deethylase; HCE, l,2 ,3 ,4 ,9 ,9 -h ex ach lo ro -l,4 ,4 a,5 ,6 ,7 ,8 ,8 aoctahydro-exo-7,8-epoxy-1,4-methanonaphthalene hydroxylase; P-450, cytochrome
P-450 level
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(Phalacrocorax aristotelis), cormorant (Phalacrocorax carbo), and guillemot ( Uria
aalge), have been shown to have MFO activities that are considerably lower than
those o f other avian species and in fact, activities have been noted to be comparable
to those in fish (Knight and W alker, 1981; W alker, et a l., 1987). Omnivorous birds,
on the other hand, have wide dietary ranges which are thought to result in a more
varied exposure to xenobiotics thereby creating a need for a more active M FO system
(Walker, et a l., 1987; Knight and Walker, 1981). It has been argued that the hepatic
cytochrome P-450 systems of birds with complex diets are more developed and have
greater metabolic capacity than birds with specialized diets (Ronis and W alker, 1989).
One exception to this finding is the puffin (Fratercula arctica). Although the puffin
is a fish-eating bird, M FO activity (for organochlorine substrates) in this species has
been shown to be greater than other avian species and is reported to be comparable
to that seen in the rat (Knight and Walker, 1981).

Potential sources of intraspecies variation in MFO activity include age, sex, and
reproductive status.

With regard to age, changes in MFO activity have been

documented in the herring gull (Larus argentatus), chicken, barn owl, kestrel
(Accipiter nisus), and sparrowhawk (Falco tinmmculus) during various stages of
development. Ellenton and co-investigators (Ellenton, et al., 1985) found that AHH
and EROD activities increased with embryonic development whereas aminopyrine
demethylase (APDM ) activity decreased.

In addition, AHH activity was more

inducible at day 25 o f incubation than at day 20.

No consistent changes were
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apparent for other substrates.

In nestlings, no consistent changes in M FO activity

were noted in this study, but activity was higher than that o f the embryos. Peakall
and co-workers (Peakall, et a l., 1986) found that APDM activity decreased with age
in herring gull (Larus argentatus) nestlings while no change was noted in EROD or
AHH activities or cytochrome P-450 levels.

In chickens, M FO activity has been

demonstrated to be inducible at day 17 of incubation with constitutive activity peaking
at day 1 following hatching (Ellenton, et al., 1985; Rinzky and Perry, 1983).

In

contrast, M FO activity in the barn owl was found to be lower at day 1 post-hatch than
at any other age studied (Rinzky and Perry, 1983). In the sparrowhawk and kestrel,
M FO activities were found to be lower in juvenile birds than in adults (W alker, et a l.,
1987). In another study, Ronis noted that aldrin epoxidase activity increased with age
in cockerels (Walker, et al., 1987).

No significant differences in M FO activity between males and females have been
observed for the puffin (Fratercula arctica), Leach’s petrel (Oceanodroma leucorhoa),
or herring gull (Larus argentatus) (Knight and W alker, 1982; Peakall, et al., 1986;
Peakall, et al., 1987).

Also, no sex differences were demonstrated in the chicken

embryo (Hamilton et a l., 1983), chicken hatchling (Brunstrom, 1986), or in the adult
wild pigeon (Husain et al., 1984). However, an increase in M FO activity has been
reported in the female razorbill (Alca torda) at the onset o f the breeding season and
it is speculated that, in light of the known involvement of the M FO system in steroid
metabolism, this increase is associated with the elevation of steroid levels that occurs
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at the time o f egg laying (Knight and W alker, 1982a). Similar findings have been
reported in the black-necked grebe (Podiceps nigricollis) (Fossi, et a l., 1986), wood
pigeon (Columba palumbus), yellow-legged herring gull (Lam s argentatus cachinnans)
and herring gull (Larus argentatus smithsonainus) (Fossi, et a l., 1990). Differences
between the sexes have been noted in the guillemot (Uria aalge) and cormorant
(Phalacrocorax carbo) in which M FO activity in the female was half that in the male
(W alker and Ronis, 1989). Sell and coworkers (1971) noted an inverse relationship
between M FO activity and clutch length in the chicken. Rao and McKinley (1969)
observed a difference in the rate of oxidation of organophosphorus insecticides in male
and female chickens, however, no difference was seen between the sexes for the
demethylating system.

It is interesting to note, that while high variability in M FO activity is observed
between avian species, little variation is seen in cytochrome P-450 content (Knight and
W alker, 1981). In addition, very little individual variation in M FO activity has been
observed in the sparrowhawk, a specialized predator species with very low MFO
activity (Walker, et a l., 1987).

The data available to date clearly indicate the

importance of characterizing the potential sources of variation in the hepatic MFO
activity of target species. It is imperative that these factors be taken into consideration
when planning biomonitoring programs based on M FO biomarkers (Peakall, et al.,
1987; Rattner et a l., 1989).
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2.3.2 Induction o f MFO Activity
Characterization o f the induction response of the cytochrome P-450 system is an
essential area o f research for the identification o f specific enzyme activities to serve
as biomarkers o f exposure in avian species. The avian hepatic microsomal M FO has
been demonstrated to be inducible by a number of environmental contaminants (Pan
and Fouts, 1978).

Polychlorinated biphenyls (PCBs), common environmental

contaminants, have been demonstrated to induce APDM and aldrin epoxidation (AE)
activities in the barn owl (Rinsky and Perry, 1983) and EROD activity in the Eider
duck (Somateria mollissima) (Brouwer, 1991).

Other persistent organochlorine

compounds that have been reported to induce the hepatic M FO in avian species
include TCDD [American robin (Turdus migratorius), AHH and EROD activities
(M artin, et a l., 1987)]; DDE [puffin (Fratercula arctica), aniline hydroxylase (ANH)
activity (Bend, et a l., 1977)]; and p ,p ’-D DT [Mallard duck (Anas platyrhynchos),
ANH and APDM activities (Sifri, et al., 1975)].

However, chicken (Gallus

domesticus) MFO was not shown to be induced by PCBs (Rinsky and Perry, 1983)
nor by p , p ’-DDT (Sifri, et a l., 1975). In fact, suppression of M FO activity has been
noted in the chicken following exposure to p , p ’-DDT (Sell, et al., 1971; Sifri, et al.,
1975; Stephen, et al., 1971). Similar results were found by Varshney and co-workers
(1986) following exposure of the chicken to malathion, an organophosphate pesticide.
In another Galliformes species, the Japanese quail (Courtnix japonica), inhibition of
ANH and APDM activities were noted following pretreatment with p ,p ’-DDT (Sifri,
et al., 1975).

Other researchers have also observed decreases in MFO activity in

Japanese quail following DDT pretreatment (Bunyan, et al., 1972; Cecil, et a l., 1978;
Gillette and Arscott, 1969; Sell, et al., 1972). Exposure to another important class
o f environmental compounds, PAHs, has been shown to induce M FO activity in a
variety o f avian species. Various types of crude oil administered to chickens (Lee,
et a l., 1986), herring gulls (Larus argentatus) (Lee, et a l., 1985), mallard ducks
(Gorseline, et a l., 1981), and puffins (Peakall, et a l., 1987) produced significant
increases in the M FO activities of these species.

Induced activities included AHH

and EROD in the chicken; AHH, EROD, ANH, and APDM in the herring gull, AHH
in the mallard; and AHH, EROD, and AE in the puffin. Prochloraz, an agricultural
fungicide, has been documented as an efficient inducer of the M FO system o f four
Galliformes species: the Japanese quail, chicken, partridge (Perdix perdix), and
pheasant (Phasianus colchicus) (Riviere, et a l., 1985). Specific activities induced in
these birds included EROD, ANH, and AE. V-(3,5-dichlorophenyl) dicarboximide,
another fungicide, has also been shown to induce the M FO system o f the Japanese
quail (Riviere, et al., 1983). In field investigations based on comparisons o f M FO
activity in herring gull embryos collected from areas of organochlorine pesticides and
TCDD contamination with embryos obtained from nonimpacted control areas, M FO
activity in the exposed group demonstrated elevated AHH and EROD activities,
depressed ANH activity, and similar APDM activity compared to the control group
(Ellenton, et a l., 1985; Boersma et a l., 1986). In a similar study, Hoffman and co
workers (Hoffman, et al., 1987) found elevated AHH activity in F orster’s tern
embryos exposed to PCBs, TCDD, and dibenzo-/?-dioxins.
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As discussed above, a number of avian hepatic microsomal M FO activities have been
demonstrated to be feasible biomarkers of environmental chemical exposure.

In

summary, the activities that have been most commonly examined in avian species for
the assessment o f environmental contamination include EROD, AHH, AE, APDM,
and ANH.

In field investigations, the most frequently monitored M FO activities

include EROD and AHH. Among the species studied, the most consistent change in
M FO activity following chemical exposure (PCBs, organochlorines, TCD D , crude
oil), under laboratory and field conditions, was the induction o f EROD and AHH
activities. Laboratory studies indicate that HCE, aminopyrine and aldrin are relatively
poor substrates for avian monooxygenases whereas ethoxyresorufin and aniline are
relatively good substrates. Aniline, aldrin, aminopyrine and HCE are metabolized by
a variety o f P-450 isoforms and therefore are rather non-specific substrates in avian
species. On the other hand, ethoxyresorufin is a specific substrate with metabolism
being primarily attributable to the P-450 isoform (CYP1A1) inducible by 3MC-type
inducers.

In addition, the metabolic capacity of avian monooxygenases has been

demonstrated to be much higher for ethoxyresorufin than with other non-specific
substrates (Ronis and W alker, 1989).

2.3.3 Correlation o f MFO Activity With Tissue Burden
An important area o f ecotoxicological investigation has been the study o f the potential
relationship between tissue burdens and M FO activity in exposed birds. M FO activity
is inversely related to the biological half-life of xenobiotics, and, thus, plays an
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important role

in determining

the degree

of bioaccumulation o f persistent

environmental pollutants and the potential susceptibility o f certain avian species to
xenobiotics that are detoxified by this system (Ronis and W alker, 1985). Low MFO
activity in certain avian species towards such xenobiotics, as in the piscivorous birds,
has been correlated with a marked tendency for these compounds to bioaccumulate in
exposed birds (Knight and W alker, 1981; W alker et a l., 1987). The correlation of
M FO activity with specific chemical residue levels is used in field studies to determine
if M FO induction is related to environmental chemical exposure (Peakall, et al.,
1980). However, to date, such field studies have been met with limited success. A
study

on herring

gull {Larus argentatus) embryos obtained from

areas of

environmental contamination was conducted by Ellenton and co-investigators (Ellenton
et a l., 1985) to determine if there was a correlation between hepatic M FO activity and
tissue residues in the exposed birds.

The study demonstrated a significant positive

correlation between the induction of AHH activity and TCDD tissue residues;
however, M FO activity was not found to be correlated with other organochlorine
(PCBs and DDE) residues present in the embryos. In a similar study conducted by
Boersma and co-workers (1986), negative correlations were noted between APDM
activity and PCB residues, APDM activity and hexachlorobenzene residues, and ANH
activity and mirex residues in herring gull embryos. Peakall and co-workers (1986)
examined the M FO activity and tissue burdens of nestling Herring gulls.

No

correlations were apparent between AHH, EROD, and AMPD activities and any of
the organochlorine residues detected.

However, cytochrome P-450 levels were
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significantly correlated with levels of hexachlorobenzene and oxychlordane present in
the tissues. Also, APDM and AHH activities were significantly correlated with each
other suggesting that these enzymes are potential alternates for biological effects
monitors (Peakall, et al., 1986).

Other studies conducted on black-crowned night

herons {Nycticorax nycticorax) (Hoffman et a l., 1986), razorbills (Alca torda), puffins
(Fratercula arctica) (Knight and W alker, 1982) and black-headed gulls (Larus
ridibundus) (Fossi, et al., 1986) obtained from areas of environmental contamination
were not able to demonstrate a correlation between M FO activity (AHH; AE, and
HCE hydroxylation;

and EROD,

(organochlorine compounds).

and AE;

respectively) and tissue burdens

In another type of bioaccumulation study, marked

variations in tissue residue levels were observed in puffins administered equal dosages
o f chemical and returned to the wild (Knight and W alker, 1982a). This intraspecies
variability in bioaccumulation is thought to be due to the individual variation in MFO
activity that has been documented in the puffin.

2 .3 .4 Correlation o f MFO Activity with Biological Effects
Additional research has focused on the toxicological implications o f pollutant tissue
residues (organochlorine and PAHs) and M FO induction (primarily CEP1A) in
exposed birds and the establishment of a causal linkage between exposure and adverse
effects observed in exposed avian populations (Gorsline, et a l., 1981; Lee, et al.,
1985; Lee et al., 1986; and Mineau, et al., 1984). Reproductive failure, congenital
malformations, impaired growth and decreased survival have been documented in
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avian species inhabiting areas o f environmental contamination (Hoffman, et a l., 1987;
Mineau, et a l., 1984; Rattner, et al., 1989; and W alker and Ronis, 1989).
Furtherm ore, laboratory studies have demonstrated that induction of the hepatic
microsomal M FO system interferes with steroid metabolism in the mallard duck (Anas
platyrhynchos), quail (Corturnix coturnix), ringdove (Streptopelia risoria) (Rattner et
a l., 1989), and white king pigeon (Peakall, et a l., 1967). However, at the present,
no direct evidence has been obtained from field studies to support the contention that
M FO induction resulting from environmental pollution is associated with these
biological effects (Rattner et a l., 1989).

2 .3 .5 Use o f Avian Developmental Stages in Biomonitoring Programs
Birds of various ages and stages of embryonic development have been utilized for
bioeffects monitoring. Adult birds have been used extensively in ecotoxicological and
M FO research. As previously discussed, significant variation in M FO activity exists
among individual birds within a given species and a number o f sources o f variation
have been identified in certain avian species.

Consequently, this variability has

complicated the elucidation of exposure and induction relationships in adult birds
(Rattner, et al,. 1989).

The use of M FO induction as a biomarker o f chemical

exposure in adult birds requires further characterization of the M FO system and the
those factors that influence it. Avian embryos are frequently chosen for use in field
and laboratory studies for several reasons:

egg collection is relatively simple and

produces minimal disturbance within the population (Ellenton, et a l., 1985; Mineau
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et a l., 1984); individual variation in M FO activity potentially associated with
differences in age, sex and reproductive status are reduced or eliminated; the hepatic
M FO system of the embryo is readily induced (Ellenton, et a l., 1985); there is less
variation in the lipid content, and thus in tissue burdens, o f eggs than in other tissues;
and the tissue burdens o f eggs are comparable to those o f the laying adult (Mineau et
a l., 1984).

However, it should be noted that the removal o f an embryo from its

natural environment or the incubation of an embryo in vitro can profoundly affect the
activities o f the hepatic MFO enzymes (Hamilton, et a l., 1983). Nestlings are also
frequently used in biomonitoring research. Nestlings are more easily collected than
adults and more readily adapt to captivity for experimental purposes.

Also, the

collection of juveniles is less destructive to the population than the removal o f adults
since the mortality of nestlings and embryos is much greater than that of adults
(Peakall, et a l., 1986). Based on the data available to date, the monitoring of MFO
activity in embryos and hatchlings offers promise as a biomarker o f chemical exposure
in avian species (Rattner, et a l., 1989).

2.4 Representative Avian Species
Birds are classified into orders based on structural and anatomical likenesses. Within
each order, birds are further classified into families based on the distinguishing
characteristics of the species that have allowed for adaptation to a particular
environment and way of life (Terres, 1980). Two orders o f birds are represented in
this study, the Galliformes and Anseriformes. The Galliformes include the chicken-
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or fowl-like terrestrial birds which are considered as game birds.

Galliformes

primarily feed on the ground obtaining seeds, grain, fruit, buds, nuts and vegetable
matter as well as insects, spiders, snails, worms and other invertebrates.

The

Galliformes order is represented in this study by the chicken (Gallus gallus or Gallus
domesticus), turkey (Melegris gallopavo) and Japanese quail (Coturnix coturnix). The
domestic chicken belongs to the Phasianidae (Pheasant) family and is a descendant of
the red jungle fowl which originated from Southeast Asia and India.

The White

Leghorn, which was utilized in this study, is classified as a M editerrean breed
(Phillips, et a l., 1985).

The Japanese quail is also a member of the Phasianidae

family and is classified as an Old World species. This migratory bird is a native of
Europe, Central Asia, Africa, and Japan (Terres, 1980; Reilly, 1968). The domestic
turkey belongs to the M eleagrididae family and is a descendant of a cross between the
M exican wild turkey and the native turkeys of North America (Phillips, et al., 1985
and Terres, 1980). The turkey is a gregarious, nonmigratory species found in wooded
areas (Reilly, 1968).

The Anseriformes order includes the waterfowl (or wildfowl) which are classified as
migratory game birds. W aterfowl are an ancient group of birds with their oldest fossil
remains dating back 80 million years. Some orthinologists believe that the waterfowl
evolved from an ancestor related to the gallinaceous birds (Terres, 1980). These birds
are found on every continent but Antarctica.

The Anseriformes represented in this

study include the duck (Anser platyrhynchos), represented by the Khaki Campbell and

61
Pekin breeds, Muscovy duck ( Cairina moschata), and goose (Anser anser). Each of
these species is member o f the Anatidae family.

The Khaki Campbell and Pekin

ducks were derived from the wild mallard duck in England and China, respectively
(Kear, 1985 and Terres, 1980).

These birds are classified as dabbling or surface-

feeding ducks and are found in marshy habitats.

They are gregarious feeders and

consume primarily aquatic plants (Terres, 1980). The Muscovy duck is a native of
Mexico and Central and South America (Terres, 1980) and is related to the M andarin
and Carolina (or North American Wood Duck) ducks (Kear, 1985). This species is
classified as a perching duck due to their ability to perch on branches and similar
structures. The Muscovy duck is nonmigratory and is found as a perm anent resident
o f coastal bottomland timbers along waterways and marsh lands. These birds feed on
small fish, aquatic insects, mollusks, aquatic plants, grain, seeds, reptiles, worms and
snails (Terres, 1980). The Muscovy duck is not considered by many breeders to be
a true duck due to a number of unique characteristics exhibited by this species.
Unlike other ducks, the Muscovy cannot spend extended amounts of time on the water
because their feathers are not as water repellant as those o f true ducks and they may
become soaked, causing the ducks to drown. They are also less tolerant o f wet and
cold weather. When crossed with other species of ducks, the offspring are typically
sterile. Also, as mentioned above, they are perching ducks (Holderread, 1978). The
domestic goose is a descendant of the wild European Greylag goose (Terres, 1980).
These birds are gregarious and nest in large colonies. Their diets exist primarily of
plant materials and they frequently graze on land (Terres, 1980; Reilly, 1968).
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The most important species from an economic point o f view are the domestic chicken,
turkey and duck. The chicken and turkey are produced commercially for both egg
and meat production. The Khaki Campbell duck is utilized for egg production while
the Pekin and Muscovy are utilized for meat production.

The quail is raised

commercially for both egg and meat production and the goose is raised primarily for
meat production (Phillips, et al. 1985).

3 .0

E X PER IM EN TA L GOALS AND D ESIGN

This study was conducted to characterize the oxidative biotransformation capacity of
the hepatic microsomal system of selected avian species representing the Galliformes
and Anseriformes orders.

The hepatic cytochrome P-450 systems o f seven avian

models and a mammalian model were investigated.

The Galliformes order was

represented by the chicken, turkey and Japanese quail. The Anseriformes order was
represented by the goose, Pekin duck, Khaki Campbell duck, and Muscovy duck.
The male rat was utilized for the mammalian model. Two groups o f animals for each
species were evaluated and these consisted of a control group, which received no
treatment, and a treatment group which was administered /Tnaphthoflavone (50
mg/kg) intraperitoneally once a day for 3 days (Figure 3-1) prior to microsomal
isolation on the fourth day. Each group consisted of six animals and investigations
were conducted on hepatic microsomes prepared from individual animals.

The goal o f this research was to initiate a database on the hepatic cytochrome P-450dependent mixed function monooxygenases of domestic avian species for the purpose
of addressing two objectives.

The first objective of this study was to obtain

fundamental information on the cytochrome P-450-dependent metabolic capacity of
certain economically major and minor food-producing avian species for a given class
o f xenobiotics and to characterize the differences in metabolism of a model compound
between the species.

The goal of this objective was to provide biotransformation

information relating to the hepatic cytochrome P-450 system of major and minor
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Figure 3-1 Structure o f beta-naphthoflavone.
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6species to support the interpretation o f data submitted to the FDA for the purpose of
obtaining approval for minor use avian drugs. For this study, the chicken and turkey
represented economically m ajor species while the Japanese quail, Pekin duck, Khaki
Campbell duck, Muscovy duck and goose represented minor species.

The second

objective of this study was to characterize selective constitutive and inducible
isozymes o f the avian hepatic cytochrome P-450 system, determine the inducibility of
the system utilizing a classical inducer of environmental relevance and investigate the
metabolism of an environmentally relevant compound via the quantitation o f individual
metabolites.

The goal of this objective was to evaluate the potential use o f the

representative avian species as sentinel organisms utilizing induction of the hepatic
cytochrome P-450 system as a biomarker of environmental chemical exposure.

To achieve these objectives a series o f investigations were undertaken:

(1)

The components o f the avian cytochrome P-450 system were quantitated
including microsomal protein yield, cytochrome P-450 content, NADPHand NADH-cytochrome c reductase activities.

(2)

Ethoxyresorufin-O-deethylase activity (Figure 3-2) was determined to
characterize the response of the avian hepatic cytochrome P-450 system to
/3-naphthoflavone treatment. Presently, five isozymes of cytochrome P-450
have been isolated from hepatic microsomes of rats treated with

NADPH

NADP +
HO
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Figure 3-2 O-deethylation ofethoxyresorufin.

. 0.

o

(8-naphthoflavone (and other 3MC-type inducers). O f these, two major
forms, CYP1A1 and CYP1A2 have been identified (Ioannides and Parke,
1987; Lau and Strobel, 1982; Sesardic et a l., 1990; Thomas, et al., 1983).
Ethoxyresorufin (an alkoxyphenoxazone derivative) has been demonstrated
to be an isozyme-selective substrate for the CYP1A1 isozyme and an
increase in the O-deethylation o f ethoxyresorufin has been shown to be
associated with induction of this isozyme (Burke, et a l., 1985; Burke and
M ayer, 1975; Guengerich, et al., 1982).

The CYP1A1 and CYP1A2

isozymes have been shown to be inducible by certain classes of
environmental pollutants in laboratory animals and man. In addition, they
have been demonstrated to increase the toxicity o f a number o f compounds
via the formation o f highly reactive intermediates (Sesardic, et al., 1990).

The hepatic microsomal oxidative biotransformation o f benzo[a]pyrene was
examined.

Four

metabolites,

3-hydroxybenzo[a]pyrene,

9-hydroxy-

benzo[a]pyrene, benzo[a]pyrene-7,8-dihydrodiol, and benzo[a]pyrene-9,10dihydrodiol, were identified and quantitated by HPLC analysis.

These

metabolites were selected based the pathways o f hepatic oxidative
metabolism identified in control and in /3NF-treated chicken embryos and
rats (Figure 3-3). In primary cultures o f chick embryo hepatocytes, Topp
and van Bladeren (1986) observed the formation o f tetrahydrotetrols, 3hydroxybenzo[o]pyrene, 9-hydroxybenzo[a]pyrene, benzo[u]pyrene 7,8-
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Figure 3-3 Pathways of benzo[ajpyrene metabolism (Grover, 1986).
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dihydrodiol, and benzo[a]pyrene 9,10-dihydrodiol by control and /3NFtreated cells. Control and induced rat hepatic microsomes have been shown
to metabolize B[a]P to a variety of phenols, dihydrodiols, and quinones.
The

major

metabolites

formed

in

the

rat

include

3-

and

9-

hydroxybenzo[ajpyrene, benzo[a]pyrene 4,5-, 7,8-, and 9,10-dihydrodiols
and benzo[a]pyrene 1,6-, 3,6-, and 6,12-diones (Cavalieri, et a l., 1988;
Grover, 1986; Jongeneelen, et a l., 1985; Levin, et a l., 1982; Winston, et
a l., 1991; Wong, et a l., 1986). Benzo[a]pyrene was selected as a substrate
for this metabolic study for two reasons.

First, the oxidative metabolic

pathways of this compound have been well described in a number of
species.

Secondly, benzo[ajpyrene is a representative substrate of an

environmentally important class of compounds, the polycyclic aromatic
hydrocarbons.

The /3NF-inducible isozymes CYP1A1 and CYP1A2 have

both been demonstrated to be involved in the metabolism o f benzo[a]pyrene
in the rat but CYP1A1 has been shown to be approximately 50 times more
active than CYP1A2.

These investigations o f the cytchrome P-450 system were conducted on hepatic
microsomes of both control and /3NF-treated birds to determine the effects of
induction on cytochrome P-450 content, catalytic activity and pathways of oxidative
metabolism.

Comparisons were sought between the avian species, between avian

orders, and between avian species and the rat.

Ethoxyresorufin-O-deethylase and
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benzo[ajpyrene hydroxylase activities were evaluated based on specific activity
(pmoles o f product produced/min/mg o f microsomal protein) and on m olar activity
(pmoles o f product produced/min/nmole of cytochrome P-450 also known as turnover
number).

4.0

MATERIALS AND METHODS

4.1

Animals

The avian species used in this study included the White Leghorn chicken (Gallus
gallus or Gallus domesticus), Japanese quail (Corturnix coturnix), turkey (Melegris
gallopavo), goose {Anser anser), duck (Anser platyrhynchos) represented by the Pekin
and Khaki Campbell breeds, and Muscovy duck (Cairina moschata).

Twelve adult

female birds of each species and breed were obtained from local vendors, with the
exception of 2 quail, which were obtained from the Department o f Veterinary Science,
Louisiana State University, Baton Rouge, Louisiana. The birds were group-housed
by species in enclosed outdoor stalls containing dried hardwood shavings purchased
from Purvis Forest Products o f Carmen, Mississippi. The quail were kept in groups
in small metal cages with grid mesh bottoms and were housed within a stall. All birds
received tap water and a 50:50 ration of cracked corn and Purina Layena mash
(obtained from Orcola, Louisiana) ad libitum. The birds were acclimated for 2 weeks
prior to being utilized in the study.

Twelve male Sprague-Dawley rats, weighing

approximately 200 g, were obtained from Hilltop Lab Animals, Inc. (Scottsdale,
Pennsylvania). The rats were group caged in a controlled environment defined by a
temperature of 21-24° C, humidity of 40-60% and a light/dark cycle of 12 hours.
The rats were given water and Purina rat chow free choice.
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4 .2

Chemicals

Ethoxyresorufin (resorufin ethyl ether) (98%) was obtained from M olecular Probes,
Inc. (Eugene, Oregon).

Resorufin (75% dye content) was purchased from Aldrich

Chemical Company, Inc. (Milwaukee, Wisconsin).

/3-Naphthoflavone (90-95% ),

cytochrome c type III from horse heart (95-100%), NADPH (/3-nicotinamide adenine
dinucleotide phosphate, tetrasodium salt, type III, reduced form) (98% ), NADH ((3nicotinamide adenine dinucleotide, reduced form) (98% ), glucose-6-phosphate
dehydrogenase (crystalline suspension in 3.2M (NH4)2S 0 4, pH 7, activity 300-400
units/m g protein), glucose-6-phosphate (crystalline, monosodium salt), nicotinamide
adenine dinucleotide phosphate (sodium salt) (98-100% ), and benzo[ajpyrene (98%)
were purchased from Sigma Chemical Company (St. Louis, M issouri).

3-

Hydroxybenzo[a]pyrene ( > 98% purity by H PLC), 9-hydroxybenzo[a]pyrene ( >
98% purity by HPLC), benzo[a]pyrene-trans-7,8-dihydrodiol(-) ( > 99% purity by
H PLC), and benzo[a]pyrene-trans-9,10-dihydrodiol ( > 9 9 % purity by HPLC) were
obtained from the NCI Chemical Carcinogen Repository, M idwest Research Institute
(Kansas City, Missouri). W ater used for the HPLC solvent system was triple-distilled
and passed through a M odular Polisher I water purifying system (Continental W ater
Systems Corp., San Antonio, Texas).

All other chemicals and biochemical agents

used in this study were obtained from commercial suppliers and were of a quality that
met or exceeded analytical grade standards.
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4 .3

Treatment

A suspension of /3-naphthoflavone (5,6-benzoflavone) was prepared in peanut oil at
a concentration of 50 mg/ml. The suspension was stored a 4° C and brought to room
temperature prior to use. The birds and rats were randomly divided into control and
treatm ent groups consisting o f six animals each.

The treatment groups were

administered 50 mg/kg /3-naphthoflavone intraperitoneally once a day for three
consecutive days and the animals were sacrificed on the fourth day.

The control

groups received no treatment.

4.4

Microsomal Preparation

The animals were sacrificed by decapitation and microsomes were prepared from
livers o f individual animals. All steps involved in the microsomal preparation were
carried out at 4° C. The livers were removed, weighed and placed in 1.15% M KC1.
The livers were minced with scissors, rinsed with 1.15% M KC1 and homogenized in
STE buffer (0.25M sucrose, 10 niM Trizma HC1 and 1 mM EDTA; pH 7.4) at a 1:4
tissue weight/ buffer volume ratio using a Potter-type Teflon-glass motor driven pestle
homogenizer. Microsomal pellets were prepared from the homogenates by differential
centrifugation (Lake, 1987). The homogenates were centrifuged (Beckman J-21B) for
three 10 minute intervals at 600 x g, 8000 x g and 14,500 x g.
mitochondrial

supernatant

fractions

were

then

centrifuged

(Sorvall

The postOTD-65

Ultracentrifuge Oil Turbine Drive, Dupont Instruments) at 105,000 x g for 60 minutes
to obtain the microsomal fractions. The post-105,000 x g microsomal pellets were

74
resuspended in 0.125 M KC1 and recentrifuged at 105,000 x g for 60 minutes. The
final microsomal pellets were resuspended with a glass hand-held homogenizer in a
solution o f 0.125 M KC1 in 20 percent v/v glycerol and stored at -80° C in 1 ml
aliquots.

Fresh aliquots of microsomes were brought to 4° C just prior to use for

each investigation conducted (except for the determination o f cytochrome P-450
content which was conducted prior to microsomal storage).

4.5

Protein Determination

The microsomal protein concentrations were determined by the method o f Lowry et
al. (1951). A standard curve was constructed for each set of samples utilizing a series
o f concentrations of bovine serum albumin (BSA). The microsomal suspensions were
diluted 1:100 with triple-distilled water.
following constituents were prepared:

Four buffer solutions consisting o f the

Buffer A, Na2C 0 3 (20 mg/1) and NaOH (4

mg/1); Buffer B,, 2% sodium potassium tartrate; Buffer B2, 1% C u S 0 4-7H20 ; and
Buffer C, 1 part each of Buffers B, and B2 and 100 parts Buffer A. To 0.1 ml of the
diluted microsomal suspensions, 2 ml of Buffer C were added and the sample was
vortexed. Following a 10. minute incubation period at room temperature, 0.2 ml of
Folin reagent was added and the sample was again vortexed.

After a 30-minute

incubation period at room temperature, the absorbance o f each sample at 750 run was
measured with a Shimadzu UV-160 spectrophotometer, and the protein concentration
was

automatically

determined

from

the

standard

curve

generated

by

the

spectrophotometer. A representative standard curve for the analysis o f microsomal
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protein concentration using BSA is presented in Figure A -l in the Appendix.

All

samples and standard curve BSA solutions were prepared and measured in duplicate.
The yield o f microsomal protein/g liver was determined by dividing the microsomal
fraction o f protein (mg/ml) by the microsomal fraction tissue concentration (g o f fresh
liver/ml) (Lake, 1987).

4.6

Cytochrome P-450 Content

The cytochrome P-450 content of the hepatic microsomes was determined by the
method of Omura and Sato (1964a). The microsomal suspensions were diluted 1:20
in 0.1M potassium phosphate buffer (pH 7.5). A few crystals (1-2 mg) of sodium
dithionate were added and the solution was gently mixed. A reference and a sample
cuvette containing 1 ml of the reduced microsomal solution were placed in a splitbeam spectrophotometer (Shimadzu UV-160).

A baseline o f equal absorbance

between the cuvettes was recorded from 350 to 490 nm. The sample cuvette was then
saturated with carbon monoxide by gently bubbling carbon monoxide (1 bubble/sec
~ 40 sec) through the solution. A difference spectrum of the reduced cytochrome
P-450 bound to carbon monoxide versus the non-bound reduced cytochrome P-450
was then recorded from 350 nm to 490 nm. The difference in absorbance observed
at 350 nm relative to 490 nm (AA450.490) and an extinction coefficient of 91 m M 'Icm '1
(Omura and Sato, 1964a) were used to quantitate the total content o f cytochrome P450 (nmoles of cytochrome P-450/ml of microsomes). This value was divided by the
protein concentration o f the microsomal suspension (mg/ml) to obtain the specific
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content o f cytochrome P-450 in units of nmoles o f cytochrome P-450/mg of
microsomal protein.

4.7

NADH- an d N A D PH -D ependent C ytochrom e c R eductase

The activities of the microsomal flavoprotein reductases were determined using
cytochrome c as an artificial electron acceptor due to the relative difficulty involved
in measuring the actual NADH- and NADPH-cytochrome P-450 reductase activities.
This assay is based on the reduction o f ferric cytochrome c to ferrous cytochrome c
which has a characteristic maximum absorption at A = 550 nm (Lake, 1967). The
method of Phillips and Langdon (1962), as modified by Yasukochi and Masters
(1976), was used to determine NADH- and NADPH-dependent cytochrome c
reductase activities. A solution of cytochrome c was prepared by combining 31 mg
cytochrome c type III from horse heart, 33 ml triple-distilled water and 17 ml of 1 M
phosphate buffer. For measurement of the NADH-cytochrome c reductase activity,
the microsomal suspensions were diluted (1:5 for the avian species and 1:10 for the
rat) in 1 M phosphate buffer (pH 7.7). For the determination of NADPH-cytochrome
c reductase activity, the microsomal suspensions were used at full concentration for
the avian species and diluted 1:10 in 1 M phosphate buffer (pH 7.7) for the rat.
Aliquots (2.5 ml) of cytochrome c solution were placed into reference and sample
cuvettes. To the cytochrome c solution, microsomes (0.005 ml for the birds and 0.01
ml for the rat) were added, the solutions were gently mixed and the cuvettes were
place in a dual-beam Shimadzu UV-160 spectrophotometer. The spectrophotometer
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was set in the kinetic mode with a lag time of 5 sec, rate time o f 75 sec, interval time
o f 15 sec, and X = 550 nm. The spectrophotometer was balanced between the two
cuvettes. The reaction was initiated by adding 10 /d o f freshly prepared NADPH (10
mM) or NADH (lOmM) to the sample cuvette and gently mixing the solution. The
cuvette was immediately returned to the sample chamber and the change in absorbance
over the course of the reaction time was recorded. The AA550 in conjunction with an
extinction coefficient of 21.1 m M 'Icm '1 (Lake, 1967; VanGelder and Slater, 1962) was
used to quantitate NADH- and NADPH-cytochrome c reductase activities (nmole of
cytochrome c reduced/min/ml microsomes). This value was divided by the protein
concentration o f the microsomes (mg/ml) to obtain the activities in nmole of
cytochrome c reduced/min/mg of microsomal protein.

4.8

Ethoxyresorufin-O-Deethylase

Ethoxyresorufin-D-deethylase activity was determined by the method o f Lake (1987).
Trial assays at varying protein levels were conducted to establish reaction linearity
with regard to protein level for the rat and the avian microsomes o f the control and
/3NF treatment groups (Figures A-2 through A-5).

The results of the trial assays

indicated that the appropriate microsomal protein contents for the reaction mixture
were 0.4 mg for the avian species and 0.15 mg for the rat. The reaction mixture (1.8
ml), which consisted of 50 mM tris hydroxy methyl aminomethane (Tris) HC1 buffer
(pH 8.4), 5 mM M gS 04, 3 units of glucose-6-phosphate dehydrogenase, 5 mM
glucose-6-phosphate, 0.5 mM N A D P+ and hepatic microsomes, was prepared and
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maintained at 4° C until used. The reaction tubes were preincubated at 37° C for 5
minutes and 0.5 /xM 7-ethoxyresorufin (0.2 ml 0.5 mM) was added to the mixture to
initiate the reaction. The reaction was carried out at 37° C for 10 min in a shaking
water bath. The reaction mixture was placed on ice and the reaction was stopped by
the addition o f 1 ml o f zinc sulfate (5 % w/v) followed by 1 ml of a saturated barium
hydroxide solution. The reaction mixture was centrifuged (Beckman J-21B) for 10
min at 2000 x g at 4° C.

To 1.5 ml of the supernatant, 3 ml of 0.5 M glycerine-

NaOH buffer (pH 8.5) were added and the mixture was vortexed.

Resorufin

formation was measured on a spectrofluorometer (Farrand Optical Col, Valhalla, New
York) with the excitation and emission wavelengths set at 535 nm and 582 nm,
respectively, and quantitated using resorufin as a standard.

A standard curve was

constructed for each set of samples utilizing a series of concentrations o f resorufin.
A typical resorufin standard curve for the determination of ethoxyresorufin Odeethylase activity is presented in Figure A-6 in the Appendix. All samples were run
in duplicate.

4.9

Benzo[a]pyrene Hydroxylase

Aryl hydrocarbon hydroxylase activity was determined as described by Guengerich
(1982). All samples were run in duplicate. Linear enzymatic kinetics based on the
formation o f 3-OH B[a]P, 9-QH B[a]P, 7,8-diol B[a]P, and 9,10-diol B[a]P were
determined with regard to protein concentration and incubation time for the avian and
rat microsomes (Figures A-7 through A -12 in the Appendix). The reaction mixture
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(0.9 ml) consisted of 50 mM potassium phosphate buffer (pH 7.4), 5 mM M gCl2, 1
mM N A D P+, 80 jiM benzo[ajpyrene, and 0.5 mg microsomal protein. Following a
3 min preincubation period at 37° C, the reaction was initiated by the addition o f 3
units o f glucose-6-phosphate dehydrogenase and 10 mM glucose-6-phosphate (0.1 ml).
The reaction mixture was incubated for 20 min at 37° C in a water bath. The mixture
was then placed on ice and the reaction was terminated by the addition of 1 ml of cold
acetone followed by vortexing. The mixture was extracted twice with ethyl acetate.
The extraction procedure included the addition of 1.5 ml o f ethyl acetate to the
reaction mixture followed by vortexing and then centrifugation at high speed for 5
min. The top layer was removed and retained for analysis. This procedure was then
repeated. The extracts were evaporated to dryness with nitrogen and reconstituted in
250 /xl o f acetonitrile.

M etabolite separation was achieved by high pressure liquid chromatography (HPLC)
(Hewlett Packard HP 1090 HPLC system - HP 79994A Chemstation) utilizing a
reversed-phase octadecylsilyl derivatized silica (ODS) column (Vydac 201 TP, 5/x, 4.6
mm I.D . x 15 cm) (The Sep/a/ra/tions Group, Hesperia, California) with a replaceable
guard column.

Column temperature was maintained at 40° C.

Trial runs were

conducted with standards and microsomal extracts to refine the HPLC param eters for
optimization of metabolite separation and detection. The solvent system utilized for
the analyses was isocratic and consisted of water and acetonitrile (65:35 v/v) at a flow
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rate of 2.0 ml/min. An injection volume of 10 /xl was used via an automated injection
system.

Detection of B[a]P, 3-OH B[a]P, 9-OH B[a]P, B[a]P-trans-7,8-dihydrodiol (-), and
B[a]P-trans-9,10-dihydrodiol was achieved through the use of a programmable
fluorescence detector and a photodiode array detector operating in series.

The

fluorescence detector was set at an excitation wavelength of 260 nm and an emission
wavelength of 420 nm. The photodiode array detector was set at a wavelength of 254
nm with a bandwidth of 20 nm, a reference spectrum o f 550 nm with a bandwidth of
100 nm, and a spectrum range of 210-500 nm. Wavelength selection was based on
data provided in the NCI Analytical Datasheets.

Benzo[ajpyrene and the B[a]P metabolites were identified by retention time through
the UV diode array detector and the fluorescence detector, respectively. Quantitation
of the metabolites was achieved through the use o f external standard calculations.
Standards were prepared from stock solutions of B[a]P and each o f the metabolites.
The concentration ranges of the standard solutions were based on the anticipated levels
o f metabolite production as determined by preliminary assay runs for protein and
reaction time determinations. Peak areas were used to establish standard curves for
each analyte by plotting the integration areas of the generated peaks. Standard curves
were established for each compound being analyzed by utilizing a series o f four
concentrations which were 1.95, 3.90, 5.85 and 7.80 ng//ul for B[a]P 9,10-diol; 0.25,
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0.50, 0.75 and 1.00 ng//d for B[a]P 7,8-diol; 0.73, 1.46, 2.19 and 2.92 ng/^tl for 9OH B[a]P; 1.99, 3.99, 5.98 and 7.93 ng//xl for 3-OH B[a]P; and 20.0, 40.0, 60.0 and
80.0 ng/jttl for B[a]P.

A representative standard curve for each analyte and the

respective correlation coefficients are presented in Figures A-13 through A-17 in the
Appendix.

A method blank was prepared for each analyte to determine if there were any
components in the reaction mixture which might interfere with the identification and
quantitation of the compounds of interest.

Each method blank consisted of 50 mM

potassium phosphate buffer (pH 7.4), 5 mM M gCl2, 1 mM N A D P+, 80 /^M
benzo[a]pyrene, glucose-6-phosphate dehydrogenase, 10 mM glucose-6-phosphate (1.0
ml total), acetone (1 ml), and 21.46 fig o f B[a]P or one of the metabolites.

The

quantity of analyte selected for the method blank was equivalent to the amount of
B[fl]P used in the aryl hydrocarbon hydroxylase assay.

The blank mixture was

extracted twice with 1.5 ml of ethyl acetate as described for the B[a]P hydroxylase
assay. The extract was evaporated to dryness with nitrogen, reconstituted in 250 fil
o f acetonitrile and analyzed by HPLC.

The method blank chromatograms for each

analyte are presented in Figures A-18 through A-22 in the Appendix.

A microsomal blank was prepared for each species to determine if there were any
microsomal components which may interfere with the identification and quantitation
o f the compounds o f interest. Each microsomal blank consisted o f 50 mM potassium

phosphate buffer (pH 7.4), 5 mM

M gCl2, 1 mM N A D P+, 0.5 mg of microsomal

protein, glucose-6-phosphate dehydrogenase, 10 mM glucose-6-phosphate (1.0 ml
total), and acetone (1 ml).

The blank mixture was extracted twice with 1.5 ml of

ethyl acetate as described for the B[a]P hydroxylase assay.

The extract was

evaporated to dryness with nitrogen, reconstituted in 250 /xl of acetonitrile and
analyzed by HPLC. The chromatograms of microsomal blanks for each species are
presented in Figures A-23 through A-30 in the Appendix. These chromatograms and
the method blank chromatograms demonstrated that the assay process was relatively
free from interfering substances and that the analytical method employed had the
ability to adequately resolve and detect the metabolites o f interest from the
assay/microsomal components.

To determine recovery, a known quantity of each analyte was added to the reaction
mixture which consisted o f 50 mM potassium phosphate buffer (pH 7.4), 5 mM
M gCl2, 1 mM N A D P+, glucose-6-phosphate dehydrogenase, 10 mM glucose-6
phosphate and acetone. The mixture was extracted twice with 1.5 ml of ethyl acetate
as described for the B[a]P hydroxylase assay. The extract was evaporated to dryness
with nitrogen, reconstituted in 250 /xl of acetonitrile and analyzed by HPLC.

The

recovery response was then compared to the external standard response to determine
the percent recovery of the analytes. The recovery for B[a]P and its metabolites was
determined to be greater than 95 percent.

Percent recovery for B[a]P was also

determined during subsequent analyses to monitor extraction efficiency.
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All analyses were conducted in duplicate. A calibration curve was constructed for
each set o f samples analyzed. In addition, a method blank was run with each set of
samples. Standards were analyzed after every six samples to serve as a check on the
resolving capability of the column throughout the run. Representative chromatograms
of B[a]P and microsomal metabolite formation for each species are presented in
Figures A-31 through A-38 in the Appendix.

4.10

Statistical Analysis

Significant differences between control and /3NF-treated groups for each species and
for each order were determined utilizing the Student’s t test (SAS,Institute, Inc.,
1988).

Avian orders were also compared within each treatment group with a

Student’s t test. The t test procedure is based on a single comparison o f two group
means. Three levels of significance, p < 0.05, p < 0.01, and p < 0.001, were used
for the t test.

Analysis o f variance was used to determine the significance o f treatment group,
species and the interaction of treatment group by species. To test the significance of
differences between species within each treatment group, two multiple comparison
techniques were employed, Scheffe’s test and Tukey’s test (SAS,Institute, Inc., 1988).
These methods are multiple comparison tests for pairs of group means which arise in
an analysis of variance. Scheffe’s test is more conservative, i.e ., it is more likely not
to find a significant difference between groups, than Tukey’s test.

Three levels of
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significance were examined in the statistical analysis of multiple comparisons, p <
0.05, p < 0.01, and p < 0.001. These statistical analyses were conducted utilizing
the SAS statistical package version 6.03 (SAS,Institute, Inc., 1988).

5.0

RESULTS

The components o f the hepatic microsomal cytochrome P-450 system, including
microsomal protein, specific content of cytochrome P-450, NADPH-dependent
cytochrome c reductase activity and NADH-dependent cytochrome c reductase
activity, were quantitated for the control and /3-naphthoflavone treatment groups o f
each species. The effects of /3-naphthoflavone (/3NF) treatment on ethoxyresorufin-0deethylase and benzo[a]pyrene hydroxylase activities were evaluated on a basis of
specific activity (quantity of product formed per milligram o f microsomal protein) and
m olar activity (quantity o f product formed per nmole of cytochrome P-450, also
referred to as turnover number) for the representative avian species and the rat.
Statistical comparisons were conducted to determine significant differences between:
•

Control and /3NF-treatment groups of each species,

•

Control groups o f the avian species,

•

/3NF-treatment groups of the avian species,

•

Control and /3NF-treatment groups of each avian order (Galliformes
and Anseriformes),

•

Control groups o f each avian order,

•

/3NF-treatment groups of each avian order, and

•

Avian and mammalian species (rat).
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Statistical differences for each of these comparisons are presented for three levels of
significance:

p < 0.05, p < 0.01, and p < 0.001.

The acronyms utilized to

designate the species and treatment group are presented in Table 5-1.

5.1

Components o f the Hepatic Microsomal Cytochrome P-450 System

5.1.1

Microsomal Protein Content

Comparison o f Control and /3NF-Treatment Groups.
The differences observed in the microsomal protein content (expressed as milligrams
o f microsomal protein per gram o f liver) between the control and /3-naphthoflavone
treatment groups ranged from no difference in content to an increase o f 90 percent
with an average increase in microsomal protein o f 50 percent for the avian species.
No significant difference in the content of microsomal protein was seen in the male
rat. Significant increases in the content of microsomal protein were detected in the
/3NF-treatment groups compared to the respective control groups for the goose (1.9fold) and Pekin duck (1.6-fold) (p < 0.01) and for the chicken (1.6-fold), turkey
(1.3-fold), and Khaki Campbell duck (1.4-fold) (p < 0.05).

Comparison o f Avian Species.
The constitutive levels of microsomal protein per gram o f liver were comparable
among the avian species.

The microsomal protein levels for the

/3NF-treatment

groups were significantly greater in the Pekin duck (p < 0.01) and Khaki Campbell
duck (p < 0.05) compared to the quail.
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T able 5-1
T rea tm e n t G ro u p D esignations
CC

CHICKEN CONTROL

CT

CHICKEN TREATMENT

QC

QUAIL CONTROL

QT

QUAIL TREATM ENT

GC

GOOSE CONTROL

GT

GOOSE TREATM ENT

TC

TURKEY CONTROL

TT

TURKEY TREATMENT

PDC

PEKIN DUCK CONTROL

PDT

PEKIN DUCK TREATM ENT

KDC

KHAKI CAMPBELL DUCK CONTROL

KDT

KHAKI CAMPBELL DUCK TREATMENT

MDC

MUSCOVY DUCK CONTROL

M DT

MUSCOVY DUCK TREATMENT

ANC

ANSERIFORMES CONTROL

ANT

ANSERIFORMES TREATMENT

GAC

GALLIFORMES CONTROL

GAT

GALLIFORMES TREATMENT

MRC

MALE RAT CONTROL

MRT

MALE RAT TREATMENT
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Comparison o f Avian Orders.
F or the avian orders, the Anseriformes jSNF-treatment group had significantly higher
microsomal protein per gram o f liver than the Anseriformes control group (p <
0.001) and the Galliformes (SNF-treatment group (p < 0.05).

There was no

significant difference noted (p < 0.05) between the Galliformes control and treatment
groups.

Comparison of Avian Species and Male Rat.
In a comparison of the avian and mammalian species, the average constitutive level
o f microsomal protein per gram of liver for the avian species was approximately 60
percent o f that detected in the male rat. The male rat control group had significantly
higher (p < 0.001) microsomal protein per gram o f liver than the quail, chicken,
goose and Muscovy duck control groups. For the (3NF-treatment groups, the levels
of microsomal protein in the avian species were comparable to the levels o f the treated
male rat. The only significant (p < 0.05) difference between the male rat and the
avian species was with the quail.

The content of hepatic microsomal protein in the avian species and the rat are
presented in Table 5-2.
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T able 5-2
C on ten t o f M icrosom al P ro tein in A vian an d R a t H ep atic M icrosom es

T rea tm e n t G ro u p

mg of m icrosom al p ro tein
p e r g ram o f liver

CC

7 + 2

CT

11+4

QC

7+ 4

QT

7 + 3

GC

7 + 2

GT

13 ± 3

TC

9 + 3

TT

12 + 3

PDC

9 + 2

PDT

14 + 3

KDC

9 + 2

KDT

13 + 3

MDC

6+ 4

M DT

11+6

ANC

8 + 3

ANT

13+4

GAC

8 + 3

GAT

10 + 4

MRC

14 + 2

MRT

14 + 2
(table continued)
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Table 5-2
Content o f Microsomal Protein in Avian and Rat Hepatic Microsomes
Significant Differences Between Control and /SNF-Trcatment Groups
p < 0.05

p < 0.01

p < 0.001

CT > CC

-

-

GT > GC

GT > GC

-

TT > TC

-

-

PDT > PDC

PDT > PDC

-

KDT > KDC

-

-

Significant Differences Between Avian Species
p < 0.05

p < 0.01

p < 0.001

KDT > QT*

-

-

PD T > QT *

PDT > QT*

-

Significant Differences Between Avian Orders
p < 0.05

p < 0.01

p < 0.001

ANT > ANC

ANT > ANC

ANC > ANT

ANT > GAT

-

-

Significant Differences Between Avian Species and M ale Rat
p < 0.05

p < 0.01

p < 0.001

M RC > QC

MRC > QC

M RC > QC*

MRC > CC

MRC > CC

MRC > CC*

MRC > GC

MRC > GC

MRC > GC*

MRC > MDC

MRC > MDC

MRC > MDC*

MRT > QT*

-

-

*Denotes a significant difference for Tukey’s test but not for Scheffe’s test

5.1.2

Specific Content o f Cytochrome P-450

Comparison of Control and ffNF-Treatment Groups.
W ithin the avian species, significant increases detected in cytochrome P-450 content
(nmoles o f cytochrome P-450 per milligram o f microsomal protein) o f the /3NFtreatment groups ranged from 1.7- to 3.2-fold with an average increase of 2.7 times
the levels of P-450 detected in the respective control groups. The greatest increase
in the specific content o f cytochrome P-450 was seen in the Pekin duck (3.2-fold)
treatment group (p < 0.05).

Significant increases in the specific content o f P-450

were also noted in the jSNF-treatment groups for the goose (2.6-fold), Muscovy duck
(2.2-fold), turkey (1.7-fold), and male rat (1.4-fold) (p < 0.001); and the chicken
(1.8-fold) (p < 0.01) when compared to the respective control groups for each
species.

Comparison o f Avian Species.
The specific content o f cytochrome P-450 was comparable among the control groups
of the avian species.

For the /3NF-treatment groups, the specific content of

cytochrome P-450 for the turkey was significantly higher (p < 0.05) than that o f the
Khaki Campbell duck and the chicken. No other significant differences in cytochrome
P-450 content were noted.
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Comparison o f Avian Orders.
The Anseriformes /3NF-treatment group (p < 0.001) and the Galliformes /3NFtreatment group (p <

0.01) had significantly higher P-450 content than their

respective control groups. There was no significant difference in the P-450 content
between the Galliformes and Anseriformes for either the control or treatment groups.

Comparison of Avian Species and Male Rat.
There were no significant differences (p < 0.05) noted between the levels of
cytochrome P-450 in the avian species and the male rat for either the control or /3NFtreatment groups.

The specific content of cytochrome P-450 of the avian and rat hepatic microsomes are
presented in Table 5-3.

5.1.3

N A D H -D ependent C ytochrom e c R eductase

Comparison Control and ffNF-Treatment Groups.
There were no significant differences in the NADH-dependent cytochrome c reductase
activity between the control and jSNF-treatment groups of any of the species studied.

Comparison of Avian Species.
There were numerous significant differences noted in NADH-dependent cytochrome
c reductase activity between the avian control groups and between the avian treatment
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Table 5-3
Cytochrome P-450 Content o f Avian and Rat Hepatic Microsomes

Treatment Group

nmoles o f P-450 per mg
o f microsomal protein

CC

0.5 + 0.2

CT

0.9 ± 0.3

QC

1.2 ± 1.4

QT

2.0 ± 1.4

GC

0.6 + 0.2

GT

1.6 ± 0.3

TC

0.6 ± 0.1

TT

2.1 ± 0.5

PDC

0.5 ± 0.1

PDT

1.6 ± 0.7

KDC

0.5 ± 0.2

KDT

0.9 ± 0.5

MDC

0.6 ± 0.3

MDT

1.3 ± 0.2

ANC

0.5 ± 0.2

ANT

1.4 ± 0.5

GAC

0.8 ± 0.8

GAT

1.7 ± 1.0

MRC

0.9 ± 0.2

MRT

1.3 ± 0.1
(table continued)
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Table 5-3
Cytochrome P-450 Content of Avian and Rat Hepatic Microsomes

Significant Differences Between Control and j8NF-Treatment Groups
p < 0.05

p < 0.01

p < 0.001

CT > CC

CT > CC

-

GT > GC

GT > GC

GT > GC

TT > TC

TT > TC

TT > TC

PDT > PDC

-

-

M DT > MDC

M DT > MDC

M DT > MDC

MRT > MRC

M RT > MRC

M RT > MRC

Significant Differences Between Avian Species
p < 0.05

■

B

f

l i H

i

p < 0.001

TT > KDT*

-

-

TT > CT*

-

-

Significant Differences Between Avian Orders
p < 0.05

p < 0.01

p < 0.001

ANT > ANC

ANT > ANC

ANT > ANC

GAT > GAC

GAT > GAC

-

Significant Differences Between Avian Species and M ale Rat
p < 0.05

p < 0.01

p < 0.001

-

-

-

*Denotes a significant difference for Tukey’s test but not for Scheffe’s test
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groups. The most significant differences in activity (p < 0.001) between the control
groups included goose > turkey, goose > chicken, Khaki Campbell duck > turkey,
and Khaki Campbell duck > chicken.

For the treatment groups, the most significant

differences (P < 0.001) included a greater reductase activity in the Khaki Campbell
duck than in the turkey or chicken. Less significant differences (p < 0.01) included
greater activity in the goose control group compared to the Muscovy control group,
Pekin duck control group compared to the turkey and chicken control groups, the
Muscovy treatment group compared to the chicken and turkey treatment groups, and
(p < 0.05) Pekin duck treatment group compared to the turkey treatment group.

Comparison o f Avian Orders.
There were no significant differences between the reductase activities o f the control
and /JNF-treatment Anseriformes groups or between the control and treatment
Galliformes groups (p < 0.05). In comparison o f the orders, the NADH-dependent
cytochrome c reductase activity in the Anseriformes was significantly (p < 0.001)
greater ( ~ 2-fold) than that of the Galliformes for both the control groups and the
treatment groups.

Comparison o f Avian Species and Male Rat.
The average constitutive reductase activity in the avian species was comparable to that
o f the male rat. Comparison o f the male rat versus the avian species indicated only
one significant difference and that was between the goose and the male rat control

96
groups. The reductase activity of the goose control was 1.9 times greater than that
o f the male rat control.

In the /3NF-treatment groups, there were no significant

differences in activity between the avian species and the rat.

The NADH-dependent cytochrome c reductase activities (expressed as nmoles of
cytochrome c reduced per minute per mg o f microsomal protein) for the avian and
male rat hepatic microsome control and j8-naphthoflavone-treatment groups are
presented in Table 5-4.

5 .1 .4

N A D PH -D ependent C ytochrom e c R eductase

Comparison o f Control and ffNF-Treatment Groups.
There were no significant differences in NADPH-dependent cytochrome c reductase
activity between the control and /3NF-treatment groups for any o f the species studied.

Comparison o f Avian Species.
NADPH-dependent reductase activity was comparable among the avian control
groups. For the jSNF-treatment groups, the only significant difference (p < 0.05)
noted between the avian species was a greater reductase activity in the goose
compared to the Muscovy duck.
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T able 5-4
N A D H -D ependent C ytochrom e c R eductase A ctivity in
A vian an d R at H epatic M icrosom es
T rea tm e n t G ro u p

nmoles o f cytochrom e c reduced
p er m inute p e r mg o f p ro tein

CC

232 ±

98

CT

212 ±

95

QC

584 ± 299

QT

541 ± 135

GC

923 ± 247

GT

583 ± 302

TC

233 ±

TT

199 ± 47

PDC

641 ± 129

PDT

614 ± 780

KDC

759 ± 224

85

KDT

804 ± 391

MDC

461 + 208

M DT

746 + 283

ANC

696 ± 259

ANT

687 ± 296

GAC

349 ± 246

GAT

317 ± 188

MRC

488 ± 92

M RT

551 ± 85
(table continued)
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T able 5-4
N A D H -D ependent C ytochrom e c R eductase A ctivity in
A vian an d R a t H epatic M icrosom es
Significant D ifferences Between C ontrol an d /SN F-Treatm ent G ro u p s
p < 0,05

p < 0.01

p < 0 .0 0 1

-

-

-

S ignificant D ifferences Between A vian Species
p < 0.05

p < 0.01

p < 0.001

GC > MDC

GC > MDC*

-

GC > TC

GC > TC

GC > TC

GC > CC

GC > CC

GC > CC

KDC > TC

KDC > TC

KDC > TC*

KDC > CC

KDC > CC

KDC > CC*

PDC > TC*

PDC > TC*

-

PDC > CC*

PDC > CC*

-

KDT > CT

KDT > CT*

KDT > CT*

KDT > TT

KDT > TT*

KDT > TT*

M DT > CT

M DT > CT*

-

M DT > TT

M DT > T T *

-

PDT > TT*

-

-

Significant D ifferences Between A vian O rd ers
p < 0.05

p < 0.01

p < 0.001

ANC > GAC

ANC > GAC

ANC > GAC

ANT > GAT

ANT > GAT

ANT > GAT

Significant D ifferences Between Avian Species an d M ale R at
p < 0.05
-

p < 0.01

p < 0.001

-

-

*Denotes a significant difference for Tukey’s test but not for Scheffe’s test
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Comparison o f Avian Orders.
There were no significant differences in reductase activity between the control and
/3NF-treatment groups for either the Galliformes or the Anseriformes. Likewise, there
were no significant differences in reductase activity between the Galliformes and
Anseriformes control or /3NF-treatment groups.

Comparison o f Avian Species and Male Rat.
Overall, NADPH-dependent cytochrome c reductase activity was comparable for all
species studied for both the control and treatment groups. Therefore, there were no
significant differences in activity between the avian species and the male rat.

The NADPH-dependent cytochrome c reductase activities (expressed as nmoles of
cytochrome c reduced per minute per mg of microsomal protein) for the avian and
male rat hepatic microsomal control and /3-naphthoflavone-treatment groups are
presented in Table 5-5.

5.2

Ethoxyresorufin-O-Deethylase

5.2.1

Ethoxyresorufin-O-Deethylase - Specific Activity

Comparison o f Control and i3NF-Treatment Groups.
Dramatically greater levels o f EROD activity (based on specific activity) were
observed in the /3NF-treatment groups compared to the respective control groups for
all species studied. The differences in activity level for each species, in order of
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T able 5-5
N A D PH -C ytochrom e c R eductase A ctivity in
A vian an d R at H epatic M icrosom es

T re a tm e n t G ro u p

nmoles o f cytochrom e c red u ced
p er m inute p er m g o f p ro tein

CC

93 + 25

CT

109 ± 37

QC

165 ± 132

QT

162 ± 60

GC

160 ± 33

GT

176 ± 48

TC

117+24

TT

110 + 35

PDC

117 ± 25

PDT

123 + 18

KDC

114 + 13

KDT

121 + 21

M DC

84 + 14

M DT

98 ± 23

ANC

119 + 35

ANT

129 + 40

GAC

130 ± 80

GAT

126 ± 50

MRC

168 ± 32

M RT

137 ± 42
(table continued)
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Table 5-5
NADPH-Cytochrome c Reductase Activity in
Avian and Rat Hepatic Microsomes
Significant Differences Between Control and j8NF-Treatment Groups
p < 0.05

p < 0.01

p < 0.001

-

-

-

Significant Differences Between Avian Species
p < 0.05

p < 0.01

p < 0.001

GT > MDT*

-

-

Significant Differences Between Avian Orders
p < 0.05
-

p < 0.001
-

-

Significant Differences Between Avian Species and M ale Rat

-

p < 0.01

p < 0.001

-

-

*Denotes a significant difference for Tukey’s test but not for Scheffe's test

decreasing magnitude, included: male rat (69-fold) > chicken (39-fold) > goose ~
turkey = Pekin duck (20-fold) > quail ~ Khaki Campbell duck (16-fold) >
Muscovy duck (9-fold). All differences in activity were significant at the p < 0.001
level except for the quail which was significant at the p < 0.01 level. Although the
Muscovy duck had the smallest difference in activity between groups, it should be
noted that this species demonstrated the highest constitutive level o f EROD activity
among the species studied (including the male rat) and that in the /3NF-treatment
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groups, the activity o f the Muscovy was comparable to the activity o f the other avian
treatment groups.

Comparison o f Avian Species.
Constitutive ethoxyresorufin-O-deethylase activity was comparable among the avian
species studied. For the treatment groups, significant differences in activity included
Pekin duck > quail (p < 0.001) and the turkey > quail (p < 0.01).

Other

differences of lesser significance (p < 0.05, differences significant for Tukey’s test
but not for Scheffe’s test) between the avian treatment groups included greater EROD
activity in the Khaki Campbell duck, chicken and Muscovy duck compared to that
observed in the quail.

Comparison o f Avian Orders.
The EROD activities o f the Anseriformes and Galliformes /JNF-treatment groups were
significantly (p < 0.001) increased over the activities o f their respective control
groups. The Anseriformes and the Galliformes /3NF-treatment groups demonstrated
a 15-fold and 25-fold greater activity, respectively, than the constitutive activities of
the respective control groups. Constitutive EROD activity o f the Anseriformes was
significantly (p < 0.05) higher than that of the Galliformes. No significant difference
in activity was detected between the Anseriformes and Galliformes |3NF-treatment
groups.
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Comparison o f Avian Species and Male Rat.
The avian species had constitutive EROD activities comparable to those of the male
rat. Therefore, there were no significant differences (p < 0.05) in EROD activity
between the control groups o f the avian species and the male rat.

In contrast, the

EROD activity demonstrated by the male rat treatment group was significantly greater
(p < 0.001) than that seen in the treatment groups o f each o f the avian species
studied.

Statistical comparison o f the activities of the control and (3NF treatment

groups indicated that the male rat had a 4-times greater (69-fold vs. 17-fold) increase
in EROD activity than the average increase exhibited by the avian species as a whole.

The ethoxyresorufin-O-deethylase activities (expressed as pmoles o f resorufin
produced per minute per mg of microsomal protein) for the avian and male rat hepatic
microsomal control and /6-naphthoflavone-treatment groups are presented in Table 5-6.

5 .2.2

Ethoxyresorufin-O-Deethylase - Molar Activity

Comparison o f Control and 6NF-Treatm ent Groups.
As with specific activity, significant differences in EROD activity were seen between
the control and /3NF-treatment groups for all the species studied.

However, the

increases noted in terms of turnover number were less pronounced than those noted
in terms o f specific activity. Differences in molar activity, between the control and
/3NF-treated groups, presented in order of decreasing magnitude, included male rat
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T able 5-6
Ethoxyresorufin-O -D eethylase A ctivity in A vian an d R a t
H epatic M icrosom es - Specific A ctivity

T reatm en t G ro u p

pinoles of reso ru fin p ro d u ced p e r m inute p er
m g o f p rotein

CC

14 + 7

CT

546 ± 205

QC

11+7

QT

178 + 92

GC

22 ± 11

GT

483 + 137

TC

31 + 28

TT

637 + 122

PDC

34 + 25

PDT

700 + 254

KDC

35 ± 19

KDT

558 + 124

MDC

64 + 65

M DT

544 + 149

ANC

39 ± 37

ANT

571 ± 181

GAC

18 + 19

GAT

454 + 247

MRC

25+5

MRT

1719 + 339
(table continued)
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T able 5-6
E thoxyresorufin-O -D eethylase Activity in A vian an d R a t
H epatic M icrosom es - Specific A ctivity
S ignificant D ifferences Between C ontrol an d /SN F-Treatm ent G ro u p s
p < 0.05

p < 0.01

p < 0.001

CT > CC

CT > CC

CT > CC

QT > QC

QT > QC

-

GT > GC

GT > GC

GT > GC

TT > TC

TT > TC

TT > TC

PDT > PDC

PDT > PDC

PDT > PDC

KDT > KDC

KDT > KDC

KDT > KDC

M DT > MDC

M DT > MDC

M DT > M DC

M RT > MRC

MRT > MRC

M RT > MRC

S ignificant Differences Between Avian Species
p < 0.05

p < 0.001

PDT > QT

PDT > QT

PDT > QT*

TT > QT

TT > QT*

-

KDT > QT*

-

-

CT > QT *

-

-

M DT > QT *

-

-

Significant D ifferences Between Avian O rd ers
p < 0.05

p < 0.01

p < 0.001

ANC > GAC

-

-

ANT > ANC

ANT > ANC

ANT > ANC

GAT > GAC

GAT > GAC

GAT > GAC
(table continued)
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Table 5-6
Ethoxyresorufin-O-Deethylase Activity in Avian and Rat
Hepatic Microsomes - Specific Activity
Significant Differences Between Avian Species and M ale Rat
p < 0.05

p < 0.01

p < 0.001

MRT > PDT

MRT > PDT

MRT > PDT

MRT > TT

MRT > TT

MRT > TT

MRT > KDT

MRT > KDT

MRT > KDT

MRT > CT

MRT > CT

MRT > CT

MRT > MDT

MRT > MDT

MRT > MDT

MRT > GT

MRT > GT

MRT > GT

MRT > QT

MRT > QT

MRT > QT

^Denotes a significant difference for Tukey’s test but not for Scheffe’s test

(47.5-fold) > chicken (21.4-fold) > Khaki Campbell duck (9.3-fold) > Pekin duck
= Japanese quail (7.8-fold) > goose ~ turkey (7.2-fold) > Muscovy duck (3.7fold).

These differences were significant at the p < 0.001 level for the Muscovy

duck and the male rat, at the p < 0.01 level for the turkey, quail, and chicken, and
at the p < 0.05 level for the goose, Pekin duck, and Khaki Campbell duck.

As

discussed in terms o f specific activity, the Muscovy duck had the highest constitutive
level o f EROD activity but had the smallest difference in EROD activity between the
control and treatment groups based on turnover number.

However, for the |3NF
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treatment group, EROD activity in the Muscovy duck was comparable to the levels
observed by the treatment groups o f the other species.

Comparison of Avian Species.
Only a few significant differences in EROD activity were noted between the avian
species.

For the control groups, EROD activity was comparable among the avian

species except for a significant difference between the Muscovy duck and the quail (p
< 0.05, the difference was significant for Tukey’s test but not for Scheffe’s test).
Between the (JNF-treatment groups, significant differences in EROD activity included
greater activity in the Khaki Campbell duck (p < 0.01) and the chicken (p < 0.05,
the difference was significant for Tukey’s test but not for Scheffe’s test) compared to
the quail.

Comparison o f Avian Orders.
The EROD activities were significantly (p < 0.001) greater in the Anseriformes (6.6fold) and Galliformes (12-fold) /3NF-treatment groups compared to the respective
control groups. The activity o f the Anseriformes control group was significantly (p
< 0.01) greater (2.6-fold) than that of the Galliformes control group. However, there
were no significant differences in EROD activity between the Anseriformes and
Galliformes /3NF-treatment groups.
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Comparison of Avian Species and Male Rat.
The level o f constitutive EROD activity for the avian species was equivalent to that
o f the male rat. In contrast, the /3NF-treatment group for the male rat demonstrated
EROD activities that were significantly greater (3-fold) than the activities, on average,
o f the j8NF-treatment avian groups.

Levels of significance for these differences

included p < 0.001 for the Pekin duck, Muscovy duck, turkey, goose, and quail, p
< 0.01 for the chicken, and p < 0.05 (difference was significant for Tukey’s test but
not for Scheffe’s test) for the Khaki Campbell duck.

The ethoxyresorufin-O-deethylase activities (expressed as pmoles o f resorufin
produced per minute per nmole of cytochrome P-450) for the avian and male rat
hepatic microsomal control and 0-naphthoflavone-treatment groups are presented in
Table 5-7.

5.3

Benzo[a]pyrene Hydroxylase

5.3.1

3-Hydroxybenzo[a]pyrene - Specific Activity

Comparison o f Control and ffNF-Treatment Groups.
Based

on

specific

activity,

significant

increases

in

the

formation

of

3-

hydroxybenzo[a]pyrene (3-OH B[tf]P) were observed in the j3NF-treatment groups,
compared to the respective control groups, for the chicken (4-fold) (p < 0.001) and
the quail (2-fold) (p < 0.05). No significant difference in 3-OH B[a]P formation was
detected in the other species studied.
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T able 5-7
Ethoxyresorufin-O -D eethylase A ctivity in A vian an d R at
H epatic M icrosom es - M o lar A ctivity

T reatm en t G ro u p

pmoles of reso ru fin p roduced
p er m inute p e r nm ole o f P-450

CC

30 ± 15

CT

644 ± 341

QC

13 + 10

QT

102 + 49

GC

44 + 34

GT

310 ± 117

TC

46 + 38

TT

330 + 130

PDC

69 ± 49

PDT

544 + 345

KDC

80 ± 61

KDT

747 ± 472

MDC

114 + 114

M DT

424 ± 110

ANC

77 ± 71

ANT

506 ± 328

GAC

30 ± 27

GAT

359 ± 304

MRC
MRT

28 ±

2

1280 ± 224
(table continued)
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T able 5-7
E thoxyresorufin-O -D eethylase A ctivity in A vian an d R at
H epatic M icrosom es - M o lar A ctivity
S ignificant D ifferences Between C ontrol an d /JN F-T reatinent G ro u p s
p < 0.05

p < 0.01

p < 0.001

CT > CC

CT > CC

-

QT > QC

QT > QC

-

GT > GC

-

-

TT > TC

TT > TC

-

PDT > PDC

-

-

KDT > KDC

-

-

MDT > MDC

MDT > MDC

MDT > MDC

MRT > MRC

MRT > MRC

MRT > MRC

Significant Differences Between Avian Species
p < 0.05

p < 0.001

MDC > QC*

-

-

KDT > QT

KDT > QT*

-

CT > QT*

-

-

Significant D ifferences Between A vian O rd ers
p < 0.05

p < 0.01

p < 0.001

ANT > ANC

ANT > ANC

ANT > ANC

ANC > GAC

ANC > GAC

-

GAT > GAC

GAT > GAC

GAT > GAC
(table continued)
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Table 5-7
Ethoxyresorufin-O-Deethylase Activity in Avian and Rat
Hepatic Microsomes - Molar Activity
Significant Differences Between Avian Species and M ale Rat

p < 0.05

p < 0.01

p < 0.001

MRT > KDT*

-

-

MRT > CT

MRT > CT*

-

MRT > PDT

MRT > PDT

MRT > PDT*

MRT > MDT

MRT > MDT

MRT > MDT

MRT > TT

MRT > TT

MRT > TT

MRT > GT

MRT > GT

MRT > GT

MRT > QT

MRT > QT

MRT > QT

*Denotes a significant difference for Tukey’s test but not for Scheffe’s test

Comparison of Avian Species.
Significant differences in the formation of 3-OH B[a]P between the avian control
groups included turkey > chicken (p < 0.001) and quail (p < 0.01), and Khaki
Campbell duck > chicken (p < 0.01).

Less significant (p < 0.05, difference

significant for Tukey’s test but not significant for Scheffe’s test) differences between
control groups included turkey > Pekin duck and turkey > goose. It is interesting
to note that the greatest production of 3-OH B |a]P was by the turkey for both the
control and |3NF-treated groups. In addition, the level of 3-OH B[a]P produced by
the turkey control was greater than the levels produced by the treatment groups of the
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other avian species and, in spite o f the outstanding production of 3-OH B[a]P by the
turkey, only a 13% increase in 3-OH B[a]P formation was present in the treatment
group compared to the control. In contrast, the chicken had the lowest 3-OH B[a]P
formation among the avian species, but had the greatest increase (4.3-fold) in
formation between the control and /3NF-treatment groups. In comparison o f the avian
/3NF-treatment groups, the formation o f 3-OH B[a]P by the turkey was significantly
greater than that o f the chicken. Less significant (p < 0.05, difference significant for
T ukey’s test but not significant for Scheffe’s test) differences between the treatment
groups included greater 3-OH B[«]P production by the turkey, Khaki Campbell duck
and quail compared to the goose.

Comparison o f Avian Orders.
The formation of 3-OH B[a]P by the Galliformes treatment group was significantly
(p < 0.05) greater (2-fold) than that of the Galliformes control group.
Anseriformes control and treatment groups were

The

not significantly different.

Production o f 3-OH B[o]P by the Galliformes treatment group was significantly (p <
0.05) greater than that o f the Anseriformes treatment group but there was no
significant difference detected between the control groups.

Comparison of Avian Species and Male Rat.
Significant differences in the production of 3-OH B[a]P between the avian and male
rat controls included greater 3-OH B[a]P formation in the turkey (3.2-fold) (p <
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0.01) and Khaki Campbell duck (2.7-fold) (p < 0.05, difference significant for
Tukey’s test but not significant for Scheffe’s test) compared to that o f the male rat.
Form ation of 3-OH B[a]P by the jSNF-treatment groups was also significantly greater
in the turkey (2.9-fold) (p < 0.01) and the Khaki Campbell duck (2.1-fold) (p <
0.05, difference significant for Tukey’s test but not significant for Scheffe’s test) than
in the male rat.

The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f 3-OH B[a]P
produced per minute per mg of microsomal protein) for the avian and male rat hepatic
microsomal control and 0-naphthoflavone-treatment groups are presented in Table 5-8.

5.3.2

3-Hydroxybenzo[a]pyrene - Molar Activity

Comparison of Control and Treatment Groups.
In comparison with the control groups, significantly (p < 0.05) greater quantities of
3-OH B[a]P were produced (based on turnover number) by the treatment groups of
the chicken (2.4-fold) and quail (1.7-fold). In contrast, significantly (p < 0.05) lower
levels o f 3-OH B[a]P formation were produced by the treatment groups of the goose
(4-fold), turkey (3-fold), and Muscovy duck (1.6-fold) respective to their control
groups. No difference in 3-OH production was seen between the control and /3NFtreatment groups of the Pekin duck, Khaki Campbell duck, and male rat.
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T able 5-8
B enzo[a]pyrene H ydroxylase A ctivity in A vian an d R at H epatic
M icrosom es: F o rm atio n o f 3-H ydroxybenzo[a]pyrene - Specific Activity

T reatm en t G ro u p

pinoles o f 3-O H B [a]P p ro d u ced
p e r m inute p e r m g o f p ro tein

CC

102 + 51

CT

436 ± 97

QC

236 ± 264

QT

534 ± 184

GC

317 ± 174

GT

232 ± 80

TC

714 + 256

TT

805 ± 244

PDC

323 ± 264

PDT

481 ± 93

KDC

595 + 237

KDT

577 ± 139

MDC

381 ± 196

MDT

520 ± 133

ANC

404 ± 236

ANT

453 ± 172

GAC

351 + 337

GAT

592 ± 237

MRC

221 ± 112

MRT

280 ± 130
(table continued)
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Table 5-8
B enzo[a]pyrene H ydroxylase Activity in A vian an d R a t H epatic
M icrosom es: F orm atio n of 3-H ydroxybenzo[a]pyrene - Specific A ctivity
S ignificant D ifferences Between C o n tro l an d T rea tm e n t G ro u p s
p < 0.05

p < 0.01

p < 0.001

CC > CT

CC > CT

CC > CT

QT > QC

-

-

S ignificant D ifferences Between Avian Species
p < 0.05

p < 0.01

p < 0.001

TC > PDC*

-

-

TC > GC*

-

-

TC > QC

TC > QC*

-

TC > CC

TC > CC

TC > CC*

KDC > CC

KDC > CC*

-

TT > PDT*

-

-

TT > CT*

TT > CT*

-

TT > GT*

-

-

KDT > GT*

-

-

QT > GT*

-

-

Significant D ifferences Between A vian O rd ers
p < 0.05

p < 0.01

p < 0.001

GAT > ANT

-

-

GAT > GAC

-

-

(table continued)
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T able 5-8
B enzo[a]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: F orm ation of 3-H ydroxybenzo[a]pyrene - Specific Activity
Significant D ifferences Between Avian Species an d M ale R a t
p < 0.05

p < 0.01

p < 0.001

TC > MRC

TC > MRC*

-

KDC > MRC*

-

-

TT > MRT

TT > MRT

TT > MRT

KDT > MRT*

-

-

^Denotes a significant difference for Tukey’s test but not for Scheffe’s test.

Comparison o f Avian Species.
Significant differences between the avian control groups included greater 3-OH B[a]P
formation by the Khaki Campbell duck compared to the chicken, quail (p < 0.001),
and goose (p < 0.05, difference significant for Tukey’s test but not significant for
Scheffe’s test) and by the turkey compared to the chicken and quail (p < 0.001). In
terms of molar activity, the Khaki Campbell duck control and treatment groups had
the greatest formation o f 3-OH B[a]P rather than the turkey as was seen when the
statistical analysis was based on specific activity.
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Comparison of Avian Orders.
The Anseriformes control group produced a significantly (p < 0.01) greater quantity
(2-fold) o f 3-OH B[a]P than the treatment group. There was no significant difference
in 3-OH B[a]P metabolite formation seen between the Galliformes control and /JNFtreatment groups.

In addition, no significant difference was detected between the

avian orders for either the control or treatment groups.

Comparison of Avian Species and Male Rat.
Comparisons between the avian and male rat control groups indicated the turkey (p
< 0.001) and the Khaki Campbell duck (p < 0.01) produced significantly greater
quantities of 3-OH B[a]P than the male rat. Constitutive production of 3-OH B[n]P
by the remaining species was comparable to that of the male rat.

O f the treatment

groups, the only species significantly different from the male rat were the Khaki
Campbell duck (p < 0.001) and the chicken (p < 0.05, difference significant for
Tukey’s test but not significant for Scheffe’s test).

The Khaki Campbell duck and

chicken treatment groups produced greater quantities of 3-OH B[a]P, 3.2- and 2.4fold, respectively, than was produced by the male rat. Formation o f the 3-OH B[a]P
metabolite by the treatment groups o f the other species was similar to that observed
in the male rat.
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The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f 3-OH B[a]P
produced per nmole o f cytochrome P-450) for the avian and male rat hepatic
microsomal control and (3-naphthoflavone-treatment groups are presented in Table 5-9.

5.3.3

9-Hydroxybenzo[a]pyrene - Specific Activity

Comparison of Control and ffNF-Treatment Groups.
Evaluation o f the results of the 6 individual animals within each control group
indicated that 9-hydroxybenzo[a]pyrene (9-OH B[<a]P) was produced by only 5 o f the
male rats, 5 o f the Pekin ducks, and 4 o f the Muscovy ducks. Six out o f 6 animals
produced 9-OH B[<?]P within the control groups o f the other species.

Based on

specific activity, the formation o f 9-OH B[a]P in the /JNF-treatment groups was
significantly greater than that o f the control groups for all the species studied. The
greatest increases following jSNF-treatment were present in the Pekin duck (4.4-fold)
and the chicken (4-fold), followed by the male rat (3.3-fold), goose (3-fold), Khaki
Campbell duck (3-fold), Muscovy duck (3-fold), quail (2-fold), and the turkey (1.5fold). Levels o f significance for these increases included p < 0.001 for the chicken,
goose, Pekin duck, and Khaki Campbell duck and p < 0.05 for the quail, Muscovy,
and male rat.
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T able 5-9
B enzo[a]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: F o rm atio n o f 3-H ydroxybenzo[a]pyrene - M o lar A ctivity

T re a tm e n t G ro u p

pmoles of 3-O H B [a]P 7,8 -p ro d u ced
p er m inute p er nm ole o f P-450

CC

219 ± 113

CT

516 ± 221

QC

192 ± 58

QT

317 ± 106

GC

568 + 333

GT

144 + 46

TC

1201 ± 553

TT

422 ± 132

PDC

639 ± 426

PDT

339 ± 113

KDC

1293 ± 669

KDT

702 ± 276

MDC

663 ± 152

M DT

415 ± 154

ANC

791 ± 517

ANT

440 ± 262

GAC

537 ± 580

GAT

409 ± 175

MRC

245 ± 112

MRT

219 ± 89
(table continued)
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T able 5-9
B enzo[a]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: F o rm atio n o f 3-H ydroxybenzo[a]pyrene - M o lar A ctivity
S ignificant D ifferences Between C ontrol an d /JN F-T reatm ent G ro u p s
p < 0.05

p < 0.01

p < 0.001

CT > CC

-

-

QT > QC

-

-

GT > GC

-

-

TC > TT

-

-

MDC > M DT

-

-

S ignificant D ifferences Between A vian Species
p < 0.05
KDC > GC*

p < 0.01
■

p < 0,001

-

-

KDC > CC

KDC > CC

KDC > CC*

KDC > QC

KDC > QC

KDC > QC*

TC > CC

TC > CC*

TC > CC*

TC > QC

TC > QC*

i

KDT > PDT*

KDT > PDT*

-

KDT > QT

KDT > QT*

-

KDT > GT

KDT > GT

KDT > GT

CT > GT*

CT > GT*

-

> QC*

S ignificant D ifferences Between A vian O rd ers
p < 0.05

p < 0.01

p < 0.001

ANC > ANT

ANC > ANT

(table continued)
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T able 5-9
B enzo[a]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: F o rm atio n of 3-H ydroxybenzo[a]pyrene - M o lar A ctivity
S ignificant D ifferences Between Avian Species an d th e M ale R at
p < 0,05

p < 0.01

p < 0.001

KDC > MRC

KDC > MRC

KDC > MRC*

TC > MRC

TC > MRC*

-

KDT > MRT

KDT > MRT

KDT > MRT

CT > MRT*

-

-

*Denotes a significant difference for Tukey’s test but not for Scheffe’s test

Comparison of Avian Species.
Ranking of the avian species based on the formation o f 9-OH B[a]P resulted in
following sequences: turkey > chicken = quail ~ goose = Muscovy duck = Khaki
Campbell duck > Pekin duck for the control groups and turkey ~ chicken > goose
> quail > Pekin duck > Muscovy duck > Khaki Campbell duck for the treatment
groups. It should be noted that the turkey had the greatest formation o f 9-OH B[a]P
among the control groups

and

among

the treatment groups,

yet had the

smallestdifference (1.5-fold) in formation between the control and treatment groups.
It is also interesting to note that the constitutive level o f 9-OH formation for the
turkey was greater ( ~ 2-fold) than the treated levels of the other avian species
(excluding the chicken). Numerous significant (p < 0.001) differences were noted
between the avian species.

For the control groups, significant (p <

0.001)
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differences were noted between the turkey and each of the other avian species.
Production of the 9-OH B[a]P metabolite was similar among the remaining avian
control groups. Between the treatment groups, 9-OH B[n]P formation by the turkey
and the chicken was significantly (p < 0 .0 0 1 ) greater than formation by the goose,
quail, Muscovy duck, Pekin duck, and Khaki Campbell duck.

No significant

differences were observed between the treatment groups of the other avian species.

Comparison o f Avian Orders.
Significant differences were detected between the control and treatment groups o f both
the Anseriformes (p < 0.001) and the Galliformes (p < 0.01). Production o f 9-OH
B[#]P by the j8NF-treatment groups were significantly greater (Anseriformes 3-fold,
Galliformes, 2-fold) than that of the respective control groups. Significant differences
between orders included greater formation of 9-OH B[a]P by the Galliformes control
group (3.9-fold) compared to the Anseriformes control group (p < 0.01) and greater
production

in the Galliformes

treatment group

(2.4-fold) compared

to

the

Anseriformes treatment group (p < 0.001).

Comparison of the Avian Species and Male Rat.
In general, 9-OH B[a]P production by the avian species equaled or exceeded that of
the male rat for both the control groups and the treatment groups. Significant (p <
0.001) differences in 9-OH B[a]P formation were present between the turkey and the
male rat control groups, chicken and male rat treatment groups and the turkey and the
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male rat treatment groups.

The differences in 9-OH B[a]P formation between the

control and /3NF-treatment groups for the avian species (1.5- to 4-fold) were
comparable to that o f the male rat (3-fold).

The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f 9-OH B[fl]P
produced per minute per mg of microsomal protein) for the avian and male rat hepatic
microsomal control and (S-naphthoflavone-treatment groups are presented in Table 5-

10.

5 .3 .4

9-Hydroxybenzo[a]pyrene - Molar Activity

Comparison o f Control and ffNF-Treatment Groups.
The only significant (p < 0.05) difference in 9-OH B[a]P formation detected between
the control and treatment groups, based on molar activity, was for the chicken (2-fold
increase in the treatment group respective to the control group).

Comparison of Avian Species.
The levels o f 9-OH B[tf]P formation among the avian species included turkey >
chicken ~ Muscovy duck ~ goose ~ Khaki Campbell duck = quail = Pekin duck
for the control groups and chicken > turkey = Khaki Campbell duck ~ Muscovy
duck ~ goose * quail * Pekin duck for the /3NF-treatment groups.

There were

numerous significant differences in 9-OH formation between the avian species.
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T able 5-10
B enzo[a]pyrene H ydroxylase A ctivity in A vian a n d R a t H ep atic
M icrosom es: F o rm atio n o f 9-H ydroxybenzo[a]pyrene - Specific A ctivity

T rea tm e n t G ro u p

pinoles o f 9-O H B [a]P p ro d u ced
p er m inute p e r m g o f p ro tein

CC

49 ± 21

CT

195 + 53

QC

41 ± 41

QT

78 ± 19

GC

28 + 16

GT

83 ± 22

TC

154 ± 74

TT

232 + 70

PDC

14 + 8

PDT

61 ± 17

KDC

20 + 9

KDT

59 + 20

MDC

23 + 29

M DT

73 + 34

ANC

21 + 17

ANT

69 + 25

GAC

81 + 71

GAT

168 ± 83

MRC

24 ± 14

MRT

78 + 48
(table continued)
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T able 5-10
B enzo[a]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: F o rm atio n o f 9-H ydroxybenzo[a]pyrene - Specific A ctivity
Significant D ifferences Betw een C ontrol a n d j8N F-Treatm ent G ro u p s
p < 0.05

p < 0.01

p < 0.00J

CT > CC

CC > CT

CC > CT

QT > QC

-

-

GT > GC

GT > GC

GT > GC

PDT > PDC

PDT > PDC

PDT > PDC

K DT > KDC

KDT > KDC

KDT > KDC

M D T > MDC

-

-

M RT > MRC

-

-

Significant D ifferences Between A vian Species
p < 0.05

p < 0.001

TC > CC

TC > CC

TC > CC*

TC > QC

TC > QC

TC > QC

TC > GC

TC > GC

TC > GC

TC > MDC

TC > MDC

TC > MDC

TC > KDC

TC > KDC

TC > KDC

TC > PDC

TC > PDC

TC > PDC

TT > GT

TT > GT

TT > GT

TT > QT

TT > QT

TT > QT

TT > M DT

TT > M DT

TT > M DT

TT > PDT

TT > PDT

TT > PDT

TT > KDT

TT > KDT

TT > KDT

CT > GT

CT > GT*

CT > GT*
(table continued)
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T able 5-10
B enzo[a]pyrene H ydroxylase A ctivity in A vian a n d R at H epatic
M icrosom es: F orm atio n of 9-H ydroxybenzo[a]pyrene - Specific A ctivity
CT > QT

CT > QT

CT > QT*

CT > M DT

CT > MDT

CT > MDT*

CT > PDT

CT > PDT

CT > PDT

CT > KDT

CT > KDT

CT > KDT

S ignificant D ifferences Between A vian O rd ers
p < 0.05

p < 0.01

p < 0.001

ANT > ANC

ANT > ANC

ANT > ANC

GAT > GAC

GAT > GAC

-

GAT > ANT

GAT > ANT

GAT > ANT

GAC > ANC

GAC > ANC

-

S ignificant D ifferences Between Avian Species a n d th e M ale R a t
p < 0.05

p < 0.001

TC > MRC

TC > MRC

TC > MRC

TT > MRT

TT > MRT

TT > MRT

CT > MRT

CT > MRT

CT > MRT*

^Denotes a significant difference for Tukey’s test but not for Scheffe’s test

Comparisons of the control groups indicated that 9-OH B[a]P formation by the turkey
was significantly (p < 0.001) greater than that of the other avian species.

F or the

treatment groups, 9-OH B[a]P formation by the chicken was significantly greater than
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than that o f the other avian treatment groups (p < 0.01 for the turkey and p < 0.001
for the other species).

Comparison o f Avian Orders.
The Anseriformes treatment group produced a significantly (p < 0.05) greater level
of 9-OH B[a]P than the control group. No significant difference was seen between
the Galliformes control and treatment groups. 9-Hydroxybenzo[a]pyrene formation
in the Galliformes control and treatment groups was significantly (p < 0.01) greater
than the formation seen in the Anseriformes control and treatment groups,
respectively.

Comparison of Avian Species and Male Rat.
In the avian species, the formation of 9-OH B[a]P by the control and treatment groups
was equivalent to or greater than that o f the male rat control. Significant (p < 0.001)
differences between the avian species and the male rat included greater 9-OH B[a]P
formation in the turkey control compared to the male rat control and in the chicken
treatment group compared to the male rat treatment group.

The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f 9-OH B[a]P
produced per nmole of cytochrome P-450) for the avian and male rat hepatic
microsomal control and /3-naphthoflavone-treatment groups are presented in Table 511.
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T able 5-11
B enzo[a]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: F o rm atio n of 9-H ydroxybenzo[a]pyrene - M o lar A ctivity

T reatm en t G ro u p

pinoles o f 9-O H B [a]P p ro d u ced
p er m inute p e r nm ole o f P-450

CC

105 + 38

CT

231 + 103

QC

38 ± 11

QT

47 ± 18

GC

45 + 20

GT

52 + 15

TC

256 + 142

TT

124 ± 50

PDC

29 ± 17

PDT

45 ± 18

KDC

42 ± 24

KDT

71 ± 27

MDC

51 ± 62

MDT

59 ± 35

ANC

38 ± 25

ANT

57 ± 26

GAC

132 ± 126

GAT

132 ± 100

MRC

28 ± 19

MRT

60 ± 35
(table continued)
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T able 5-11
B enzo[a]pyrene H ydroxylase Activity in A vian an d R a t H epatic
M icrosom es: F o rm atio n o f 9-H ydroxybenzo[a]pyrene - M o lar A ctivity
S ignificant D ifferences Between C ontrol an d /SN F-Treatm ent G ro u p s
p < 0.05

p < 0.01

p < 0.001

CC > CT

-

-

Significant D ifferences Between Avian Species
p < 0.05

p < 0.01

p < 0.001

TC > CC

TC > CC*

TC > CC*

TC > GC

TC > GC

TC > GC

TC > KDC

TC > KDC

TC > KDC

TC > QC

TC > QC

TC > QC

TC > MDC

TC > MDC

TC > MDC

TC > PDC

TC > PDC

TC > PDC

CT > TT

CT > TT*

-

CT > KDT

CT > KDT

CT > KDT

CT > M DT

CT > MDT

CT > M DT

CT > GT

CT > GT

CT > GT

CT > QT

CT > QT

CT > QT

CT > PDT

CT > PDT

CT > PDT

Significant D ifferences Between Avian O rd ers
p < 0.01

p < 0.01

p < 0.001

GAC > ANC

GAC > ANC

-

GAT > ANT

GAT > ANT -

-

ANT > ANC

-

(table continued)
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T able 5-11
B enzo[a]pyrene H ydroxylase A ctivity in A vian a n d R a t H epatic
M icrosom es: F o rm atio n of 9-H ydroxybenzo[a]pyrene - M o lar A ctivity
S ignificant D ifferences Between A vian Species a n d th e M ale R at
p < 0.05

p < 0.01

p < 0.001

TC > MRC

TC > MRC

TC > MRC

CT > MRT

CT > MRT

CT > M RT

^Denotes a significant difference for Tukey’s test but not for Scheffe’s test.

5 .3 .5

B enzo[a]pyrene 7,8-D ihydrodiol - Specific A ctivity

Comparison o f Control and ffNF-Treatment Groups.
Significant increases in benzo[o]pyrene 7,8-dihydrodiol (B[<s]P 7,8-diol) formation
were present in treatment groups, compared to the respective control groups, for all
o f the species studied. The most significant increases were seen in the chicken (22fold), turkey (10-fold), Pekin duck (7-fold), and male rat (3-fold) (p < 0.001)
followed by the Khaki Campbell duck (7-fold) (p < 0.01), quail (9-fold) and the
goose (p < 0.05). It should be noted that B[a]P 7,8-diol was not produced by any
member o f the goose control group. In addition, B[a]P 7,8-diol was not produced by
2 animals within the Muscovy control group.

However, all 6 animals within the

goose and Muscovy duck treatment groups did produce B[a]P 7,8-diol.
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Comparison o f Avian Species.
W ithin the avian control groups, and within the avian treatment groups, the greatest
production o f B[a]P 7,8-diol was by the Muscovy duck. In comparison o f the avian
control groups, the only significant (p < 0.05, difference significant for Tukey’s test
but not significant for Scheffe’s test) difference in B[a]P 7,8-diol formation was
between the Muscovy duck and goose. In contrast, numerous significant differences
were detected between the avian jSNF-treatment groups.

The most significant

differences in B[a]P 7,8-diol formation included Muscovy > quail and goose (p <
0.001) followed by Khaki Campbell duck > quail and goose (p < 0.01).

Less

significant (p < 0.05, difference significant for Tukey’s test but not significant for
Scheffe’s test) differences included the Muscovy > chicken and turkey and the Pekin
duck > quail and goose.

Comparison o f Avian Orders.
Both the Anseriformes and Galliformes treatment groups produced significantly (p <
0.001) greater (5-fold and 11-fold, respectively) levels of B[a]P 7,8-diol than their
respective control groups. There was also a significantly greater formation of 7,8-diol
by the Anseriformes control (4-fold) (p < 0.05) and treatment ( 2-fold) (p < 0.01)
groups compared to the respective Galliformes control and treatment groups.
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Comparison o f Avian Species and Male Rat.
In general, the formation o f B[a]P 7,8-diol by the avian control and treatment groups
was equivalent to that of the male rat control and treatment groups, respectively.
Therefore, there were no significant differences in B[a]P 7,8-diol formation between
the avian species and the male rat for either the control or treatment groups.
However, the difference in formation o f B[a]P 7,8-diol between the control and /3NFtreatm ent groups was much more pronounced (7 to 21.5-fold) in the avian species than
in the male rat (3.3-fold) except for the Muscovy duck (3.3-fold).

The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f B[a]P 7,8-diol
produced per minute per mg o f microsomal protein) for the avian and male rat hepatic
microsomal control and /3-naphthoflavone-treatment groups are presented in Table 5-

12.

5 .3 .6

Benzo[a]pyrene 7,8-Dihydrodiol - Molar Activity

Comparison o f Control and ffNF-Treatment Groups.
In terms of m olar activity, B[a]P 7,8-diol formation by the /3NF-treatment groups was
significantly greater than that for the control groups for the quail, Khaki Campbell
duck (p < 0.001), chicken, goose, turkey (p < 0.01), and male rat ( p < 0.05).
The most pronounced difference was seen in the quail (48-fold), followed by the
chicken (13-fold), turkey (3-fold), and Khaki Campbell duck (3.3-fold).
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T able 5-12
B enzo[a]pyrene H ydroxylase Activity in Avian an d R a t H epatic
M icrosom es: F o rm atio n o f B enzo[a]pyrene 7,8-dihydrodiol
Specific Activity

T rea tm e n t G ro u p

pmoles o f B [a]P 7,8-dihydrodiol p ro d u ced
p er m in u te p er m g of p ro tein

CC

2+ 2

CT

43 ± 14

QC

2 + 4

QT

18 ± 12

GC

ND1

GT

17 + 9

TC

4 ± 5

TT

40 + 9

PDC

10 + 7

PDT

66 + 22

KDC

11 ± 9

KDT

76 ± 39

MDC

27 + 38

M DT

89 + 36

ANC

12 + 21

ANT

61 + 38

GAC

3+ 4

GAT

34 + 16

MRC

14 + 11

MRT

46 + 16
(table continued)
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T able 5-12
B enzo[a]pyrene H ydroxylase Activity in A vian an d R a t H epatic
M icrosom es: F o rm atio n of B enzo[a]pyrene 7,8-dihydrodiol
Specific Activity
S ignificant D ifferences Between C ontrol an d j5N F-Treatm ent G ro u p s
p < 0.05

p < 0.01

p < 0.001

CT > CC

CT > CC

CT > CC

QT > QC

-

-

GT > GC

-

-

TT > TC

TT > TC

TT > TC

PD T > PDC

PDT > PDC

PDT > PDC

KDT > KDC

KDT > KDC

-

M DT > MDC

-

-

M RT > MRC

MRT > MRC

MRT > MRC

Significant Differences Between A vian Species
p < 0,05

p < 0,001

M DC > GC*

-

-

M DT > CT*

-

-

M DT > TT*

-

-

M DT > QT

MDT > QT

M DT > QT*

M DT > GT

MDT > GT

M DT > GT*

KDT > QT

KDT > QT*

-

KDT > GT

KDT > GT*

-

PDT > QT*

-

-

PDT > GT*

-

-

(table continued)
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Table 5-12
Benzo[a]pyrene Hydroxylase Activity in Avian and Rat Hepatic
Microsomes: Formation o f Benzo[a]pyrene 7,8-dihydrodioI
Specific Activity
Significant Differences Between Avian Orders
p < 0,05

p < 0.01

p < 0.001

ANT > ANC

ANT > ANC

ANT > ANC

GAT > GAC

GAT > GAC

GAT > GAC

ANT > GAT

ANT > GAT

-

ANC > GAC

-

-

Significant Differences Between Avian Species and M ale Rat
p < 0.05
-

p < 0.001
-

-

'N D indicates a nondetectable value
^Denotes a significant difference for Tukey’s test but not for Scheffe’s test

Comparison o f Avian Species.
Between the avian control groups, there was a significantly greater formation o f B[a]P
7,8-diol in the Muscovy compared to the goose and the quail (p < 0.05, difference
significant for Tukey’s test but not significant for Scheffe’s test).
differences were noted between the avian treatment groups.

Numerous

The most significant

differences in B[a]P 7,8-diol formation for the /3NF-treatment groups were between
the Khaki Campbell duck and the turkey, quail, and goose (p < 0.001) and between
the Muscovy and the turkey (p < 0.01), quail and goose (p < 0.001), and between

136
the Muscovy and turkey (p < 0.01).

Less significant differences (p < 0.05,

difference significant for Tukey’s test but not significant for Scheffe’s test) were
present between the chicken and the quail, the chicken and the goose, the Pekin duck
and the quail, and the Pekin duck and the goose.

Comparison o f Avian Orders.
Both the Anseriformes (p < 0.01) and Galliformes (p < 0.001) treatment groups
produced significantly greater (2-fold and 7-fold, respectively) levels o f B[a]P 7,8-diol
than their respective control groups.

There was also a significantly (p < 0.01)

greater production o f B[a]P 7,8-diol metabolite by the Anseriformes control (6-fold)
and treatment (2-fold) groups over the respective Galliformes groups.

Comparison of Avian Species and Male Rat.
In general, the avian control and treatment groups produced levels of B[<j ]P 7,8-diol
comparable to that o f the male rat.

The only significant (p < 0.01) difference in

B[a]P 7,8-diol formation between the avian and male rat groups was between the
treatment groups o f the Khaki Campbell duck and the male rat.

The benzo[a]pyrene hydroxylase activities (expressed as pmoles of B[a]P 7,8-diol
produced per nmole o f cytochrome P-450) for the avian and male rat hepatic
microsomal control and /3-naphthoflavone-treatment groups are presented in Table 513.
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T able 5-13
B enzo[a]pyrene H ydroxylase A ctivity in A vian and R a t H epatic
M icrosom es: F o rm atio n of B enzo[a]pyrene 7,8-dihydrodiol
M o lar Activity

T reatm en t G ro u p

pinoles o f B [a]P 7,8-dihydrodiol p ro d u ced
p er m inute p er nm ole o f P-450

CC

4 ± 6

CT

51 ± 23

QC

0.4 ± 1

QT

19 + 5

GC

ND1

GT

10 + 5

TC

6 + 7

TT

20 ± 8

PDC

23 + 16

PDT

51 ± 25

KDC

25 + 25

KDT

82 + 20

MDC

42 ± 50

M DT

69 + 38

ANC

23 + 32

ANT

53 ± 36

GAC

4 + 5

GAT

27 + 23

MRC

14 + 11

MRT

33 + 13
(table continued)
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T able 5-13
B enzo[«]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: F o rm atio n o f B enzo[a]pyrene 7,8-dihydrodiol
M o lar Activity
Significant D ifferences Between C ontrol an d /3N F-Treatm ent G ro u p s
p < 0.05

p < 0.01

p < 0.001

CC > CT

CC > CT

-

QT > QC

QT > QC

QT > QC

GT > GC

GT > GC

-

TC > TT

TC > TT

-

KDC > KDT

KDC > KDT

KDC > KDT

M RT > MRC

-

-

S ignificant D ifferences Between A vian Species
p < 0.05

p < 0.01

p < 0.001

M DC > QC*

-

-

M DC > GC*

-

-

KDT > TT

K D T > TT

KDT > TT*

KDT > GT

KDT > GT

KDT > GT

KDT > QT

KDT > QT

KDT > QT

M DT > TT

M DT > TT*

-

M DT > GT

M DT > GT

M DT > GT*

M DT > QT

M DT > QT

M DT > QT*

CT > GT*

-

-

CT > QT*

-

-

PDT > GT*

-

-

PDT > QT*

-

-

(table continued)
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Table 5-13
Benzo[a]pyrene Hydroxylase Activity in Avian and Rat Hepatic
Microsomes: Formation of Benzo[o]pyrene 7,8-dihydrodiol
Molar Activity
Significant Differences Between Avian Orders
p < 0,05

p < 0.01

p < 0.001

ANC > GAC

ANC > GAC

-

ANT > GAT

ANT > GAT

-

ANT > ANC

ANT > ANC

-

GAT > GAC

GAT > GAC

GAT > GAC

Comparison o f Avian Species and M ale Rat
p < 0.05

p < 0.01

p < 0.001

KDT > MRT

KDT > MRT*

-

*ND indicates a nondetectable value
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test.

5 .3 .7

B enzo[a]pyrene 9,10-D ihydrodiol - Specific A ctivity

Comparison o f Control and ffNF-Treatment Groups.
O f the control groups, the only species which formed the B[a]P 9,10-dihydrodiol
(B[tf]P 9,10-diol) metabolite were the Khaki Campbell duck and the male rat. W ithin
the Khaki Campbell duck control group, only 2 of the 6 animals formed B[a]P 9,10diol.

In the /3NF-treatment groups, B[a]P 9,10-diol was formed by all the species

studied.

However, only 20 to 40 percent of the animals within each o f the avian
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treatment groups formed the metabolite.

The only significant difference between

control and treatment groups for this metabolite was for the goose (p < 0 .0 5 ).

Comparison of Avian Species.
Metabolite formation among the avian species was comparable for both the control
and treatment groups. Hence, there were no significant differences between the
control groups nor between the /3NF-treatment groups o f the avian species.

Comparison o f Avian Orders.
Benzo[a]pyrene 9,10-dihydrodiol formation was significantly greater in the (itreatment

groups compared

to the respective

control

groups for both the

Anseriformes (p < 0.001) and the Galliformes (p < 0.05).

It should be noted that

within the control groups o f the Galliformes order, none o f the species formed B[o]P
9,10-diol and within the Anseriformes order, only the Khaki Campbell duck formed
the metabolite. There were no significant differences in B[a]P 9,10-diol formation
between the Anseriformes and Galliformes.

Comparison o f Avian Species and Male Rat.
Benzo[o]pyrenc 9,10-dihydrodiol formation by the male rat control and treatment
groups was significantly (p < 0.001) greater than that o f the respective avian groups.
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The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f B[a]P 9,10-diol
formed per minute per mg o f microsomal protein) in avian and male rat hepatic
microsomes o f control and P-naphthoflavone treatment groups are presented below
in Table 5-14.

5.3.8

Bcnzo[a]pyrene 9,10-Dihydrodiol - Molar Activity

Comparison o f Control and BNF-Treatment Groups.
In terms o f molar activity, the only species that had a significant difference in B[a]P
9,10-diol formation between the control and pNF-treatment groups were the goose
and the male rat.

Comparable quantities o f B[a]P 9,10-diol were formed by the

control and treatment groups o f the remaining avian species.

Comparison o f Avian Species.
Benzo[a]pyrene 9,10-dihydrodiol production was similar among the control groups
and among the treatment groups o f the avian species.

There were no significant

differences in B[a]P 9,10-diol formation (p < 0.05) between the control groups nor
between the pNF-treatment groups o f the avian species.

Comparison o f Avian Orders.
Benzo[fl]pyrene 9,10-dihydrodiol formation by the Galliformes PNF-treatment group
was significantly (p < 0.05) greater than that o f the control group.
significant differences were noted within or between the orders.

No other
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T able 5-14
Benzo[fl]pyrcnc H ydroxylase Activity in A vian and R at H epatic
M icrosom es: F o rm atio n of Benzo[o]pyrene 9,10-dihydrodiol Specific Activity

T rea tm e n t G ro u p

pmoles of B[«]P 9,10-dihydrodiol p ro d u ced
p e r m inute p e r mg of protein

CC

ND1

CT

25 ± 24

QC

ND

QT

10 ± 22

GC

ND

GT

25 ± 25

TC

ND

TT

4 ± 8

PDC

ND

PDT

20 ± 20

KDC

7 ± 14

KDT

23 ± 21

MDC

ND

MDT

13 ± 16

ANC

2 ± 7

ANT

20 ± 20

GAC

ND

GAT

13 ± 20

MRC

96 ± 29

MRT

204 ± 51
(table continued)
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T able 5-14
Benzo[fl]pyrene H ydroxylase A ctivity in A vian and R at H epatic
M icrosom es: F o rm atio n of Bcnzo[n]pyrene 9,10-dihydrodiol Specific Activity

Significant D ifferences Between C ontrol and /5N F-Trcatm cnt C ro u p s
p < 0.05

p < 0.01

p < 0.00!

GT > GC

-

-

Significant Differences Between Avian Species
p < 0.05

p < 0.01

p < 0.001

-

-

-

Significant Differences Between A vian O rd ers
p < 0.05

p < 0.01

p < 0.001

ANT > ANC

ANT > ANC

ANT > ANC

GAT > GAC

-

-

Significant Differences Between A vian Species and M ale R a t
p < 0.05

p < 0.01

p < 0.001

MRC > KDC

MRC > KDC

MRC > KDC

MRC > TC

MRC > TC

MRC > TC

MRC > CC

MRC > CC

MRC > CC

MRC > PDC

MRC > PDC

MRC > PDC

MRC > MDC

MRC > MDC

MRC > MDC

MRC > QC

MRC > QC

MRC > QC

MRC > GC

MRC > GC

MRC > GC

MRT > GT

MRT > GT

MRT > GT

MRT > CT

MRT > CT

MRT > CT

MRT > KDT

MRT > KDT

MRT > KDT

MRT > PDT

MRT > PDT

MRT > PDT
(table continued)
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Table 5-14
Benzo[fl]pyrene Hydroxylase Activity in Avian and Rat Hepatic
Microsomes: Formation of Benzo[«]pyrene 9,10-dihydrodiol Specific Activity
MRT > MDT

MRT > MDT

MRT > MDT

M RT > QT

MRT > QT

MRT > QT

MRT > TT

MRT > TT

MRT > TT

‘ND indicates a nondetectable value

Comparison o f Avian Species and Male Rat.
In terms o f molar activity, significant differences in the formation o f B[n]P 9,10-diol
between the avian species and the male rat were identical to those based on specific
activity as discussed in Section 5.3.7.

The benzo[o]pyrene hydroxylase activities (in terms o f molar activity - pmoles of
B[a]P 9,10-diol formed per minute per nmoles o f cytochrome P-450) in avian and
male rat hepatic microsomal o f control and p-naphthoflavone treatment groups are
presented in Table 5-15.

5.3.9

Total Metabolite Formation - Specific Activity

Total metabolite formation is represented by the sum o f the four B[n]P metabolites
identified

and

quantitated

in

this

study:

3-hydroxybenzo[r/]pyrene,

9-
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hydroxybenzo[a]pyrene, benzo[a]pyrene 7,8-dihydrodiol, and benzo[a]pyrene 9,10dihydrodiol.

Comparison o f Control and BNF-Treatment Groups.
Significant increases in total B[a]P metabolite formation by the treatment groups,
compared to the respective control groups, were seen for the chicken (5-fold) (p <
0.001), quail (2-fold), Pekin duck (2-fold), and male rat (1.7-fold) (p < 0.05). For
the turkey, Khaki Campbell duck, Muscovy duck, and goose, no significant
differences in total B[a]P metabolite formation were observed between the control
and treatment groups.

Comparison o f Avian Species.
The most significant (p < 0.001) differences in total metabolite formation between
the avian species were present between the turkey and chicken control groups and
the turkey and goose treatment groups. Significant (p < 0.01) differences were also
detected between the turkey and the Pekin duck, goose, and quail control groups.
Less significant differences (p < 0.05, difference significant for Tukey’s test but not
significant for Scheffe’s test) were seen between the turkey and Muscovy duck
control groups, the Khaki Campbell duck and chicken control groups, the turkey and
quail treatment groups, and the turkey and Pekin duck treatment groups.

The

rankings o f total B[o]P metabolite formation for the avian control groups included
turkey > Muscovy duck « Pekin duck « goose « quail « chicken and Khaki
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T able 5-15
B enzo[«]pyrene H ydroxylase A ctivity in A vian an d R at H epatic
M icrosom es: F o rm atio n of Bcnzo[«]pyrene 9,10-dihydrodiol M olar Activity

T rea tm e n t G ro u p

pmoles of B[fl]P 9,10-dihydrodiol p roduced
p e r m inute p e r nm ole of P-450

CC

ND1

CT

32 ± 31

QC

ND

QT

3 ± 5

GC

ND

GT

14 ± 13

TC

ND

TT

2 ± 4

PDC

ND

PDT

14 ± 12

KDC

27 ± 58

KDT

20 ± 15

MDC

ND

MDT

10 ± 14

ANC

7 ± 28

ANT

14 ± 14

GAC

ND

GAT

12 ± 23

MRC

110 + 29

MRT

151 ± 32
(table continued)
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T able 5-15
Benzo[«]pyrene H ydroxylase A ctivity in Avian and R at H epatic
M icrosom es: F o rm atio n of B enzo[«]pyrene 9,10-dihydrodiol M o lar Activity
Significant Differences Between C ontrol an d jSN F-Trcatm cnt G roups
p < 0.05

p < 0.01

p < 0.001

GT > GC

-

-

MRT > MRC

-

-

Significant Differences Between A vian Species
p < 0.05

p < 0.01

p < 0.001

-

-

-

Significant Differences Between Avian O rd ers
p < 0.05

p < 0.01

p < 0.001

GAT > GAC

-

-

Significant Differences Between Avian Species and M ale R a t
p < 0.05

p < 0.01

p < 0.001

MRC > KDC

MRC > KDC

MRC > KDC

MRC > TC

MRC > TC

MRC > TC

MRC > CC

MRC > CC

MRC > CC

MRC > PDC

MRC > PDC

MRC > PDC

MRC > MDC

MRC > MDC

MRC > MDC

MRC > QC

MRC > QC

MRC > QC

MRC > GC

MRC > GC

MRC > GC

MRT > KDT

MRT > KDT

MRT > KDT

MRT > TT

MRT > TT

MRT > TT

MRT > CT

MRT > CT

MRT > CT

MRT > PDT

MRT > PDT

MRT > PDT
(table continued)
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Table 5-15
Benzo[«]pyrene H ydroxylase Activity in A vian and R at H epatic
M icrosom es: F o rm atio n of Benzo[flJpyrene 9,10-dihydrodiol M o lar A ctivity
MRT > MDT

MRT > MDT

MRT > MDT

MRT > QT

MRT > QT

MRT > QT

MRT > GT

MRT > GT

MRT >GT

'ND indicates a nondetectable value

Campbell duck > chicken. For the avian treatment groups, the ranking o f formation
included turkey > chicken = quail « goose. It is interesting to note, that among the
avian species, the turkey produced the greatest quantity o f total B[a]P metabolites
for both the control and treatment groups but had the smallest difference in
metabolite formation between the control and treatment groups.

Comparison o f Avian Orders.
There was a significant increase in total B[o]P metabolite formation in the treatment
groups compared to the control groups for both the Anseriformes (p < 0.05) and
Galliformes (p < 0.01).

While there was no significant difference between the

control groups, metabolite formation by the Galliformes treatment group was
significantly (p < 0.05) greater than that o f the Anseriformes treatment group.
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Comparison o f Avian Species and Male Rat.
Comparison o f total B[a]P metabolite formation between the avian species and male
rat indicated that all o f the avian species, with the exception o f the turkey, produced
total metabolite levels that were equivalent to those o f the male rat.

The only

significant differences in total B[a]P metabolite formation between the avian species
and the male rat were for the turkey and male rat control groups (p < 0.01) and for
the turkey and male rat treatment groups (p < 0.05, difference significant for Tukey’s
test but not significant for Scheffe’s test).

Metabolite formation by the avian

treatment groups was 2-fold to 5-fold greater than that o f the respective control
groups.

For the male rat a 1.7-fold greater metabolite production was seen in the

treatment group compared to the control group.

The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f total metabolites
formed per minute per mg o f microsomal protein) in avian and male rat hepatic
microsomal control and P-naphthofiavone treatment groups are presented in Table
5-16.

5.3.10 T o tal M etabolite F o rm atio n - M o lar Activity
Comparison of Control and pNF-Treatment Groups.
Based on molar activity, a significantly (p < 0.05) greater level o f total B[a]P
metabolites were formed by the chicken (2.5-fold) and quail (1.7-fold) treatment
groups compared to their respective control groups. Significant (p < 0.05) decreases
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T able 5-16
Benzo[«]pyrene H ydroxylase A ctivity in A vian an d R a t H epatic
M icrosom es: Total M etab o lite1 F o rm atio n - Specific A ctivity

T reatm en t G roup

pmoles of total B[«]P m etabolites p ro d u ced p e r
m inute p e r m g of p rotein

CC

153 ± 73

CT

699 ± 176

QC

278 ± 308

QT

640 ± 233

GC

345 ± 183

GT

358 ± 125

TC

872 ± 324

TT

1081 ± 309

PDC

347 + 264

PDT

628 ± 128

KDC

634 ± 254

KDT

735 ± 210

MDC

431 ± 248

MDT

690 ± 216

ANC

439 ± 254

ANT

603 ± 222

GAC

434 ± 406

GAT

806 ± 306

MRC

353 ± 159

MRT

608 ± 208
(table continued)
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T able 5-16
B enzo[o]pyrene H ydroxylase Activity in A vian an d R at H epatic
M icrosom es: T otal M etab o lite1 F o rm atio n - Specific A ctivity
Significant Differences Between C ontrol and /3N F-Trcatm cnt G ro u p s
p < 0.05

p < 0.01

p < 0.00!

CT > CC

CT > CC

CT > CC

QT > QC

-

-

PDT > PDC

-

-

MRT > MRC

-

-

Significant Differences Between Avian Species
p < 0.05

p < 0.01

p < 0.001

TC > MDC*

-

-

TC > PDC*

TC > PDC*

-

TC > GC*

TC > GC*

-

TC > QC

TC > QC*

-

TC > CC

TC > CC

TC > CC*

KDC > CC*

-

-

TT > QT*

-

-

TT > GT

TT > GT

TT > GT*

TT > PDT*

-

-

Significant Differences Between A vian O rd ers
p < 0.05

p < 0.01

p < 0.001

GAT > ANT

-

-

ANT > ANC

-

-

GAT > GAC

GAT > GAC

(table continued)
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Table 5-16
Benzo[a]pyrene Hydroxylase Activity in Avian and Rat Hepatic
Microsomes: Total Metabolite' Formation - Specific Activity
Significant Differences Between Avian Species and M ale Rat
p < 0.05

p < 0.001

TC > MRC*

TC > MRC*

-

TT > MRT*

-

-

’Total metabolite formation includes the metabolites B[a]P 9,10-dihydrodiol, B[a]P
7,8-dihydrodiol, 9-hydroxy-B[a]P, and 3-hydroxy-B[a]P
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test.

in total metabolite formation were detected in the treatment groups o f the goose (2.8fold) and turkey (2.7-fold) relative to their control groups. No significant differences
were seen between the control and treatment groups o f the remaining avian species.

Comparison o f Avian Species.
Comparison o f the avian control groups indicated significant differences in the
metabolism o f B[a]P between the turkey and the chicken (p < 0.001), the turkey and
the quail (p < 0.001), the Khaki Campbell duck and the quail (p < 0.001) and the
Khaki Campbell duck and the chicken (p < 0.01).

Significant differences in total

metabolite formation between the treatment groups included the Khaki Campbell
duck and the goose (p < 0.001), the chicken and the goose (p < 0.001), the Khaki
Campbell duck and the quail (p < 0.01), the Khaki Campbell duck and the Pekin
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duck (p < 0.05, difference significant for Tukey’s test but not significant for
Scheffe’s test), and the chicken and the quail (p < 0.05, difference significant for
Tukey’s test but not significant for Scheffe’s test).

Comparison o f Avian Orders.
A significantly (p < 0.05) lower level o f total metabolite formation was present in
the Anseriformes treatment group (1.6-fold) compared to the control group.

No

significant difference was observed in the Galliformes treatment group respective to
the control group. No significant differences between the orders were noted.

Comparison o f Avian Species and Male Rat.
Comparison o f total metabolite formation in the avian controls and the male rat
control indicated that total formation by the turkey and the Khaki Campbell duck
control groups were significantly (p < 0 .0 1 ) greater (3.7- and 3.5-fold, respectively)
than that o f the male rat control group.

Total metabolite formation in the avian

treatment groups was comparable to that o f the male rat treatment group for all the
species studied.

The benzo[a]pyrene hydroxylase activities (expressed as pmoles o f total metabolite
formed per minute per nmole o f cytochrome P-450) in avian and male rat hepatic
microsomal control and p-naphthoflavone treatment groups are presented in Table
5-17.

154

Table 5-17
Benzo[fl]pyrene Hydroxylase Activity in Avian and Rat Hepatic
Microsomes: Total Metabolite Formation - Molar Activity
Treatment Group

pmoles o f total B[a]P metabolites produced
per minute per nmole o f P-450

CC

327 ± 149

CT

830 ± 369

QC

229 ± 68

QT

386 ± 99

GC

613 ± 348

GT

222 ± 70

TC

1463 ± 716

TT

542 ± 200

PDC

692 ± 444

PDT

445 ± 155

KDC

1387 ± 793

KDT

876 ± 306

MDC

741 ± 209

MDT

554 ± 248

ANC

858 ± 561

ANT

542 ± 313

GAC

672 ± 701

GAT

580 ± 305

MRC

396 ± 167

MRT

453 ± 148
(table continued)
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Table 5-17
Benzo[fl]pyrene Hydroxylase Activity in Avian and Rat Hepatic
Microsomes: Total Metabolite Formation - Molar Activity
Significant Differences Between Control and /SNF-Trcatmcnt Groups
p < 0,05

p < 0.01

p < 0.001

TC > TT

-

-

CT > CC

-

-

QT > QC

-

-

GC > GT

-

-

Significant Differences Between Avian Species
p < 0.05

p < 0.01

p < 0.001

TC > CC

TC > CC*

TC > CC*

TC > QC

TC > QC

TC > QC*

KDC > CC

KDC > CC*

-

KDC > QC

KDC > QC*

KDC > QC*

KDT > PDT*

-

-

KDT > QT*

KDT > QT*

-

KDT > GT

KDT > GT

KDT > GT*

CT > QT*

-

-

CT > GT

CT > GT*

CT > GT*

Significant Differences Between Avian Orders
p < 0.05

p < 0.01

p < 0.001

ANC > ANT

-

-

Significant Differences Between Avian Species and M ale Rat
p < 0.05

p < 0.01

p < 0.001

TC > MRC

TC > MRC*

-

KDC > MRC*

KDC > MRC*

-

'Total metabolite formation includes the metabolites B[t?]P 9,10-dihydrodiol, B[a]P
7,8-dihydrodiol, 9-hydroxy-B[a]P, and 3-hydroxy-B[a]P
*Denotes a significant difference for Tukey’s test but not for Scheffe’s test.
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5.3.11 Overview of Bcnzo[«]pyrene Metabolism
This section provides an overview o f the hepatic microsomal oxidative metabolism
o f B[a]P by each species and each avian order.

The B[a]P metabolite profiles

produced by each species and each order are represented by a ranking o f the
metabolites in order o f decreasing magnitude o f formation; 3-hydroxybenzo[a]pyrene
is

designated

by

3-OH,

9-hydroxybenzo[a]pyrene

is

designated

by

9-OH,

benzo[a]pyrene 7,8-dihydrodiol is designated by 7,8-diol, and benzo[a]pyrene 9,10dihydrodiol is designated by 9,10-diol.

The changes observed in the metabolic

profiles associated with pNF-treatment are also summarized.

In addition, shifts in

the profiles due to relative changes in metabolite formation in the treatment group
compared to the control group are presented as the percent change observed for each
metabolite based on the percent each metabolite contributed to the total metabolite
formation.

Chicken.
The metabolic profiles for the chicken were as follows:
Control:

3-OH > 9-OH > 7,8-diol

Treatment:

3-OH > 9-OH > 7,8-diol > 9,10-diol

Changes in the profile associated with PNF-treatment included:
A significant increase in the formation o f 3-OPI, 4.3-fold (specific
activity) and 2.4-fold (molar activity)
A significant increase in the formation o f 9-OH, 4-fold (specific
activity) and 2.2 fold (molar activity)
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A significant increase in the formation o f 7,8-diol, 22-fold (specific
activity) and 12.8-fold (molar activity)
Formation o f 9,10-diol (no significant increase)
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (3.6%) and 7,8-diol (4.9%) and a relative decrease in the
formation o f 9-OH (4.1%) and 3-OH (4.4%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (3.9%) and 7,8-diol (4.9%) and a relative decrease in the
formation o f 9-OH (4.2%) and 3-OH (4.6%)
A significant increase in B[a]P hydroxylase activity (based on total
metabolite formation)

Quail.
The metabolic profiles for the quail were as follows:
Control:

3-OH > 9-OH > 7,8-diol

Treatment:

3-OH > 9-OH > 7,8-diol > 9,10-diol

Changes in the profile associated with pNF-treatment included:
A significant increase in the formation o f 3-OH, 2.3-fold (specific
activity) and 1.7-fold (molar activity)
A significant increase in the formation o f 9-OH (1.9-fold) based on
specific activity and no change based on molar activity
A significant increase in the formation o f 7,8-diol, 9-fold (specific
activity) and 47.5-fold (molar activity)
Formation o f 9,10-diol (no significant increase)
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (1.6%) and 7,8-diol (2.1%) and a relative decrease in the
formation o f 9-OH (2.5%) and 3-OH (1.2%)
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In terms o f molar activity, a relative increase in the formation o f 9,10diol (0.8%) and 7,8-diol (4.7%) and a relative decrease in the
formation o f 9-OH (4.3%) and 3-OH (1.2%)
A significant increase in B[a]P hydroxylase activity (based on total
metabolite formation)

Goose.
The metabolic profiles for the goose were as follows:
Control:

3-OH > 9-OH

Treatment:

3-OH > 9-OH > 9,10-diol « 7,8-diol

Changes in the profile associated with PNF-treatment included:
A significant decrease in the formation o f 3-OH, 3.9-fold based on
molar activity and no significant change based on specific activity
A significant increase in the formation o f 9-OH, 3-fold based on
specific activity and no change based on molar activity
Formation o f 7,8-diol (increase significant)
Formation o f 9,10-diol (increase significant)
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (7%), 7,8-diol (4.8%), and 9-OH (15.1%) and a relative
decrease in the formation o f 3-OH (26.9%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (6.4%), 7,8-diol (4.5%), and 9-OH (16.3%) and a relative
decrease in the formation o f 3-OH (27.2%)
A significant decrease in B[c/]P hydroxylase activity in terms o f molar
activity, no change in terms o f specific activity (based on total
metabolite formation)
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Turkey.
The metabolic profiles for the turkey were as follows:
Control:

3-OH > 9-OH > 7,8-diol

Treatment:

3-OH > 9-OH > 7,8-diol > 9,10-diol

Changes in the metabolic profile associated with (3NF-treatment included:
A significant decrease (2.8-fold) in 3-OH formation in terms o f molar
activity, no significant change in terms o f specific activity
No significant change in 9-OH formation
A significant increase in 7,8-diol formation, 10-fold (specific activity)
and 3.3-fold (molar activity)
Formation o f 9,10-diol (increase not significant)
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (0.3%), 7,8-diol (3.2%), and 9-OH (3.8%) and a relative
decrease in the formation o f 3-OH (7.4%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (0.4%), 7,8-diol (3.1%), and 9-OH (4.3%) and a relative decrease
in the formation o f 3-OH (7.8%)
A significant decrease in B[a]P hydroxylase activity in terms o f molar
activity, no change in terms o f specific activity (based on total
metabolite formation)

Pekin Duck.
The metabolic profiles for the Pekin duck were as follows:
Control: 3-OH > 9-OH * 7,8-diol
Treatment:

3-OH > 7,8-diol w 9-OH > 9,10-diol

Changes in the metabolic profile associated with pNF-treatment included:
No significant change in 3-OH formation
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A significant increase (4.4-fold) in 9-OH formation in terms o f
specific activity and no significant change in terms o f molar activity
A significant increase in 7,8-diol formation, 6.6-fold based on specific
activity and no significant change based on molar activity
Formation o f 9,10-diol (increase not significant)
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (3.2%), 7,8-diol (7.6%), and 9-OH (9.3%) and a relative
decrease in the formation o f 3-OH (16.5%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (3.1%), 7,8-diol (8.1%), and 9-OH (5.8%) and a relative decrease
in the formation o f 3-OH (7.8%)
A significant increase in B[«]P hydroxylase activity in terms of
specific activity, no change in terms o f molar activity (based on total
metabolite formation)

Khaki Campbell Duck.
The metabolic profiles for the Khaki Campbell duck included:
Control:

3-OH > 9-OH « 7,8-diol ~ 9,10-diol

Treatment:

3-OH > 7,8-diol « 9-OH > 9,10-diol

Changes in the metabolic profile associated with pNF-treatment included:
No significant change in 3-OH formation
A significant increase (3-fold) in 9-OH formation in terms o f specific
activity and no significant change in terms o f molar activity
A significant increase in 7,8-diol formation, 6.9-fold (specific activity)
and 3.3-fold (molar activity)
No significant change in the formation o f 9,10-diol
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (2%), 7,8-diol (8.6%), and 9-OH (4.8%) and a relative
decrease in the formation o f 3-OH (15.5%)

161
In terms o f molar activity, a relative increase in the formation o f 9,10diol (0.3%), 7,8-diol (7.6%), and 9-OH (5.1%) and a relative decrease
in the formation o f 3-OH (13%)

Muscovy Duck.
The metabolic profiles for the Muscovy duck included:
Control:

3-OH > 7,8-diol * 9-OH

Treatment:

3-OH > 7,8-diol w 9-OH > 9,10-diol

Changes in the metabolic profile associated with PNF-treatment included:
A significant decrease in the formation o f 3-OH, 1.6-fold (molar
activity) and no significant change based on specific activity
A significant increase in the formation o f 9-OH, 3.2-fold (specific
activity) and no change based on molar activity
A significant increase in the formation o f 7,8-diol, 3.3-fold (specific
activity) and 1.6-fold (molar activity)
Formation o f 9,10-diol (increase not significant)
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (1.9%), 7,8-diol (6.5%), and 9-OH (5.2%) and a relative
decrease in the formation o f 3-OH (13.6%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (1.9%), 7,8-diol (6.9%), and 9-OH (4%) and a relative decrease
in the formation o f 3-OH (27.2%)

Anseriformes.
The metabolic profiles for the Anseriformes were as follows:
Control:

3-OFI > 9-OH * 7,8-diol > 9,10-diol

Treatment:

3-OH > 9-OH « 7,8-diol > 9,10-diol

Changes in the profile associated with PNF-treatment included:
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A significant decrease in the formation o f 3-OH, 1.8-fold (molar
activity) and no significant change based on specific activity
A significant increase in the formation o f 9-OH, 3.3-fold (specific
activity) and 1.5 fold (molar activity)
A significant increase in the formation o f 7,8-diol, 5.1-fold (specific
activity) and 2.3-fold (molar activity)
A significant increase in the formation of 9,10-diol, 10-fold based on
specific activity and no significant change based on molar activity
In terms o f specific activity, a relative increase in the formation o f
9,10-diol (2.8%), 7,8-diol (7.4%), and 9-OH (6.6%) and a relative
decrease in the formation o f 3-OH (16.9%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (1.7%), 7,8-diol (6.7%), 9-OH (5.7%) and a relative decrease in
the formation o f 3-OH (14.1%)
A significant increase in B[a]P hydroxylase activity (based on total
metabolite formation)

Galliformes.
The metabolic profiles for the Galliformes were as follows:
Control:

3-OH > 9-OH > 7,8-diol

Treatment:

3-OH > 9-OH > 7,8-diol > 9,10-diol

Changes in the profile associated with PNF-treatment included:
A significant decrease in the formation o f 3-OH, 1.7-fold (specific
activity) and no significant change based on molar activity
A significant increase in the formation o f 9-OH, 2.1-fold (specific
activity) and no significant change based on molar activity
A significant increase in the formation o f 7,8-diol, 11.3-fold (specific
activity) and 6.8-fold (molar activity)
Formation o f 9,10-diol (increase significant)
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In terms o f specific activity, a relative increase in the formation o f
9,10-diol (1.6%), 7,8-diol (3.5%), and 9-OH (2.2%) and a relative
decrease in the formation o f 3-OH (7.4%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (2.1), 7,8-diol (4%), 9-OH (3.1%) and a relative decrease in the
formation o f 3-OH (9.3%)
A significant increase in B[a]P hydroxylase activity in terms o f
specific activity, no change in terms of molar activity (based on total
metabolite formation)

Male Rat.
The metabolic profiles for the male rat were as follows:
Control:

3-OH > 9,10-diol > 9-OH > 7,8-diol

Treatment:

3-OH > 9,10-diol > 9-OH > 7,8-diol

Changes in the profile associated with PNF-treatment included:
No significant changes in the formation o f 3-OH
A significant increase in the formation o f 9-OH, 3.3-fold (specific
activity) and no significant change in terms o f molar activity
A significant increase in the formation o f 7,8-diol, 3.3-fold (specific
activity) and 2.3-fold (molar activity)
A significant increase in the formation o f 9,10-diol, 1.4-fold based on
molar activity, no significant change based on specific activity
In terms o f specific activity, a relative increase in the formation of
9,10-diol (6.6), 7,8-diol (3.7%), and 9-OH (6%) and a relative
decrease in the formation o f 3-OH (16.2%)
In terms o f molar activity, a relative increase in the formation o f 9,10diol (4.9%), 7,8-diol (3.6%), 9-OH (6%) and a relative decrease in the
formation o f 3-OH (14.4%)
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A significant increase in B[a]P hydroxylase activity in terms o f
specific activity , no change in terms o f molar activity (based on total
metabolite formation)

The metabolic profiles for the control and treatment groups o f each species and avian
order are presented in Table 5-18. The percent contribution o f each metabolite to
the total metabolite formation (based on the four metabolites quantitated in this
study) is presented in Table 5-19 in terms o f specific activity and in Table 5-20 in
terms o f molar activity.
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Table 5-18
M etabolism o f Benzo[a]pyrene by Avian and Rat Hepatic Microsomes
Ranking o f Metabolite Formation
CC

3-OH1 > 9-OH2 > 7,8-diol3

CT

3-OH > 9-OH > 7,8-diol > 9,10-diol4

QC

3-OH > 9-OH > 7,8-diol

QT

3-OH > 9-OH > 7,8-diol > 9,10-diol

GC

3-OH > 9-OH

GT

3-OH > 9-OH > 9,10-diol ~ 7,8-diol

TC

3-OH > 9-OH > 7,8-diol

TT

3-OH > 9-OH > 7,8-diol > 9,10-diol

PDC

3-OH > 9-OH * 7,8-diol

PDT

3-OH > 7,8-diol ~ 9-OH > 9,10-diol

KDC

3-OH > 9-OH « 7,8-diol « 9,10-diol

KDT

3-OH > 7,8-diol « 9-OH > 9,10-diol

MDC

3-OH > 7,8-diol * 9-OH

MDT

3-OH > 7,8-diol « 9-OH > 9,10-diol

ANC

3-OH > 9-OH « 7,8-diol > 9,10-diol

ANT

3-OH > 9-OH « 7,8-diol > 9,10-diol

GAC

3-OH > 9-OH > 7,8-diol

GAT

3-OH > 9-OH > 7,8-diol > 9,10-diol

MRC

3-OH > 9,10-diol > 9-OH > 7,8-diol

MRT

3-OH > 9,10-diol > 9-OH > 7,8-diol

'3-Hydroxybenzo[a]pyrene
29-Hydroxybenzo[a]pyrene
3Benzo[a]pyrene 7,8-dihydrodiol
4Benzo[a]pyrene 9,10-dihydrodiol
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Table 5-19
Metabolism o f Benzo[a]pyrene by Avian and Rat Hepatic Microsomes
Percent o f Total Metabolites1 Formed - Specific Activity
Treatment Group

3-OH2

9-OH3

7,8-D iol4

9,10-D iol5

CC

66.7

32.0

1.3

0

CT

62.3

27.9

6.2

3.6

QC

84.6

14.7

0.7

0

QT

83.4

12.2

2.8

1.6

GC

91.9

8.1

0

0

GT

65

23.2

4.8

7

TC

81.9

17.7

0.5

0

TT

74.5

21.5

3.7

0.3

PDC

93. L

4.0

2.9

0

PDT

76.6

9.7

10.5

3.2

KDC

94.0

3.2

1.7

1.1

KDT

78.5

8.0

10.3

3.1

MDC

88.4

5.3

6.3

0

MDT

74.8

10.5

12.8

1.9

ANC

92.0

4.8

2.7

0.5

ANT

75.1

11.4

10.1

3.3

GAC

80.7

18.6

0.7

0

GAT

73.3

20.8

4.2

1.6

MRC

62.2

6.8

3.9

27.0

MRT

46.0

12.8

7.6

33.6

'Total Metabolites refers to the four metabolites quantitated in this study
23-Hydroxybenzo[a]pyrene
39-Hydroxybenzo [a] py rene
4Benzo[a]pyrene 7,8-dihydrodiol
5Benzo[a]pyrene 9,10-dihydrodiol
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Table 5-20
Metabolism o f Benzo[a]pyrene by Avian and Rat Hepatic Microsomes
Percent of Total M etabolites1 Formed - Molar Activity
Treatment Group

3-OH2

9-OH3

7,8-Diol4

9,10-DioI5

CC

66.8

32.0

1.2

0

CT

62.2

27.8

6.1

3.9

QC

83.3

16.5

0.2

0

QT

82.1

12.2

4.9

0.8

GC

92.7

7.3

0

0

GT

65.5

23.6

4.5

6.4

TC

82.1

17.5

0.4

0

TT

74.3

21.8

3.5

0.4

PDC

92.5

4.2

3.3

0

PDT

75.5

10.0

11.4

3.1

KDC

93.2

3.0

1.8

2.0

KDT

80.2

8.1

9.4

2.3

MDC

87.7

6.7

5.6

0

MDT

75.0

10.7

12.5

1.9

ANC

92.1

4.4

2.7

0.8

ANT

78.0

10.1

9.4

2.5

GAC

79.8

19.6

0.6

0

GAT

70.5

22.7

4.6

2.1

MRC

61.7

7.0

3.5

27.7

MRT

47.3

13.0

7.1

32.6

'Total Metabolites refers to the four metabolites quantitated in this study
23-Hydroxybenzo[a]pyrene
39-Hydroxybenzo[a]pyrene
4Benzo[a]pyrene 7,8-dihydrodiol
5Benzo[tf]pyrene 9,10-dihydrodiol

6.0

DISCUSSION OF RESULTS

The following sections 6.1 to 6.3 are a discussion of the results reported in Section
5.1 to 5.3.
6.1

Components of the Hepatic Cytochrome P-450 Monooxygenase System

6.1.1

Microsomal Protein and Cytochrome P-450 Content

6.1.1.1

Galliformes

This study demonstrated a yield of 7 mg microsomal protein/g liver for both the
chicken and the quail. A review of the literature revealed that the reported yield of
hepatic microsomal protein ranged from 4.3 to 19.8 mg protein/g liver for the chicken
(Banton, 1990; Rinsky and Perry, 1983; Dalvi, et al., 1987; Manning, et a l., 1990;
Buynitzky, et al., 1978; Buckpitt and Boyd, 1982; Riviere, et a l., 1985; Davison and
Sell, 1972; Sifri, et al., 1975) and from 4.8 to 31.2 mg/g for the quail (Carpenter,
et a l., 1985; Buckpitt and Boyd, 1982; Riviere, et al., 1983; Sifri, et a l., 1975;
Riviere, et a l., 1985; Dalvi, et a l., 1987). These ranges represent data collected from
birds o f varying breed, age and sex.

For the turkey, a single value o f 6.5 ± 0.4

mg/g (Dalvi, et al., 1987) was found in the literature which was comparable to the
yield o f 9 + 3 mg/g observed in this study.

In the present study, the hepatic microsomal cytochrome P-450 levels observed for the
chicken and quail were 0.5 and 1.2 nmoles/mg microsomal protein, respectively.
Reported values ranged from 0.12 to 0.48 nmoles cytochrome P-450/mg microsomal
protein for the chicken (Banton, 1989; Rinsky and Perry, 1983; Poland and Glover,
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1977; Haug, et a l., 1980; Sell, et al., 1971; Buckpitt and Boyd, 1982; Erich and
Larsen, 1983; Manning, et a l., 1990; Buynitzky et a l., 1978; Riviere, et a l., 1985;
Lapadula, et a l., 1984) and from 0.1 to 1.1 nmoles/mg for the quail (Carpenter, et
a l., 1985; Buckpitt and Boyd, 1982; Riviere, et a l., 1983; Riviere, et a l., 1985;
Dalvi, et a l., 1987). Only one study was found in the literature in which the hepatic
P-450 content was characterized for the turkey (Dalvi et al., 1987).

These

investigators observed a cytochrome P-450 content of 0.36 + 0.03 nmoles/mg which
is slightly lower than the 0.6 ± 0 . 1 nmoles/mg measured in this study.

The constitutive levels o f microsomal protein and cytochrome P-450 were similar
among the Galliformes species studied. Riviere et al. (1985) found similar yields of
hepatic microsomal protein from the chicken and Japanese quail. Sifri and coworkers
(1975) demonstrated a higher level of microsomal protein in the Japanese quail than
in the White Leghorn chicken but observed comparable levels of P-450 for these
species. Dalvi et al. (1987) found significantly (p < 0.05) greater constitutive levels
o f microsomal protein in the quail (Bobwhite) compared to the chicken (Rock-type)
and turkey (white) but no significant difference was noted between the chicken and
turkey.

Quantitation of hepatic microsomal cytochrome P-450 content in the same

study indicated significantly greater (p < 0.05) levels in the turkey compared to the
chicken and quail and in the chicken compared to the quail (Dalvi, et a l., 1987).
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Following /JNF treatment, comparable levels of hepatic microsomal protein and
cytochrome P-450 were observed among the Galliformes birds with the exception of
a significantly (p < 0.05, significant for Tukey’s test but not for Scheffe’s test)
greater (1.3 times) content o f P-450 in the turkey compared to the chicken. The only
notable difference seen between the species o f this order was a significant induction
of microsomal protein and P-450 content following /3NF administration in the chicken
and turkey but not in the quail. In the present study, microsomal protein yield in the
chicken and turkey was 1.6- and 1.3-fold, respectively, the basal levels.

For

cytochrome P-450 content, a 1.8-fold increase was observed in the chicken and a 3.5fold increase was seen in the turkey which was the largest increase observed among
all the species examined. Two studies were found in the literature in which the yield
of microsomal protein was determined for control and /3NF- or 3M C-treated chickens.
Buynitzky et al. (1978) demonstrated an increase amounting to 1.1- to 1.6-fold that
of controls for microsomal protein following treatment with 3MC while no change
was observed by Manning et al. (1990) following 0N F treatment. Previous studies
on the effects of /3NF or 3MC administration on hepatic microsomal cytochrome P450 content in the chicken demonstrated increases in P-450 content ranging from 1.7to 4-fold (Banton, 1990; Ilaug et al., 1980; Manning et a l., 1990; Powis, et al.,
1976; Buynitzky, et a l., 1978; Althaus, et al., 1972; Darbey, et a l., 1984; Darbey
et al., 1985; Darbey, et al., 1986; Topp and van Bladeren, 1986). Past studies on
the hepatic cytochrome P-450 system of the Japanese quail found no change in the
yield o f microsomal protein associated with /3NF or 3MC treatment while increases
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ranging from 280 to 473 % control values were reported for P-450 content (Buckpitt
and Boyd, 1982; Carpenter, et a l., 1985; Buckpitt, et a l., 1982; Riviere, 1984). Neal
et a l., (1986) observed a 176% increase in protein and a 905% increase in P-450
content o f hepatic microsomes isolated from Japanese quail treated with 3MC.

No

studies were available which evaluated the response o f the turkey hepatic microsomal
system to /5NF or other 3MC-type inducers.

6 .1 .1 .2 Anseriformes
Reported levels of microsomal protein in untreated ducks (mallard) of varying ages
and sex ranged from 13.8 to 31.6 mg/g liver (Davison and Sell, 1972; Gorsline et al.,
1981; Sifri, et a l., 1975; Dalvi, et a l., 1987). In comparison with these values, the
levels determined in the present study were lower, 9 + 2 mg/g for the Pekin and
Khaki Campbell ducks and 6 + 4 mg/g for the Muscovy duck. Only one study was
found in the literature in which the components of the hepatic microsomal system of
the goose (gray) were quantitated (Dalvi et al., 1987).

These researchers found a

basal microsomal protein level o f 10 mg/g in this species which is consistent with the
findings o f this study.

Constitutive cytochrome P-450 levels observed in the present study for the Pekin,
Khaki Campbell and Muscovy ducks are consistent with levels previously reported for
other breeds o f ducks. The cytochrome P-450 levels quantitated for hepatic
microsomes isolated from mallard and Aylsebury x Pekin ducks ranged from 0.18 to
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0.53 nmole/mg (Bartlett and Kirinya, 1976; Sifri, et al., 1975; Dalvi, et al., 1987).
Only one study in the literature reported hepatic microsomal cytochrome P-450
content for the goose (Dalvi, et a l., 1987).

These investigators observed a

cytochrome P-450 level of 0.29 ± 0.04 nmoles/mg in the gray goose which is lower
than the level observed in this study (0.6 + 0.2 nmoles/mg).

This investigation found that the hepatic microsomal protein yield and cytochrome P450 content was similar among the Anseriformes species examined for both the
untreated and 0N F treated birds. Dalvi et al. (1987) conducted a comparative study
of these parameters for the gray goose and mallard duck. These researchers observed
a significantly (p < 0.05) greater (1 .6-fold) yield of hepatic microsomal protein in the
mallard duck compared to the goose and a significantly (p < 0.05) greater (1.6-fold)
content o f cytochrome P-450 in the goose compared to the duck.

No other studies

were found in which the cytochrome P-450 content o f the duck and goose were
compared.

Induction o f hepatic microsomal protein yield and cytochrome P-450 content was
observed in the Anseriformes following treatment with /3NF.

However, it is

interesting to note that for microsomal protein, all species showed an increase (1.4 to
1.9-fold) except for the Muscovy, whereas for P-450 content, increases (2.2 to 3.2fold) were seen in all but the Khaki Campbell duck. No studies could be found in the
literature which compared the hepatic microsomal protein and cytochrome P-450
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content o f control and /3NF- (or 3MC) treated microsomes o f any o f the Anseriformes
species examined here.

However, one study did report a 320 percent increase in

cytochrome P-450 content in the Eider duck (Somateria mollissima) associated with
exposure to 3 ,3 ’,4 ,4 ’ tetrachlorobiphenyl, a 3MC-type inducer (Brouwer, 1991). The
Eider duck is a sea duck and is classified within the M ergini tribe o f the Anatidae
family within the Anseriformes order (Kear, 1985).

6 .1 .1 .3 Comparison o f Galliformes and Anseriformes
The constitutive hepatic microsomal protein and cytochrome P-450 levels observed in
the present study were comparable among the species of the Galliformes and
Anseriformes orders.

However, following 0N F treatment, some differences were

noted between the orders. The Anseriformes order demonstrated a 1.6-fold increase
in protein in response to /3NF treatment whereas no change in protein yield was
observed in the Galliformes order. Consequently, a significantly (p < 0.05) greater
(1.3-fold) level of microsomal protein was seen in the j3NF treated Anseriformes
compared to the /3NF treated Galliformes.

Induction o f hepatic cytochrome P-450

content by /3NF treatment was observed in both orders. However, the increase seen
in the Anseriformes (3-fold) was slightly greater than that seen in the Galliformes (2fold). No studies were found in the literature which compared microsomal protein
levels for the Anseriformes and Galliformes species. Only one study was found in the
literature which sought a comparison in cytochrome P-450 content between species of
the Galliformes and Anseriformes orders. Sifri, Sell and Davison (1975) reported a
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lower hepatic cytochrome P-450 level in the Mallard duck compared to that o f the
chicken and Japanese quail.

In general, comparison o f these orders indicated similar levels o f hepatic microsomal
protein and cytochrome P-450 for control and treatment groups o f the represented
species.

6 .1 .1 .4 Comparison of the Rat and the Avian Species
The present study demonstrated the rat hepatic microsomal protein and cytochrome
P-450 levels, and the response of these parameters to /3NF administration, to be
consistent with findings reported by other researchers. These results indicated that the
yield o f microsomal protein in the rat was significantly greater than that o f the quail,
chicken, goose and Muscovy duck but was not significantly different than that o f the
turkey, Pekin duck or Khaki Campbell duck.

One study, which examined the

components of the cytochrome P-450 system of a variety of species, found that the
yield o f microsomal protein per gram o f liver was comparable for the chicken, Khaki
Campbell duck and rat (Patterson and Roberts, 1970). Dalvi et a l., (1987) found that
the observed yield of microsomal protein for the rat was significantly greater (1.5- to
3.7-times) than that of the white turkey, chicken, gray goose and mallard duck but
was comparable to that of the Bobwhite quail. The same group found a 1.5- to 3.3fold greater cytochrome P-450 content in rat microsomes compared to microsomes
isolated from the white turkey, Rock-type chicken, gray goose, mallard duck and
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Bobwhite quail. Bartlett and Kirinya (1976) observed a 400% greater cytochrome P450 level in the rat compared to the duck (Aylesbury x Pekin).

In contrast to the

findings of Dalvi et al. and Bartlett and Kirinya, the present study found no significant
difference in the cytochrome P-450 content o f the hepatic microsomes isolated from
the rat and the avian species used in this study.

In general, the induction of microsomal protein and cytochrome P-450 content
associated with /3NF treatment was more marked in the avian species compared to the
rat.

Following |8NF treatment, no significant changes in microsomal protein yield

were observed for the rat, quail, or Muscovy duck. In contrast, significant increases
(ranging from 1.3 to 1.9-fold) in protein yield were observed for the chicken, turkey,
goose, Pekin and Khaki Campbell ducks.

Topp and van Bladeren (1986) observed

comparable levels of hepatic cytochrome P-450 in the chicken and the rat following
/3NF treatment as did this study. Induction of cytochrome P-450 content in the avian
species (excluding the Japanese quail and Khaki Campbell duck) was approximately
twice (2.7-fold greater than basal levels on average) the level of induction observed
for the rat (1.4-fold greater than constitutive levels). This finding is consistent with
the conclusions drawn from the literature review conducted by Ronis and W alker
(1989) in which the effects of 3MC-type inducers on avian species were reviewed and
summarized.
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6.1.2

NADH- an d N A D PH -C ytochrom e c R eductase

6.1.2.1 G alliform es
The observed hepatic microsomal NADH- and NADPH-cytochrome c reductase
activities were similar among the Galliformes species examined.

The NADH- and

NADPH-cytochrome c reductase activities measured in the chicken and quail hepatic
microsomes were consistent with activities reported for these species by other
researchers (Banton, 1990; Buynitzky, et al., 1978; Buckpitt and Boyd, 1982; Pilch
and Coomes, 1981; Rinsky and Perry, 1983; Carpenter, et a l., 1985; Riviere, 1983).
No previously reported values for reductase activity could be found for the turkey.
In the present study, no change in NADH- or NADPH-cytochrome c reductase
activity was seen following treatment with /3NF.

Banton (1990) and Buckpitt and

Boyd (1982) also found no change in NADPH-cytochrome c reductase activity in
chicken and quail microsomes following pretreatment of the birds with (3NF and 3MC,
respectively. Banton (1990) also found no change in NADH-cytochrome c reductase
activity in chicken hepatic microsomes associated with /3NF administration. Buynitzky
et al. (1978) also observed no change in NADPH cytochrome c reductase in the
chicken following administration of 3MC.

In contrast, Powis et al. (1976)

demonstrated an increase in hepatic microsomal NADPH-cytochrome c reductase
activity associated with 3MC administration in chicken embryos and chicks.
Similarly, Carpenter and coworkers found a significant increase in NADPHcytochrome c reductase activity in hepatic microsomes isolated from /3NF-treated
Japanese quail (Carpenter, et a l., 1985).

Ill

6 .1.2.2 Anseriformes
In general, comparable levels o f NADH- and NADPH-cytochrome c reductase activity
were seen for the Anseriformes species studied.

Differences noted between the

Anseriformes species included a greater level of constitutive NADH-cytochrome c
reductase activity in the goose compared to the Muscovy and a greater level of
NADPH-cytochrome c reductase activity in the goose compared to the Muscovy duck
following treatment with /3NF.

No change in NADH- or NADPH-cytochrome c

reductase activity was noted in the Anseriformes species following 0N F treatment.
No studies were found in the literature in which the hepatic microsomal NADH- or
NADPH-cytochrome c reductase activity was quantitated for the goose or the duck.

6 .1.2.3 Comparison of Galliformes and Anseriformes
The hepatic microsomal NADPH-cytochrome c reductase activity levels observed in
the present study were comparable for the Galliformes and Anseriformes species
evaluated for both the control and the $N F treated birds. In contrast, a significantly
(p < 0.001) greater ( = 2-fold) hepatic microsomal NADH-cytochrome c reductase
activity was observed for the Anseriformes birds compared to the Galliformes birds.

6 .1 .2 .4 Comparison of Rat and Avian Species
The NADH- and NADPH-cytochrome c reductase activity levels observed for the rat
were consistent with levels reported in previous studies.

As reported by other

researchers, no change in hepatic microsomal NADH- or NADPH-cytochrome c
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reductase activity was associated with /3NF administration in the rat. This finding was
also consistent with the observed response o f the avian NADH- and NADPHcytochrome c reductases. The NADH- and NADPH-reductase activity for both orders
o f birds were found to be comparable with that o f the rat.

6.1.3

Overview

In summary,

the constitutive components of the hepatic cytochrome P-450

monooxygenase system (with the exception of NADH-cytochrome c reductase) were
demonstrated to be present at comparable levels in the representative Galliformes and
Anseriformes species.

Basal NADH-cytochrome c reductase activity was observed

to be greater in the Anseriformes than in the Galliformes.

Comparison o f the

individual species indicated that basal NADH-cytochrome c reductase activity was
greater in the goose and Khaki Campbell duck compared to the chicken and turkey.
In addition, following jSNF, there was significantly greater NADH-cytochrome c
reductase activity in the Khaki Campbell duck compared to the chicken and turkey.
Other less significant differences between treatment groups included greater protein
yield in the Khaki Campbell and Pekin ducks compared to the quail and greater P-450
content in the turkey compared to the Khaki Campbell duck and chicken.

In comparison of the avian and rat hepatic microsomal systems, there were some
similarities and differences noted. Basal levels for microsomal protein yield were, in
general, greater in the rat than in the avian species (chicken, quail, goose and
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Muscovy duck).

Constitutive cytochrome P-450 levels and NADH- and NADPH-

cytochrome c reductase activities were comparable for the avian and mammalian
classes.

In response to /3NF treatment, increases in microsomal protein yield were

observed for the avian species but no increase in the amount of protein per gram of
liver was seen for the rat. M ore dramatic increases in cytochrome P-450 levels were
observed in the avian species compared to the rat. No change in NADH- or NADPHcytochrome c reductase activity was observed for the birds or the rat. These findings
are consistent with those of other studies. Microsomal protein level, cytochrome P450 content, NADH-cytochrome c reductase activity and NADPH-cytochrome c
reductase activity are presented for each species in Figures 6-1, 6-2, 6-3, and 6-4,
respectively.

Upon review of the available studies characterizing the avian hepatic microsomal
cytochrome P-450 monooxygenase system, it is readily apparent that there is
considerably greater interexperimental variability in avian data than in data collected
on laboratory species such as the rat. Interexperimental variability in data obtained
on the constitutive avian hepatic microsomal system appears to be quantitative rather
than qualitative.

Comparison of studies characterizing the response o f the avian

hepatic microsomal system to treatment with /3NF or 3MC, indicates that there are
qualitative as well as quantitative differences present between the data sets.
Qualitative differences in the response of the avian cytochrome P-450
system to 3MC-type inducers were noted for microsomal protein level (chicken and

180
19

-

18

53

17

-

15

-

12

—

7

—

6

-

4

—

3

-

2

-

O H

Species and Treatment Group

Figure 6-1 Hepatic microsomal protein content of control and BNF-treated
avian species and male rats.
CC = Chicken Control; CT = Chicken Treated; QC = Quail Control; QT = Quail Treated;
TC = Turkey Control; TT = Turkey Treated; GC = Goose Control; GT = Goose Treated;
PDC = Pekin Duck Control; PDT = Pekin Duck Treated; KDC = Khaki Campbell Duck Control;
KDT = Khaki Campbell Duck Treated; M DC = Muscovy Duck Control;
MDT = Muscovi Duck Treated; ANC = Anseriformes Control; ANT = Anseriformes Treated;
GAC = Galliformes Control; GAT = Galliformes Treated; MRC = Male Rat Control
MRT = Male Rat Treated. These abbreviations are the same for Figures 6-2 through 6-16.
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Figure 6-2 Hepatic microsomal cytochrome P-450 content o f control and
BNF-treated avian species and male rats. See Figure 6-1 for
species identifications.
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Figure 6-3 Rate o f hepatic microsomal NADPH-cytochrome c reductase
activity in control and BNF-treated avian species and male rats.
See Figure 6-1 for species identifications.
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Figure 6-4 Rate o f hepatic microsomal NADH-cytochrome c reductase
activity in control and BNF-treated avian species and male rats.
See Figure 6- 1 for species identifications.
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quail), cytochrome P-450 content (quail), and NADPH-cytochrome c reductase
activity (chicken and quail).

The interexperimental variability observed between studies presented in the literature
may be attributable to greater genetic variability among birds; differences in the
breed, sex or age of the birds studied; and differences in assay procedures or other
experimental conditions such as the inducer used and/or the dosage administered and
the degree of environmental control implemented (very limited data are available on
the influences of temperature, light and seasonal variation on the cytochrome P-450
system o f birds). Male and female birds of different breeds and o f ages ranging from
embryos o f a few days of incubation to adults were used in the cytochrome P-450
studies present in the literature.

A wide range o f variability was also noted in the

induction regimes employed by the various studies.

Reported regimes for the

administration o f 3MC-type inducing agents included 50 mg/kg/day /3NF for 3 days
(Banton, 1990), 80 mg/kg /3NF single dose (Haug, et al., 1980), 80 m g/kg/day /3NF
for 2 days (Manning, et a l. , 1990), 150 mg/kg/day 0N F for 4 days (Carpenter, et a l.,
1985), 20 m g/kg/day 3MC for 2 days (Buynitzky, et a l., 1978; Buckpitt and Boyd,
1982; Riviere, 1984), 15 m g/kg/day 3MC for 3 days (Neal, et a l., 1986), 20-80
m g/kg/day 3MC for 2 days (Buckpitt et a l., 1982) and 0.01-1000 /xg/kg/day TCDD
for 3 days (Althaus, et a l., 1972). While no studies have been conducted in avian
species to characterize dose-response relationships for the induction of cytochrome P450 components by |3NF or other 3MC-type inducers, it has been demonstrated in the
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rat that different dose regimes produce different hepatic cytochrome P-450 system
responses. For example, maximal induction of EROD activity has been demonstrated
to require a dose of 20 mg/kg (3NF (Matthew and Houston, 1990) while maximal
induction o f AHH activity was observed to require a dose of 80 m g/kg /3NF (Boobis,
et a l. , 1977). Similarly, Sawyer et al. (1986) found that the ED50 values for induction
o f AHH and EROD activities in the chicken by TCDD were 302 and 778 ng/kg,
respectively. In addition, interspecies differences in the induction response have been
observed.

For example, Brunstrom and Lund (1988) found that the ED50 for the

induction of AHH by 3 ,3 ’4 ,4 ’-tetrachlorobiphenyl was 10 times higher in the turkey
than in the chicken.

It was also noted during the literature review that there was

considerable interexperimental variability in the time period allotted between treatment
and microsomal isolation. Time periods for the various studies ranged from 24 hours
to 10 days.

Observed interexperimental variability may also stem from the comparison o f hepatic
microsomal data obtained from birds treated with different inducers, i.e. /JNF, 3MC,
TCD D , 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl, etc. Cytochrome P-450 studies conducted on
the chicken suggest that the responses of the avian hepatic microsomal system to /3NF
and 3MC may not be identical. For example, Ehrich and Larsen (1983) observed a
greater increase in the microsomal cytochrome P-450 level with 3MC treatment
compared to /3NF treatment whereas the reverse was noted for ANH activity. The
same study also demonstrated that /3NF treatment induced a broader spectrum of
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hepatic cytochrome P-450 catalyzed activities than did 3MC. In the chicken embryo,
H amilton et al. (1983) and Althaus, et al. (1972) observed that the effective dose
range for the induction o f AHH activity by /JNF was similar to that for induction by
3MC but that the maximal increase in activity produced by /3NF was approximately
half of that produced by 3MC. In addition, Ehrich et al. (1984) observed a difference
in the time lapse required between treatment and the achievement o f maximal
induction o f malaoxon detoxification for /3NF (48 hours) and 3MC (96 hours).

6.2

Oxidative Activity o f the Hepatic Cytochrome P-450 Monooxygenase
System

6.2.1

Ethoxyresorufin 0-Deethylase Activity

6.2.1.1 Galliformes
This study found that constitutive EROD activity was comparable among the
Galliformes species studied. Basal microsomal EROD activity (based on specific and
m olar activities) measured in the chicken was consistent with the activities observed
by Banton et al. (1989) and Banton (1990) but was lower (approximately 10-fold) than
the activities (pmoles o f resorufin formed/inin/mg protein) reported by Sawyer et al.
(1986), Riviere (1984), and Lee et al. (1986).

The rate o f metabolism of

ethoxyresorufin (ER) (pmoles resorufin formed/inin/mg protein) observed in this study
for the Japanese quail was 4 to 8 times lower than the values reported by Carpenter
et al. (1985), Riviere et al. (1983) and Riviere et al. (1985). No previously published
values for the hepatic microsomal metabolism of ER could be found for the turkey.
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Following (3NF treatment, EROD activity seen for the turkey was significantly greater
than that demonstrated by the Japanese quail.

The greatest induction o f EROD

metabolism among the Galliformes species was observed in the chicken (39-fold based
on specific activity).

This increase in activity is consistent with the findings of

Sawyer et al. (1986) who reported a 37.5-fold increase in EROD activity in the
chicken following treatment with TCDD.

Banton (1990) demonstrated a slightly

lower increase (27.5-fold) in hepatic EROD activity associated with j8NF treatment
while Rifkind et al. (1984) reported a slightly higher increase (50-fold) following
treatment with 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl. In contrast, Quilley and Rifkind (1986)
demonstrated a dramatic increase in EROD activity in the chicken of 200-fold with
TCDD administration while Brunstrom (1986) only observed a 2.5-fold increase
following treatment with 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl. Based on turnover number,
a 21.4-fold increase in the rate o f ER deethylation was observed in the chicken which
is considerably higher than the 7.1-fold increase reported by Banton (1990).

In the present study, the Japanese quail demonstrated a 16-fold increase in ER
metabolism (based on specific activity) following treatment with /3NF.

Similarly,

Carpenter, et al. (1985) reported a 13-fold increase in the rate of ER metabolism in
this species following treatment with (8NF. Riviere (1984) observed an increase in
EROD activity of only 2.8-fold and 2.5-fold following administration o f (3NF and
3MC, respectively. In contrast to these observations, Neal et al. (1986) reported a
53 percent decease in EROD activity in the Japanese quail following treatment with
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3MC.

No reports on the effects o f 3MC-type inducers on hepatic microsomal ER

metabolism were found in the literature for the turkey.

6 .2 .1 .2 Anseriformes
In the present study, basal hepatic microsomal ER metabolism (based on specific and
m olar activities) was found to be similar among the Anseriformes species studied.
Upon review of the literature, no reported values for constitutive EROD activity were
located for any of the Anseriformes species examined in this study.

All of the Anseriformes species demonstrated induction of hepatic microsomal EROD
activity following treatment with /3NF. Comparable increases in deethylase activity
were observed for the goose, Pekin duck and Khaki Campbell duck while the increase
in activity observed for the Muscovy duck was approximately half of that seen for the
other species. No reported values for hepatic ER metabolism were discovered in the
literature for the goose, Pekin duck, Khaki Campbell duck, or Muscovy duck.
Brouwer (1991) reported a 57-fold increase in EROD activity (based on specific
activity) in the Eider duck following exposure to 3 ,3 ’,4 ,4 ’-tetrachlorobiphenyl. This
reported increase is considerably higher that the increases observed here with /3NF for
the Pekin (20-fold), Khaki Campbell (16-fold) and Muscovy (9-fold) ducks.
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6 .2 .1 .3 Comparison o f Galliformes and Anseriformes
The constitutive rate o f ER metabolism demonstrated by the Anseriformes order was
approximately twice that seen for the Galliformes order. In contrast, induced EROD
activities were similar for the two orders.

However, when the treatment groups of

each species were evaluated individually, some significant differences were observed
between the minor species of these orders (Pekin duck > quail). Both avian orders
demonstrated an induction of EROD activity following treatment with /3NF but the
level o f induction was approximately twice as great in the Galliformes as in the
Anseriformes.

6 .2 .1 .4 Comparison o f Rat and Avian Species
Results o f this study indicated that the constitutive EROD activities of the avian
species were comparable to that of the rat. However, following /3NF treatment, the
level o f hepatic microsomal EROD activity demonstrated by the rat was significantly
greater ( ~ 3-fold) than that seen for the avian species.

In addition, the degree of

induction observed in the rat was 4 times greater than that shown by the avian species
based on specific activity and 6 times greater based on turnover number. The increase
in EROD activity observed in the present study for the rat is consistent with those
seen by other researchers (Birgersson, et a l., 1985; Burke et a l., 1985; Burke and
M ayer, 1974; Burke and M ayer 1983; Guengerich, et a l., 1982; Guengerich, et al.,
1982a; Ryan, et a l., 1982).
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Ethoxyresorufin O-deethylase activity for each species and order is presented in
Figures 6-5.

6.2.2

Benzo[fl]pyrene Hydroxylase Activity and M etabolic Profile

6.2.2.1 Galliformes
Although similar patterns of B[a]P metabolism were observed for the Galliformes,
quantitative differences in metabolite formation were noted between the species. In
general, constitutive benzo[a]pyrene hydroxylase activity (based on total metabolite
production) was observed to be significantly greater in the turkey than the chicken and
quail. Specifically, significantly greater quantities o f phenols (3-OH B[a]P and 9-OH
B[a]P) were produced by the turkey hepatic microsomes than by microsomes isolated
from the chicken and quail. The present study demonstrated that basal AHH activity
in the turkey was 5.7-fold (based on specific activity) and 4.4-fold (based on turnover
number) greater than activity levels observed for the chicken.

Consistent with this

finding, Brunstrom and Lund (1988) found that constitutive AHH activity in the turkey
was 3.5 times greater than that of the chicken. It is also interesting to note that these
researchers

observed

that the turkey required

a greater dose o f 3 ,3 ’,4 ,4 ’-

tetrachlorobiphenyl to achieve maximal induction o f AHH activity than did the
chicken.

Induction of B[a]P metabolism was observed in the chicken and quail but not in the
turkey. The greatest increase in total metabolite production was seen in the chicken
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Figure 6-5 Rate o f hepatic microsomal ethoxyresorufin O-deethylase activity
in control and BNF-treated avian species and male rats.
See Figure 6-1 for species identifications.
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(5-fold based on specific activity, 2.5-fold based on turnover number) followed by the
quail (2.3-fold based on specific activity, 1.7-fold based on turnover number). Other
researchers have reported increases in B[<r/]P hydroxylase activity following treatment
o f the chicken with 3MC-type inducers (3MC, TCDD, B[a]P, j3NF, and 3 ,3 ’,4 ,4 ’tetrachlorobiphenyl). The reported increases ranged from 2 to 40-fold over control
values (Buynitzky, et a l., 1978; Brunstrom, et al., 1986; Dogra and Israels, 1987;
Haug, et al., 1980; Poland and Glover, 1977; Althaus, et al., 1972; Hamilton, et al.,
1983; Ehrich and Larsen, 1983; Rosanoff, et al., 1984; Strittmatter and Umberger,
1969; Powis, et a l., 1976; Sawyer, et a l., 1986; Darbey, et a l., 1984; Darbey, e ta l.,
1985; Darbey, et al., 1986; Rifkind, et al., 1984; Topp and van Bladeren, 1986).
Only one study was found in the literature in which AHH activity was examined in
the Japanese quail. Carpenter, et al. (1985) demonstrated a 13-fold increase in AHH
activity over the basal level following /3NF administration. This reported increase is
greater than the increase o f 2.3-fold observed in the present study. In contrast to the
chicken and quail, no change in total metabolite formation was seen for the turkey in
terms o f specific activity and based on turnover number, a significant decrease in
metabolite production was observed. No studies were located in the literature which
quantitated the increase in AHH activity in the turkey associated with the
administration of 3MC-type inducers.

Following (3NF treatment, the metabolic profiles generated by the Galliformes species
were qualitatively similar to each other and to the control profiles (with the addition
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o f 9,10-diol formation).

Specific quantitative changes observed in the metabolic

profiles o f the chicken and quail included significant increases in the production o f 3OH B[a]P, 9-OH B[a]P and B[a]P 7,8-diol. The only qualitative change noted was
the formation o f the 9,10-diol metabolite.

For the turkey, changes in product

distribution included a significant increase in B[a]P 7,8-diol, a significant decrease in
3-OH B[a]P, no change in

9-OH, and the formation o f 9,10-diol.

Shifts in the

metabolic profiles due to changes in the relative production of individual metabolites
were noted following /?NF treatment. In the chicken and quail, there was a relative
increase in the production of dihydrodiols and a relative decrease in the production of
phenols. For the turkey, the shift in product distribution included a relative increase
in the formation o f dihydrodiols and 9-OH B[a]P and a relative decrease in 3-OH
B[a]P production. Topp and van Bladeren (1986) examined the metabolism of B[a]P
by primary cultures of control and /3NF-treated chick embryo hepatocytes.

The

product distributions observed by these researchers were similar, but not identical, to
those o f this study.

For the control hepatocytes, metabolite formation, in order of

decreasing magnitude, included 3-OH > 9-OH > 9,10-diol > 7,8-diol. For control
chicken microsomes, this study found metabolite production o f the following
sequence: 3-OH > 9-OH > 7,8-diol with no 9,10-diol formation. Following /3NF
administration, a metabolic profile of 3-OH ~ 9-OH > 7,8-diol > 9,10-diol was
observed by Topp and van Bladeren while a product distribution o f 3-OH > 9-OH
> 7,8-diol > 9,10-diol was seen in the present study.
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The results of this study illustrate a significant quantitative difference in the in vitro
metabolism of B[a]P between the two major food-producing Galliformes species
(chicken and turkey).

In addition, the findings of this study suggest that the

characteristics o f B[a]P metabolism in control and /3NF-treated quail were qualitatively
and quantitatively more similar to those of the chicken than to those o f the turkey.
M etabolite formation by the control and /3NF-treated Galliformes species is shown in
Figures 6-6 through 6-8.

6 .2 .2 .2 Anseriformes
Overall, basal AHH activity, based on total B[a]P metabolite formation, was
comparable among the Anseriformes species studied. However, quantitative as well
as qualitative differences in individual metabolite formation were noted between the
Anseriformes birds. In general, the constitutive metabolic profiles were similar for
the duck species examined. The most notable difference observed among these birds
was the constitutive formation of the B[a]P 9,10-diol metabolite by the Khaki
Campbell duck (the Khaki Campbell was the only avian species which produced this
metabolite).

Another notable difference in the metabolism of B[a]P among the

Anseriformes was found in the goose. This species demonstrated a basal metabolic
profile that did not include the formation of either of the dihydrodiol metabolites
examined.

195

550
3-OH

pmoles metabolite produced/min/mg protein

500

-

9-OH
450

-

400

-

350

-

300

-

250

-

200

-

7,8-D iol
9,10-D iol

150

100

50

—

JL

-

u
u

H
o

H

o

O
V

U

Species and Treatment Group

Figure 6-6 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (CC) and BNF-treated (CT) chickens.
3-OH = 3-hydroxybenzo[a]pyrene; 9-OH = 9-hydroxybenzo[a]pyrene
7,8-D iol = benzo[a]pyrene 7,8-dihydrodiol; 9,10-D iol = benzo[a]pyrene 9,10-dihydrodiol
These abbreviations are the same for Figures 6-6 through 6-15.
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Species and Treatment Group
Figure 6-7 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (QC) and BNF-treated (QT) Japanese quail. See Figure 6-6
for metabolite identifications.
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Figure 6-8 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (TC) and BNF-treated (TT) turkeys. See Figure 6-6
for metabolite identifications.
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In response to /3NF administration, induction o f AHH activity (pmoles o f total
metabolites produced/min/mg protein) was seen in only one Anseriformes species, the
Pekin duck. A decrease in metabolite production was observed in the goose based on
turnover number; however, no change in production was seen based on specific
activity. For the Khaki Campbell and Muscovy ducks, no differences in activity were
noted respective to control values. Profiles of metabolite formation following (3NF
were similar among the duck species examined. The only differences noted were the
quantities of individual metabolites produced. In contrast, the metabolic profile o f the
/5NF-treated goose was dissimilar to those observed for the ducks and for the control
goose.

Relative changes observed in metabolite formation for the Anseriformes

included a relative increase in dihydrodiol and 9-OH B[a]P and a relative decrease in
3-OH B[a]P.

There were no studies found during the literature review which

examined AHH activity in the Anseriformes species represented in this study.
Metabolite formation by the control and jSNF-treated Anseriformes species is
illustrated in Figures 6-9 through 6-12.

6 .2 .2 .3 Comparison of Galliformes and Anseriformes
Basal B[a]P hydroxylase activities were comparable for the Anseriformes and
Galliformes birds. In addition, categorization and comparison of the data based on
order indicated that the constitutive profiles o f B[a]P metabolism for the Anseriformes
and Galliformes (with the exception of basal B[a]P 9,10-diol formation by the Khaki
Campbell duck and the lack of 7,8-diol formation by the goose) were similar.

pmoles metabolite produced/min/mg protein
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Species and Treatment Group
Figure 6-9 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (GC) and BNF-treated (GT) geese. See Figure 6-6
for metabolite identifications.
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Figure 6-10 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (PDC) and BNF-treated (PDT) Pekin ducks. See Figure 6-6
for metabolite identifications.
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Figure 6-11 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (KDC) and BNF-treated (KDT) Khaki Campbell Ducks.
See Figure 6-6 for metabolite identifications.

202

700

pmoles metabolite produced/min/mg protein

650

600

550

500

450

400

350

300

250

200
150

100
50

0

Species and Treatment Group
Figure 6-12 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (MDC) and BNF-treated (MDT) Muscovy ducks.
See Figure 6-6 for metabolite identifications.

203
Following treatment with j3NF, induction o f AHH activity (based on specific activity)
was demonstrated for both orders. However, based on turnover number, a decrease
in total metabolite production was noted for the Anseriformes.

Benzo[a]pyrene

hydroxylase activity following (3NF was significantly greater in the Galliformes than
in the Anseriformes.

The observed shift in metabolite formation was consistent

between the avian orders (increased production of dihydrodiols and 9-OH B[a]P and
decreased production o f 3-OH B[a]P). Metabolite formation by the Galliformes and
Anseriformes orders is illustrated in Figures 6-13 and 6-14, respectively.

Quantitative and qualitative differences in B[tf]P metabolism were noted between
m ajor and minor species of the Galliformes and Anseriformes orders and also between
the m inor species of these orders.

Interspecies comparisons between these orders

indicated that product distributions of B[a]P metabolism by control microsomes were
similar for the chicken, turkey, Japanese quail, Pekin duck, and Muscovy duck (3-OH
> 9-OH > 7,8-diol). Qualitative differences in metabolite formation were noted for
the goose (3-OH > 9-OH) and the Khaki Campbell duck (3-OH > 9-OH > 7,8-diol
= 9,10-diol). In 0N F-treated birds, the patterns of B[a]P metabolism were similar
for the Galliformes species (3-OH > 7,8-diol > 9-OH > 9,10 diol) and for the
Anseriformes duck species (3-OH > 7,8-diol = 9-OH > 9,10-diol). The metabolic
profiles produced by the control (3-OH > 9-OH) and treated (3-OH > 9-OH >
9,10-diol > 7,8-diol) goose were unlike any profiles produced by the other avian
species.

pmoles metabolite produced/min/mg protein
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Species and Treatment Group
Figure 6-13 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (GAC) and BNF-treated (GAT) Galliformes species.
See Figure 6-6 for metabolite identifications.
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Figure 6-14 Hepatic microsomal production o f benzo[a]pyrene metabolites
in control (ANC) and BNF-treated (ANT) Anseriformes species.
See Figure 6-6 for metabolite identifications.
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6 .2 .2 .4 Comparison o f Rat and Avian Species
Constitutive benzo[a]pyrene hydroxylase activities observed for the avian species were
comparable to that of the rat with the exception o f the turkey and Khaki Campbell
duck which exhibited greater activities (pmole of metabolites/min/nmole P-450). In
response to treatment with jSNF, a 1.7-fold increase in total metabolite formation
(based on specific activity) was observed in the rat. This observation falls within the
lower end of the range of values reported in the literature for increases (1.6 to 14.4fold over controls) in AHH activity associated with the administration of 3MC-type
inducers (Birgersson, et a l., 1985; Poland and Glover, 1977; Guengerich, et al.,
1982; Keller, et a l., 1987; Winston, et a l., 1991; Wroblewski, et a l., 1988).

In

comparison to the rat, greater increases in total metabolite formation (pmoles of
metabolites/m in/m g of protein) following /3NF were observed in the chicken (5-fold)
and Japanese quail (2.3-fold). When evaluated on the basis of turnover number, no
change in benzo[a]pyrene hydroxylase activity was seen in the rat.

In contrast,

increases in turnover number were observed for the hepatic microsomes of the chicken
(2.5-fold) and quail (1.7-fold) and decreases were seen for the turkey and goose
microsomes.

For this study, the production o f B[a]P metabolites by control and /3NF-treated rats
included, in order of decreasing magnitude, 3-OH > 9,10-diol > 9-OH > 7,8-diol.
Qualitative as well as quantitative differences were noted between the profiles of B[a]P
metabolism published in the literature. For the purpose of comparison, the following

207
review of the metabolic profiles presented in the literature focuses only on the four
metabolites that were quantitated in the present study. The profile demonstrated by
W roblewski, et al. (1988) for basal B[a]P metabolism in the rat was consistent with
the findings o f this study. However, these researchers observed a shift in metabolite
production (9,10-diol > 7,8-diol ~ 3-OH > 9-OH) following TCDD administration
which was not observed in the study presented here.

Similar, but not identical,

profiles (3-OH > 9,10-diol > 7,8-diol > 9-OH) were seen for control and treated
(3MC-type inducing agents) rats by Wong, et al. (1986), Winston, et a l., (1991), and
Sagami, et a l., (1987). In contrast, the metabolic profiles reported by Cavaliere and
coworkers (1988) were dissimilar to the findings of this study. For control rats, the
profile included 3-OH > 9-OH > 7,8-diol ~ 9,10-diol and following TCDD
treatment, 9,10-diol > 7,8-diol = 3-OH > 9-OH (note - this profile is similar to the
profile observed by W roblewski presented above).

M etabolite formation by the

control and /3NF-treated rat is illustrated in Figure 6-15. Total metabolite formation
for all the species studied is presented in Figure 6-16.

6.2.3 Overview
The results o f this study indicate, that for the representative Galliformes and
Anseriformes species, the avian hepatic cytochrome P-450 monooxygenase system has
the capacity to perform O-deethylation of ethoxyresorufin and hydroxylation of
benzo[a]pyrene and that changes in these cytochrome P-450-dependent activites are

Species and Treatment Group
Figure 6-15 Hepatic microsomal production ofbenzo[a]pyrene metabolites
in control (MRC) and BNF-treated (MRT) male rats. See Figure
6-6 for metabolite identifications.
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Figure 6-16 Hepatic microsomal production o f total benzo[a]pyrene
metabolites in control and BNF-treated avian species and male rats.
Total metabolite production refers to the production o f 3-OH,
9-OH, 7,8-diol, and 9,10-diol metabolites. See Figure 6-1 for
species identifications.
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observed following treatment with /3NF. The constitutive capacity for ethoxyresorufin
O-deethylation and the induction of this activity associated with /3NF administration
were similar for the avian species examined.

In contrast, interspecies differences

were noted in the capacity o f the avian hepatic microsomal system to hydroxylate
B[a]P and in the effect of /3NF treatment upon total metabolite formation. Differences
in metabolic profiles were also noted between the orders.

Constitutive EROD activity was comparable among all the species studied.

When

evaluated by order, however, greater basal activity was noted for the Anseriformes
compared to the Galliformes. As seen in the rat, it appears that ethoxyresorufin has
a high specificity for the /3NF-induced hepatic microsomal cytochrome P-450 of the
avian species. Following /3NF treatment, significant increases in hepatic microsomal
EROD activity were observed for each o f the avian species examined.

Increases

based on specific activity were more pronounced than when based on turnover
number. Induced levels observed for the birds were similar except for the Japanese
quail which exhibited a significantly lower activity than all the other species except
for the goose.

Among the avian species, the induction response, based on EROD

activity, was greatest for the chicken, intermediate for the Japanese quail, turkey,
goose, Pekin duck, and Khaki Campbell duck and lowest for the Muscovy duck.
Evaluated on the basis of order, the Galliformes demonstrated an induction of activity
following /3NF that was twice that seen for the Anseriformes order. In comparison
o f the major and minor species, the most notable finding was a significant difference
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in the EROD activity between the treatment groups of the chicken and Japanese quail
and the turkey and Japanese quail. Other significant differences noted were between
the minor avian species.

Constitutive benzo[a]pyrene hydroxylase activity (based on the in vitro production of
3-OH B[a]P, 9-OH B[rz]P, B[a]P 7,8-diol, and B[<a]P 9,10-diol) was comparable for
the Galliformes and Anseriformes orders. However, significant differences in basal
activity were observed between the major species and between the major and minor
species o f these orders.

Quantitative as well as qualitative differences in B[a]P metabolism were observed
following /3NF treatment. Induction o f B[a]P metabolism was observed in some avian
species while others experienced no change or an actual decrease in metabolite
formation.

These differences were noted between the major species as well as

between the major and minor species. In addition, greater AHH activity was observed
in the Galliformes compared to the Anseriformes following /3NF.

In general, the metabolic profiles produced by the Galliformes species were similar.
However, the characteristics o f B[a]P metabolism in the quail were more like those
o f the chicken than those of the turkey.

Qualitative and quantitative differences in

B[a]P metabolism were noted between the Anseriformes species.

In general, the

patterns of B[a]P metabolism demonstrated for the duck species were similar. The
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goose however, demonstrated profiles o f metabolite formation that were different from
those observed for the ducks.

In comparison o f the Galliformes and Anseriformes,

the patterns o f B[a]P metabolism observed for the chicken, Japanese quail, and turkey
were different from those observed for the Pekin duck, Khaki Campbell duck,
M uscovy duck, and goose.

However, 3-OH B[a]P was the primary metabolite

produced by all the species studied. Interspecies and interorder differences in product
distributions were for the 9-OH B[a]P, B[a]P 7,8-diol, and B[a]P 9,10-diol
metabolites.

In comparison to the rat, the avian species exhibited comparable B[a]P hydroxylase
activity except for the turkey and Khaki Campbell duck which exhibited greater
activity (based on turnover number). Patterns of metabolite formation in the rat were
qualitatively and quantitatively dissimilar to those of the avian species.

6.3

Summary and Conclusions

6.3.1

Approval o f M inor Use Avian Drugs

This study has served to provide information on the cytochrome P-450-dependent
metabolic capacity o f seven major and minor food-producing avian species for the
classical model substrate, benzo[a]pyrene, and to characterize the differences in
metabolism o f this compound between species.

Characterization of this important

biotransform ation pathway has provided data for the estimation o f the activity of the
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avian hepatic mixed function monooxygenase system and for the relative rate of
oxidation o f structurally similar compounds in represented avian species.

The components o f the hepatic microsomal system were demonstrated to be present
at comparable levels in the Galliformes and Anseriformes species examined. This is
an important finding since interspecies differences in metabolic capacity have been
shown to be correlated with differences in cytochrome P-450 content and cytochrome
P-450 reductase activity. The findings of this study indicate that there are interspecies
differences in the capacity o f the avian hepatic cytochrome P-450 system to
hydroxylate B[a]P.

Significant quantitative differences in constitutive activity were

observed between the major species and between major and minor species. The most
notable difference observed was the high level of constitutive B[a]P hydroxylase
activity demonstrated by the turkey compared to the other avian species. This finding
suggests that drugs subject to biotransformation pathways involving polynuclear
hydroxylation may be metabolized at a comparatively faster rate in turkeys than in
other avian species. Similar metabolic profiles were demonstrated by the m ajor and
minor species and, in general, by the minor duck species. O f the birds studied, the
characteristics of B[a]P metabolism were most different for the goose. This finding
suggests, that for drugs similar in structure to the model compound B[a]P, it may not
be appropriate to base predictions of drug fate in the goose on biotransformation data
obtained in the chicken and turkey (major species).

Qualitative and quantitative

differences in the microsomal hydroxylation of B[a]P were observed between the
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m ajor species and between major and minor species following treatment with /3NF.
Differences were also noted between the orders.

This variation in response is

noteworthy from the standpoint that food-producing avian species are routinely
exposed to a variety o f chemicals that may affect cytochrome P-450-dependent
activities and thus the biotransformation of administered therapeutic agents.

The results o f this study further demonstrate that there are marked differences in the
characteristics and metabolic capacity of the avian and rat hepatic cytochrome P-450
systems. Consequently, it should be re-emphasized that predictions concerning drug
metabolism in avian species should not be based on biotransformation data generated
in the rat or other mammalian species.

This work has provided an important contribution to the comparative study of
xenobiotic metabolism in domestic avian species by characterizing the components of
the hepatic cytochrome P-450 system in seven major and minor species and by
examining the metabolic oxidative capacity o f these species though the development
o f metabolite profiles for a model substrate. It is anticipated that the results of this
study will serve to support the interpretation o f data submitted to the FD A for the
purpose o f obtaining approval for drug use in economically minor food-producing
species such as the Japanese quail, Pekin duck, Khaki Campbell duck, Muscovy duck
and goose.
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6.3.2

Domestic Avian Species as Sentinels in Ecotoxicological Studies

The results of the present study clearly indicate that the avian hepatic microsomal
cytochrome P-450 mixed function monooxygenase system of selected domestic species
is inducible by /3-naphthoflavone, a classical inducer belonging to an environmentally
relevant class of compounds, the PAHs.

The most consistent response observed

following exposure to this compound was for the O-deethylation o f ethoxyresorufin.
Significant increases in this cytochrome P-450-dependent activity were observed for
all seven species studied. This finding indicates that the avian hepatic cytochrome P450 system of domestic avian species may be inducible by PAHs present in the
environment and that the induction of EROD activity in these species may be useful
as a biom arker of exposure to this class of compounds.

In contrast, the observed effects of |3NF administration on the other microsomal
parameters examined varied between the species. However, two species, the chicken
and Pekin duck, demonstrated increases in microsomal protein, cytochrome P-450
content, and B[a]P hydroxylase activity following 0N F treatment.

Therefore, it is

possible that the induction of these parameters, particularly AHH activity, may be
used as biomarkers of environmental chemical exposure in biomonitoring programs
involving these species. The most dramatic response to jSNF treatment was observed
for the hepatic microsomes of the chicken. Not only were increases observed for all
the parameters examined (excluding cytochrome c reductase), but the chicken
demonstrated the greatest increases in EROD and AHH activity of all the avian
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species studied. This finding suggests, that for the species examined, the chicken may
be the best species to use as a sentinel for the assessment of exposure to PAHs present
in the environment.

In situ assessments, utilizing test organisms, may be used to evaluate the potential
impact of environmental contamination on human health or the health of indigenous
populations (Sandhu and Lower, 1989). In light o f the findings o f this study, it is
reasonable to propose that domestic avian species have potential application as
sentinels o f environmental chemical exposure by the utilization o f these species in in
situ assessments. Domestic species are readily available, inexpensive and relatively
easy to maintain thus making them suitable test organisms for most sites of
environmental concern.

In addition, based on the significant increases in EROD activity seen for the turkey,
quail, Khaki Campbell duck, Muscovy duck and goose following 0N F administration,
it can be concluded that indigenous populations of turkeys, ducks, geese and quail
may have potential use as sentinel species for the assessment o f environmental
contamination.

Futhermore, based on the demonstrated changes in B[a]P metabolite distributions
associated with |3NF exposure in these species, it may be possible, with further
research, to utilize induction o f the MFO system as a nondestructive biom arker of
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chemical exposure.

This concept is based on the administration a nontoxic model

compound, via the use o f bait, to indigenous avian populations and the subsequent
analysis o f excreted metabolites to determine if metabolic pathways have been altered
due to induction o f the hepatic cytochrome P-450 system.
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APPENDIX: SUPPORTING FIGURES FOR METHODS
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Figure A -l Standard curve for the analysis o f protein concentration
using bovine serum albumin (BSA).
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Figure A-2 Effect o f hepatic microsomal protein concentration on resorufin
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Figure A-3 Effect o f hepatic microsomal protein concentration on resorufin
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Figure A-4 Effect o f hepatic microsomal protein concentration on resorufin
production for the control male rat.
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O-deethylase activity.

252

Total B[a]P Metabolite Production (Peak Area)

1200

1000

800

600

400

200

0
0

1

2

3

Microsomal Protein (mg)

Figure A-7 Effect o f hepatic microsomal protein concentration on
benzo[a]pyrene metabolite production for the control chicken.
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Figure A-9 Effect o f hepatic microsomal protein concentration on
benzo[a]pyrene metabolite production for the control rat.
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Figure A -10 Effect o f hepatic microsomal protein concentration on
benzo[a]pyrene metabolite production for the BNF-treated rat.
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Figure A -l 1 Effect o f incubation time on benzo[a]pyrene metabolite
production for the BNF-treated chicken.
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Figure A-12 Effect o f incubation time on benzo[a]pyrene metabolite
production for tne BNF-treated rat.

STANDARD CURVES FOR QUANTITATION OF
BENZO[a]PYRENE AND METABOLITES
Quantitation of the metabolites was achieved through
the use of external standard calculations. Standards
were prepared from stock solutions of B[a]P and each
o f the metabolites. Peak areas were used to establish
standard curves for each analyte by plotting the
integration areas of the generated peaks.
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METHOD BLANK CHROMATOGRAMS
A method blank was prepared for each analyte
to determine if there were any components in
the reaction mixture which might interfere
with the identification and quantitation of
the compounds interest. The method blank
consisted o f the reaction mixture without the
microsomes and was spiked with B[a]P or one
of the metabolites.
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M IC R O S O M A L BLANK C H R O M A TO G R A M S
A microsomal blank was prepared for each species to
determine if there were any microsomal components
which may interfere with the identification and
quantitation of the compounds o f interest. The microsomal
blank consisted of the reaction mixture without B[a]P.
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Figure A-24 Microsomal blank chromatogram for the Japanese quail.

273

<n

mAU

(O

MICROSOMRL

BLRNK

/

TURKEY

U^T)
^Jn

in

‘A d

-V ^ c o__ m

m t t%>
w N 03 <%,

in oo tvi

TYT)

ij s x i

^

0H
2

4

G
T I me

(min,

8
)

Figure A-25 Microsomal blank chromatogram for the turkey.

LDm

-(3

p 1.258

CX3 .

274

ia
(i

1

(

1

j

BLRNK

/

GOOSE

cuo;jr

i

.

CD<#TU . 00
■ •’ v • ■ • ■
fa f5 f r

rr irtn kDd cc

;l 1 . 3 8 6

mAU

MICROSOMRL

nj
■sr
GO

uj iv

0 -1

2

4

6

T i me

8

10

( mi n . )

Figure A-26 Microsomal blank chromatogram for the goose.

275

MICROSOMRL

BLANK

/

PEKIN

.CM

10
Ti

me

( m i n .

'>

Figure A-27 Microsomal blank chromatogram for the Pekin duck.

276

10
i ■)

mAU

2

-

MICROSOMRL

BLRNK

✓

KHRKI

cn
CD

cn

d)

2

4

G
T i me

8

10

( in i n . )

Figure A-28 Microsomal blank chromatogram for the Khaki Campbell duck.
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CHROMATOGRAMS OF BENZO[a]PYRENE METABOLITE FORMATION
Representative chromatograms of hepatic microsomal
B[n]P metabolite formation by control and /3NF-treated
avian species and the rat.
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Figure A -3 1 Chromatograms of benzo[a]pyrene metabolite formation by chicken hepatic microsomes.
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Figure A-33 Chromatograms of benzo[a]pyrene metabolite formation by turkey hepatic microsomes.
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Figure A-35 Chromatograms of benzo[a]pyrene metabolite formation by Khaki Campbell duck hepatic microsomes.
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Figure A-36 Chromatograms of benzo[a]pyrene metabolite formation by Pekin duck hepatic microsomes.
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Figure A-37 Chromatograms of benzo[a]pyrene metabolite formation by Muscovy duck hepatic microsomes.
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Figure A-38 Chromatograms of benzo[a]pyrene etabolite formation by rat hepatic microsomes.
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